Sample Name	Age	Age (Detailed)	Breast Adenocarcinoma Type	Cancer and Normal Type	Cancer Sample Site	Cancer Type	Cellularity	Count of Lymph Nodes Removed	Count of Positive Lymph Nodes	Ductal Breast Carcinoma Type	ERBB2 Status	ERBB2 Status (Ductal Breast Carcinoma in Situ)	ERBB2 Status (Invasive Breast Carcinoma)	ERBB2 Status (Invasive Ductal and Invasive Lobular Breast Carcinoma)	ERBB2 Status (Invasive Ductal Breast Carcinoma)	ERBB2 Status (Invasive Lobular Breast Carcinoma)	ERBB2 Status (Medullary Breast Carcinoma)	ERBB2 Status (Mucinous Breast Carcinoma)	ERBB2 Status by Gene Expression	ERBB2 Status by IHC	Estrogen Receptor Status	Estrogen Receptor Status (Invasive Breast Carcinoma)	Estrogen Receptor Status (Invasive Ductal and Invasive Lobular Breast Carcinoma)	Estrogen Receptor Status (Invasive Ductal Breast Carcinoma)	Estrogen Receptor Status (Invasive Lobular Breast Carcinoma)	Estrogen Receptor Status (Medullary Breast Carcinoma)	Estrogen Receptor Status (Tubular Breast Carcinoma)	Estrogen Receptor Status by Gene Expression	GENIUS Classification	Grade	Grade (Breast Carcinoma)	Grade (Invasive Breast Carcinoma)	Grade (Invasive Ductal and Invasive Lobular Breast Carcinoma)	Grade (Invasive Ductal Breast Carcinoma)	Grade (Invasive Lobular Breast Carcinoma)	Grade (Mucinous Breast Carcinoma)	Grade (Tubular Breast Carcinoma)	Group	Integrative Cluster	Lymphatic Invasion	Menopause Status (Inferred)	Normal Tissue Type	Nottingham Prognostic Index (NPI)	Overall Survival Followup Time (Days)	Survival Status	_OS_INDOLD	Overall Survival Status (Detailed)	Unnamed: 47	Overal Survival	Dead of Disease	_OS	_OS_IND	Unnamed: 52	Unnamed: 53	Breat EMT 5 cluster	Unnamed: 55	Cluster 1	Cluster 2	Cluster 3	Cluster 4	Cluster 5	Unnamed: 61	Unnamed: 62	PAM50 Class	Patient ID	Progesterone Receptor Status	Progesterone Receptor Status (Breast Carcinoma)	Progesterone Receptor Status (Invasive Breast Carcinoma)	Progesterone Receptor Status (Invasive Ductal and Invasive Lobular Breast Carcinoma)	Progesterone Receptor Status (Invasive Ductal Breast Carcinoma)	Progesterone Receptor Status (Invasive Lobular Breast Carcinoma)	Progesterone Receptor Status (Medullary Breast Carcinoma)	Progesterone Receptor Status (Mucinous Breast Carcinoma)	Progesterone Receptor Status (Tubular Breast Carcinoma)	Race/Ethnicity (Inferred)	Sample Type	Set	Source Site	Stage	Stage (Breast Carcinoma)	Stage (Invasive Breast Carcinoma)	Stage (Invasive Ductal and Invasive Lobular Breast Carcinoma)	Stage (Invasive Ductal Breast Carcinoma)	Stage (Invasive Lobular Breast Carcinoma)	Stage (Medullary Breast Carcinoma)	Stage (Mucinous Breast Carcinoma)	Stage (Tubular Breast Carcinoma)	Survival Status at 1 Year	Survival Status at 1 Year (Invasive Ductal Breast Carcinoma)	Survival Status at 3 Years	Survival Status at 3 Years (Invasive Ductal and Invasive Lobular Breast Carcinoma)	Survival Status at 3 Years (Invasive Ductal Breast Carcinoma)	Survival Status at 3 Years (Invasive Lobular Breast Carcinoma)	Survival Status at 3 Years (Mucinous Breast Carcinoma)	Survival Status at 5 Years	Survival Status at 5 Years (Breast Carcinoma)	Survival Status at 5 Years (Invasive Breast Carcinoma)	Survival Status at 5 Years (Invasive Ductal and Invasive Lobular Breast Carcinoma)	Survival Status at 5 Years (Invasive Ductal Breast Carcinoma)	Survival Status at 5 Years (Invasive Lobular Breast Carcinoma)	Survival Status at 5 Years (Medullary Breast Carcinoma)	Survival Status at 5 Years (Mucinous Breast Carcinoma)	Survival Status at 5 Years (Tubular Breast Carcinoma)	TP53 Mutation Status	TP53 Mutation Status (Detailed)	TP53 Mutation Status (Invasive Ductal and Invasive Lobular Breast Carcinoma)	TP53 Mutation Status (Invasive Ductal Breast Carcinoma)	TP53 Mutation Status (Invasive Lobular Breast Carcinoma)	TP53 Mutation Status (Medullary Breast Carcinoma)	TP53 Mutation Status (Tubular Breast Carcinoma)	Treatment	Triple Negative Status	Triple Negative Status (Invasive Breast Carcinoma)	Triple Negative Status (Invasive Ductal Breast Carcinoma)	Triple Negative Status (Invasive Lobular Breast Carcinoma)	Triple Negative Status (Medullary Breast Carcinoma)	Tumor Size (mm)
MB.0000	70 - 79 Years	75.65 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		16	10	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	4		Postmenopausal		6.04	2999	Alive	0	Alive		8.216438356	0	8.216438356	0	*****	0	2		0	1	0	0	0			Normal	MB-0000	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0002	40 - 49 Years	43.19 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	25	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	4		Premenopausal		4.02	1484	Alive	0	Alive		4.065753425	0	4.065753425	0		0	1		1	0	0	0	0			Luminal A	MB-0002	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.0008	70 - 79 Years	76.97 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	8	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		6.08	1241	Dead	1	Dead of Disease		3.4	1	3.4	1		0	1		1	0	0	0	0			Luminal B	MB-0008	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.0010	70 - 79 Years	78.77 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	7		Postmenopausal		4.06	234	Dead	1	Dead of Disease		0.64109589	1	0.64109589	1		0	1		1	0	0	0	0			Luminal B	MB-0010	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage IV				Stage IV					Dead of Disease at 1 Year	Dead at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			31
MB.0020	70 - 79 Years	70 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	11	7		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	0	Estrogen Receptor Negative				Estrogen Receptor Negative			Estrogen Receptor Negative		Grade 3					Grade 3			3	4		Postmenopausal		6.13	672	Dead	1	Dead of Disease		1.84109589	1	1.84109589	1		1	4		0	0	0	1	0			Normal	MB-0020	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	1	Stage III					Stage III				Alive at 1 Year		Dead of Disease at 3 Years			Dead at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative			ERBB2/ER/PR Negative		65
MB.0036	80 - 89 Years	85.49 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	23	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		3.04	2314	Alive	0	Alive		6.339726027	0	6.339726027	0		0	1		1	0	0	0	0			Luminal A	MB-0036	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage IV				Stage IV					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0050	40 - 49 Years	44.64 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	17	3		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	8		Premenopausal		4.07	1784	Alive	0	Alive		4.887671233	0	4.887671233	0		0	2		0	1	0	0	0			Normal	MB-0050	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years											TP53 Mutation	TP53 Missense Mutation			TP53 Mutation			Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		33
MB.0059	70 - 79 Years	75.58 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	26	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	8		Postmenopausal		4.03	1718	Alive	0	Alive		4.706849315	0	4.706849315	0		0	1		1	0	0	0	0			Luminal A	MB-0059	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.0060	40 - 49 Years	45.43 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	10		Premenopausal		4.05	1846	Alive	0	Alive		5.057534247	0	5.057534247	0		0	3		0	0	1	0	0			Luminal B	MB-0060	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.0066	60 - 69 Years	61.49 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	7		Postmenopausal		4.03	1543	Alive	0	Alive		4.22739726	0	4.22739726	0		0	3		0	0	1	0	0			Luminal B	MB-0066	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.0101	40 - 49 Years	46.89 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	14	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	8		Premenopausal		3.07	2713	Alive	0	Alive		7.432876712	0	7.432876712	0		0	2		0	1	0	0	0			Normal	MB-0101	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		34
MB.0102	50 - 59 Years	51.38 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	17	16		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2					Grade 2			4	3		Postmenopausal		5.08	1333	Alive	0	Alive		3.652054795	0	3.652054795	0		0	1		1	0	0	0	0			Luminal B	MB-0102	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years											TP53 Wild Type				TP53 Wild Type			Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		40
MB.0106	40 - 49 Years	49.87 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	24	5	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				4	8		Premenopausal		4.14	1481	Alive	0	Alive		4.057534247	0	4.057534247	0		0	2		0	1	0	0	0			Luminal A	MB-0106	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			70
MB.0109	80 - 89 Years	82.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	22	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	9		Postmenopausal		4.09	1433	Alive	0	Alive		3.926027397	0	3.926027397	0		0	3		0	0	1	0	0			Basal	MB-0109	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			No Treatment	Other Biomarker Status		Other Biomarker Status			45
MB.0111	50 - 59 Years	54.23 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 1				Grade 1				4	3		Postmenopausal		2.05	3148	Alive	0	Alive		8.624657534	0	8.624657534	0		0	2		0	1	0	0	0			Luminal A	MB-0111	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			27
MB.0112	80 - 89 Years	83.89 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	23	14		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3					Grade 3			4	3		Postmenopausal		6.3	1175	Dead	1	Dead of Disease		3.219178082	1	3.219178082	1		0	1		1	0	0	0	0			Luminal A	MB-0112	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	1	Stage III					Stage III				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		150
MB.0113	30 - 39 Years	36.96 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	16	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 3				Grade 3				4	5		Premenopausal		5.03	1384	Alive	0	Alive		3.791780822	0	3.791780822	0		0	2		0	1	0	0	0			Her2	MB-0113	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.0114	40 - 49 Years	48.59 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	8		Premenopausal		3.06	402	Alive	0	Alive		1.101369863	0	1.101369863	0		1	4		0	0	0	1	0			Luminal A	MB-0114	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year																						Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.0115	30 - 39 Years	39.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	18	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Premenopausal		4.05	2002	Dead	1	Dead of Disease		5.484931507	1	5.484931507	1		0	5		0	0	0	0	1			Basal	MB-0115	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			25
MB.0116	40 - 49 Years	42.55 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	18	1		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 2					Grade 2			4	6		Premenopausal		4.12	2474	Alive	0	Alive		6.778082192	0	6.778082192	0		0	2		0	1	0	0	0			Normal	MB-0116	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	1	Stage III					Stage III				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		60
MB.0117	60 - 69 Years	60.07 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	14	1		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2			Grade 2					4	1		Postmenopausal		4.05	247	Alive	0	Alive		0.676712329	0	0.676712329	0		0	2		0	1	0	0	0			Luminal A	MB-0117	Progesterone Receptor Negative			Progesterone Receptor Negative						European	Tissue Specimen	Discovery	1	Stage II			Stage II																						TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					23
MB.0119	80 - 89 Years	82.73 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	7		Postmenopausal		4.05	364	Alive	0	Alive		0.997260274	0	0.997260274	0		0	3		0	0	1	0	0			Luminal B	MB-0119	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II																					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.0120	70 - 79 Years	72.1 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		5.05	872	Dead	1	Dead of Other Causes		2.389041096	0	2.389041096	0		0	1		1	0	0	0	0			Luminal B	MB-0120	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			26
MB.0121	70 - 79 Years	78.73 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	6	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	8		Postmenopausal		5.06	1694	Alive	0	Alive		4.64109589	0	4.64109589	0		0	1		1	0	0	0	0			Luminal A	MB-0121	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.0122	50 - 59 Years	58.95 Years		Breast Carcinoma	Primary Site	Breast Carcinoma	Moderate	3	1		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1	Grade 1							4	8		Postmenopausal		3.04	2569	Alive	0	Alive		7.038356164	0	7.038356164	0		0	2		0	1	0	0	0			Luminal A	MB-0122	Progesterone Receptor Positive	Progesterone Receptor Positive								European	Tissue Specimen	Discovery	1	Stage II	Stage II								Alive at 1 Year		Alive at 3 Years					Alive at 5 Years	Alive at 5 Years								TP53 Wild Type							Hormone Therapy, Radiotherapy	Other Biomarker Status					20
MB.0123	70 - 79 Years	76.89 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	19	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Postmenopausal		4.05	2527	Alive	0	Alive		6.923287671	0	6.923287671	0		0	1		1	0	0	0	0			Luminal B	MB-0123	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.0124	40 - 49 Years	43.46 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Low	10	2		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative	1	Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive		Grade 2			Grade 2					4	8		Premenopausal		4.1	2368	Alive	0	Alive		6.487671233	0	6.487671233	0		0	1		1	0	0	0	0			Luminal A	MB-0124	Progesterone Receptor Positive			Progesterone Receptor Positive							Tissue Specimen	Validation	1	Stage III			Stage III						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years													Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					50
MB.0125	70 - 79 Years	73.98 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	0	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 1				Grade 1				4	8		Postmenopausal		2.02	49	Alive	0	Alive		0.134246575	0	0.134246575	0		0	3		0	0	1	0	0			Luminal B	MB-0125	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II																												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			9
MB.0126	60 - 69 Years	61.95 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	8		Postmenopausal		3.07	1479	Alive	0	Alive		4.052054795	0	4.052054795	0		0	1		1	0	0	0	0			Luminal A	MB-0126	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.0127	50 - 59 Years	52.11 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Undefined	12	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 2				Grade 2				4	3		Postmenopausal		4.03	1918	Alive	0	Alive		5.254794521	0	5.254794521	0		0	2		0	1	0	0	0			Normal	MB-0127	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			13
MB.0128	50 - 59 Years	57.4 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	3		Postmenopausal		3.03	1882	Alive	0	Alive		5.156164384	0	5.156164384	0		0	2		0	1	0	0	0			Normal	MB-0128	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			14
MB.0129	60 - 69 Years	63.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	18	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	5		Postmenopausal		6.05	1157	Dead	1	Dead of Other Causes		3.169863014	0	3.169863014	0		1	4		0	0	0	1	0			Her2	MB-0129	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			24
MB.0130	50 - 59 Years	56.75 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 1				Grade 1				4	5		Postmenopausal		2.03	1870	Alive	0	Alive		5.123287671	0	5.123287671	0		0	2		0	1	0	0	0			Luminal A	MB-0130	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			17
MB.0131	60 - 69 Years	69.16 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	8		Postmenopausal		4.08	1999	Dead	1	Dead of Disease		5.476712329	1	5.476712329	1		1	4		0	0	0	1	0			Luminal A	MB-0131	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			39
MB.0133	50 - 59 Years	58.89 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	Moderate	16	1		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1							Grade 1	4	8		Postmenopausal		3.16	2612	Alive	0	Alive		7.156164384	0	7.156164384	0		0	2		0	1	0	0	0			Luminal A	MB-0133	Progesterone Receptor Negative								Progesterone Receptor Negative	European	Tissue Specimen	Discovery	1	Stage II								Stage II	Alive at 1 Year		Alive at 3 Years					Alive at 5 Years								Alive at 5 Years	TP53 Wild Type						TP53 Wild Type	Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					80
MB.0134	70 - 79 Years	73.11 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	16	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	8		Postmenopausal		5.04	388	Dead	1	Dead of Disease		1.063013699	1	1.063013699	1		0	1		1	0	0	0	0			Luminal B	MB-0134	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0135	70 - 79 Years	74.09 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	2		Postmenopausal		5.07	2398	Alive	0	Alive		6.569863014	0	6.569863014	0		0	1		1	0	0	0	0			Luminal B	MB-0135	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.0136	70 - 79 Years	72.3 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		3.03	2271	Alive	0	Alive		6.221917808	0	6.221917808	0		0	2		0	1	0	0	0			Luminal A	MB-0136	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			13
MB.0138	50 - 59 Years	51.33 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	12	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	3		Premenopausal		3.04	1405	Alive	0	Alive		3.849315068	0	3.849315068	0		0	2		0	1	0	0	0			Luminal A	MB-0138	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years											TP53 Wild Type				TP53 Wild Type			Hormone Therapy	Other Biomarker Status			Other Biomarker Status		18
MB.0139	40 - 49 Years	47.62 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	3	1		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	3		Premenopausal		4.06	2596	Alive	0	Alive		7.112328767	0	7.112328767	0		0	2		0	1	0	0	0			Luminal A	MB-0139	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		30
MB.0140	70 - 79 Years	74.07 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	18	1		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2			Grade 2					4	8		Postmenopausal		4.05	169	Alive	0	Alive		0.463013699	0	0.463013699	0		0	1		1	0	0	0	0			Luminal B	MB-0140	Progesterone Receptor Negative			Progesterone Receptor Negative						European	Tissue Specimen	Discovery	1	Stage II			Stage II																						TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					27
MB.0142	50 - 59 Years	57.99 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Moderate	10	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2						Grade 2		4	1		Postmenopausal		3.03	372	Alive	0	Alive		1.019178082	0	1.019178082	0		0	3		0	0	1	0	0			Luminal A	MB-0142	Progesterone Receptor Positive							Progesterone Receptor Positive		European	Tissue Specimen	Discovery	1	Stage I							Stage I		Alive at 1 Year																TP53 Mutation	TP53 Frameshift Mutation						No Treatment	Other Biomarker Status					16
MB.0143	80 - 89 Years	85.39 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	29	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		5.04	1630	Dead	1	Dead of Other Causes		4.465753425	0	4.465753425	0		1	4		0	0	0	1	0			Luminal A	MB-0143	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0144	70 - 79 Years	79.73 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	6	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	8		Postmenopausal		6.05	4562	Dead	1	Dead of Disease		12.49863014	1	10	0		0	1		1	0	0	0	0			Luminal B	MB-0144	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			26
MB.0145	60 - 69 Years	62.4 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	17	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	3		Postmenopausal		3.04	1841	Alive	0	Alive		5.043835616	0	5.043835616	0		0	2		0	1	0	0	0			Luminal A	MB-0145	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		20
MB.0146	80 - 89 Years	81 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Postmenopausal		5.04	2580	Alive	0	Alive		7.068493151	0	7.068493151	0		0	3		0	0	1	0	0			Luminal B	MB-0146	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0147	70 - 79 Years	79.28 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	12	9		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 2					Grade 2			4	2		Postmenopausal		5.08	1553	Dead	1	Dead of Disease		4.254794521	1	4.254794521	1		0	3		0	0	1	0	0			Luminal A	MB-0147	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		38
MB.0148	50 - 59 Years	53.16 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				4	5		Postmenopausal		4.04	53	Alive	0	Alive		0.145205479	0	0.145205479	0		1	4		0	0	0	1	0			Her2	MB-0148	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	1	Stage I				Stage I																					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				No Treatment	Other Biomarker Status		Other Biomarker Status			19
MB.0149	70 - 79 Years	77.13 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				4	10		Postmenopausal		4.08	1551	Dead	1	Dead of Other Causes		4.249315068	0	4.249315068	0		0	5		0	0	0	0	1			Basal	MB-0149	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years												Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			39
MB.0150	70 - 79 Years	70.22 Years		Breast Carcinoma	Primary Site	Breast Carcinoma	High	10	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER-/HER2-	Grade 2	Grade 2							4	4		Postmenopausal		3.04	2392	Alive	0	Alive		6.553424658	0	6.553424658	0		0	5		0	0	0	0	1			Basal	MB-0150	Progesterone Receptor Negative	Progesterone Receptor Negative								European	Tissue Specimen	Discovery	1	Stage II	Stage II								Alive at 1 Year		Alive at 3 Years					Alive at 5 Years	Alive at 5 Years								TP53 Wild Type							Hormone Therapy	Other Biomarker Status					20
MB.0151	60 - 69 Years	67.7 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	6	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	2	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	2		Postmenopausal		6.1	1477	Dead	1	Dead of Disease		4.046575342	1	4.046575342	1		0	3		0	0	1	0	0			Luminal B	MB-0151	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.0152	60 - 69 Years	63.77 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				4	4	Severe	Postmenopausal		4.02	1860	Alive	0	Alive		5.095890411	0	5.095890411	0		1	4		0	0	0	1	0			Her2	MB-0152	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			12
MB.0153	60 - 69 Years	67.12 Years		Breast Phyllodes Tumor	Primary Site	Breast Phyllodes Tumor	High	0	0		ERBB2 Negative								ERBB2 Negative									Estrogen Receptor Negative										4	4		Postmenopausal		1.06	2567	Alive	0	Alive		7.032876712	0	7.032876712	0		0	2		0	1	0	0	0			Basal	MB-0153	Progesterone Receptor Negative										Tissue Specimen	Validation	1										Alive at 1 Year		Alive at 3 Years					Alive at 5 Years																No Treatment						28
MB.0154	60 - 69 Years	62.46 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	4		Postmenopausal		3.02	1884	Alive	0	Alive		5.161643836	0	5.161643836	0		0	2		0	1	0	0	0			Luminal A	MB-0154	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			12
MB.0155	60 - 69 Years	62.72 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	Moderate	11	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1							Grade 1	4	4	Mild	Postmenopausal		2.02	1794	Alive	0	Alive		4.915068493	0	4.915068493	0		0	2		0	1	0	0	0			Normal	MB-0155	Progesterone Receptor Negative								Progesterone Receptor Negative	European	Tissue Specimen	Discovery	1	Stage I								Stage I	Alive at 1 Year		Alive at 3 Years														TP53 Wild Type						TP53 Wild Type	Hormone Therapy, Radiotherapy	Other Biomarker Status					9
MB.0157	70 - 79 Years	71.5 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	4	Mild	Postmenopausal		4.06	453	Alive	0	Alive		1.24109589	0	1.24109589	0		0	2		0	1	0	0	0			Basal	MB-0157	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			30
MB.0158	50 - 59 Years	53.78 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	0	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Postmenopausal		4.04	1729	Alive	0	Alive		4.736986301	0	4.736986301	0		1	4		0	0	0	1	0			Basal	MB-0158	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			22
MB.0159	50 - 59 Years	51.04 Years	Ductal Breast Carcinoma	Ductal Breast Carcinoma in Situ	Primary Site	Ductal Breast Carcinoma in Situ	Low	0	0	Ductal Breast Carcinoma in Situ	ERBB2 Positive	ERBB2 Positive							ERBB2 Positive									Estrogen Receptor Negative										Other	5		Postmenopausal		2.05	2259	Alive	0	Alive		6.189041096	0	6.189041096	0		1	4		0	0	0	1	0			Basal	MB-0159	Progesterone Receptor Negative										Tissue Specimen	Validation	1	Stage 0									Alive at 1 Year		Alive at 3 Years					Alive at 5 Years																No Treatment	Other Biomarker Status					23
MB.0162	50 - 59 Years	57.56 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	7		Postmenopausal		4.03	1673	Alive	0	Alive		4.583561644	0	4.583561644	0		0	2		0	1	0	0	0			Luminal A	MB-0162	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			14
MB.0164	30 - 39 Years	37.87 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Premenopausal		4.03	325	Alive	0	Alive		0.890410959	0	0.890410959	0		0	5		0	0	0	0	1			Basal	MB-0164	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II																					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			16
MB.0166	40 - 49 Years	44.98 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	4		Premenopausal		5.05	2282	Alive	0	Alive		6.252054795	0	6.252054795	0		0	2		0	1	0	0	0			Luminal A	MB-0166	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			24
MB.0167	70 - 79 Years	76.4 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		5.08	1293	Dead	1	Dead of Disease		3.542465753	1	3.542465753	1		0	3		0	0	1	0	0			Luminal B	MB-0167	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			38
MB.0168	60 - 69 Years	60.26 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	1	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	4		Postmenopausal		4.03	2283	Alive	0	Alive		6.254794521	0	6.254794521	0		0	2		0	1	0	0	0			Normal	MB-0168	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.0169	70 - 79 Years	79.28 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	14	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 2					Grade 2			4	4		Postmenopausal		3.08	2215	Alive	0	Alive		6.068493151	0	6.068493151	0		0	2		0	1	0	0	0			Normal	MB-0169	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		39
MB.0170	80 - 89 Years	83.35 Years		Invasive Breast Carcinoma	Primary Site	Invasive Breast Carcinoma	Low	10	1		ERBB2 Negative		ERBB2 Negative						ERBB2 Negative		Estrogen Receptor Positive	Estrogen Receptor Positive						Estrogen Receptor Positive		Grade 1		Grade 1						4	3		Postmenopausal		3.05	2801	Dead	1	Dead of Other Causes		7.673972603	0	7.673972603	0		0	1		1	0	0	0	0			Luminal A	MB-0170	Progesterone Receptor Negative		Progesterone Receptor Negative								Tissue Specimen	Validation	1	Stage II		Stage II							Alive at 1 Year		Alive at 3 Years					Alive at 5 Years		Alive at 5 Years														Hormone Therapy, Radiotherapy	Other Biomarker Status	Other Biomarker Status				26
MB.0171	60 - 69 Years	64.57 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	11	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3			Grade 3					4	4	Mild	Postmenopausal		4.05	163	Alive	0	Alive		0.446575342	0	0.446575342	0		0	2		0	1	0	0	0			Normal	MB-0171	Progesterone Receptor Negative			Progesterone Receptor Negative						European	Tissue Specimen	Discovery	1	Stage II			Stage II																						TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					27
MB.0172	40 - 49 Years	48.11 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	16	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	3		Premenopausal		4.04	1854	Alive	0	Alive		5.079452055	0	5.079452055	0		0	1		1	0	0	0	0			Luminal A	MB-0172	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0173	80 - 89 Years	83.99 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	24	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	7		Postmenopausal		6.09	130	Alive	0	Alive		0.356164384	0	0.356164384	0		0	3		0	0	1	0	0			Luminal B	MB-0173	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II																					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			44
MB.0174	50 - 59 Years	59.18 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	1	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				4	4		Postmenopausal		4.05	2363	Alive	0	Alive		6.473972603	0	6.473972603	0		0	5		0	0	0	0	1			Basal	MB-0174	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			24
MB.0175	60 - 69 Years	69.51 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma		0	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive		Grade 1							Grade 1	4	6		Postmenopausal		2.04	2171	Alive	0	Alive		5.947945205	0	5.947945205	0		0	3		0	0	1	0	0			Luminal A	MB-0175	Progesterone Receptor Negative								Progesterone Receptor Negative		Tissue Specimen	Validation	1	Stage I								Stage I	Alive at 1 Year		Alive at 3 Years					Alive at 5 Years								Alive at 5 Years								Hormone Therapy	Other Biomarker Status					20
MB.0176	30 - 39 Years	38.78 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	19	7	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Premenopausal		6.07	2363	Alive	0	Alive		6.473972603	0	6.473972603	0		0	2		0	1	0	0	0			Luminal A	MB-0176	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			36
MB.0177	80 - 89 Years	85.94 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	12	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	6		Postmenopausal		4.09	1368	Dead	1	Dead of Other Causes		3.747945205	0	3.747945205	0		0	2		0	1	0	0	0			Luminal A	MB-0177	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			44
MB.0180	50 - 59 Years	51.69 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	8		Postmenopausal		3.04	1870	Alive	0	Alive		5.123287671	0	5.123287671	0		0	1		1	0	0	0	0			Luminal A	MB-0180	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.0181	60 - 69 Years	68.45 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	2	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	7		Postmenopausal		4.04	2215	Alive	0	Alive		6.068493151	0	6.068493151	0		0	2		0	1	0	0	0			Luminal A	MB-0181	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0184	60 - 69 Years	68.41 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Moderate	14	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative	1	Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2						Grade 2		4	4	Absent	Postmenopausal		3.05	2297	Alive	0	Alive		6.293150685	0	6.293150685	0		0	3		0	0	1	0	0			Luminal A	MB-0184	Progesterone Receptor Positive							Progesterone Receptor Positive		European	Tissue Specimen	Discovery	1	Stage II							Stage II		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years		TP53 Wild Type							Hormone Therapy	Other Biomarker Status					25
MB.0185	70 - 79 Years	76.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	24	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		5.1	1315	Dead	1	Dead of Disease		3.602739726	1	3.602739726	1		0	1		1	0	0	0	0			Luminal B	MB-0185	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.0189	50 - 59 Years	57.79 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	6	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	6		Postmenopausal		6.1	272	Dead	1	Dead of Disease		0.745205479	1	0.745205479	1		0	2		0	1	0	0	0			Normal	MB-0189	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage IV				Stage IV					Dead of Disease at 1 Year	Dead at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			48
MB.0192	60 - 69 Years	62.55 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				4	4		Postmenopausal		2.03	1877	Alive	0	Alive		5.142465753	0	5.142465753	0		0	2		0	1	0	0	0			Normal	MB-0192	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			13
MB.0193	50 - 59 Years	51.54 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	7	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	3		Postmenopausal		6.04	283	Alive	0	Alive		0.775342466	0	0.775342466	0		0	1		1	0	0	0	0			Luminal B	MB-0193	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1																																	No Treatment	Other Biomarker Status		Other Biomarker Status			19
MB.0194	50 - 59 Years	56.45 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	21	6	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		5.04	2107	Alive	0	Alive		5.77260274	0	5.77260274	0		0	2		0	1	0	0	0			Luminal A	MB-0194	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0195	70 - 79 Years	75.18 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	25	21	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	2	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	6		Postmenopausal		6.06	2019	Alive	0	Alive		5.531506849	0	5.531506849	0		0	3		0	0	1	0	0			Luminal B	MB-0195	Progesterone Receptor Negative				Progesterone Receptor Negative					European/Asian	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.0197	50 - 59 Years	50.48 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		5.05	2018	Alive	0	Alive		5.528767123	0	5.528767123	0		0	2		0	1	0	0	0			Luminal B	MB-0197	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			24
MB.0198	40 - 49 Years	43.37 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	20	4		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative	1	Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3			Grade 3					4	8		Premenopausal		6.04	2283	Alive	0	Alive		6.254794521	0	6.254794521	0		0	2		0	1	0	0	0			Luminal B	MB-0198	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years						TP53 Wild Type		TP53 Wild Type					Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					18
MB.0199	50 - 59 Years	57.56 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	28	1		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3			Grade 3					4	3		Postmenopausal		5.04	2191	Alive	0	Alive		6.002739726	0	6.002739726	0		0	1		1	0	0	0	0			Luminal A	MB-0199	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years						TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					19
MB.0201	40 - 49 Years	49.5 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				4	5		Postmenopausal		4.04	2344	Alive	0	Alive		6.421917808	0	6.421917808	0		1	4		0	0	0	1	0			Basal	MB-0201	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0202	40 - 49 Years	46 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	4		Premenopausal		5.06	2073	Alive	0	Alive		5.679452055	0	5.679452055	0		0	2		0	1	0	0	0			Luminal A	MB-0202	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.0203	80 - 89 Years	86.24 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	7		Postmenopausal		5.05	1763	Dead	1	Dead of Other Causes		4.830136986	0	4.830136986	0		0	1		1	0	0	0	0			Luminal A	MB-0203	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.0204	70 - 79 Years	79.38 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				4	3		Postmenopausal		2.02	729	Dead	1	Dead of Disease		1.997260274	1	1.997260274	1		0	2		0	1	0	0	0			Luminal A	MB-0204	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.0205	50 - 59 Years	53.56 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	14	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 2					Grade 2			4	3		Postmenopausal		3.05	1919	Alive	0	Alive		5.257534247	0	5.257534247	0		0	2		0	1	0	0	0			Normal	MB-0205	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		26
MB.0206	50 - 59 Years	55.02 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	High	19	2		ERBB2 Negative						ERBB2 Negative		ERBB2 Negative	1	Estrogen Receptor Negative					Estrogen Receptor Negative		Estrogen Receptor Negative	ER-/HER2-	Grade 3								3	10		Postmenopausal		5.07	1585	Alive	0	Alive		4.342465753	0	4.342465753	0		0	5		0	0	0	0	1			Basal	MB-0206	Progesterone Receptor Negative						Progesterone Receptor Negative			European	Tissue Specimen	Discovery	1	Stage II						Stage II			Alive at 1 Year		Alive at 3 Years														TP53 Wild Type					TP53 Wild Type		Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative				ERBB2/ER/PR Negative	35
MB.0207	40 - 49 Years	48.13 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	8		Premenopausal		4.06	3359	Alive	0	Alive		9.202739726	0	9.202739726	0		0	1		1	0	0	0	0			Luminal A	MB-0207	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			28
MB.0209	60 - 69 Years	67.17 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER-/HER2-	Grade 2				Grade 2				4	4	Mild	Postmenopausal		3.01	1995	Alive	0	Alive		5.465753425	0	5.465753425	0		0	2		0	1	0	0	0			Normal	MB-0209	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			3
MB.0211	40 - 49 Years	42.95 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	13	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 3				Grade 3				4	9		Premenopausal		6.08	1299	Dead	1	Dead of Disease		3.55890411	1	3.55890411	1		0	2		0	1	0	0	0			Basal	MB-0211	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			40
MB.0214	40 - 49 Years	41.41 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Premenopausal		4.05	1927	Alive	0	Alive		5.279452055	0	5.279452055	0		0	5		0	0	0	0	1			Basal	MB-0214	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			27
MB.0215	70 - 79 Years	75.63 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	17	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2			Grade 2					4	3		Postmenopausal		3.08	1841	Alive	0	Alive		5.043835616	0	5.043835616	0		0	1		1	0	0	0	0			Luminal B	MB-0215	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years						TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					40
MB.0218	40 - 49 Years	43.39 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	16	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Premenopausal		5.04	2179	Alive	0	Alive		5.969863014	0	5.969863014	0		0	1		1	0	0	0	0			Luminal B	MB-0218	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0222	50 - 59 Years	50.31 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	4	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										4	4		Postmenopausal		2.04	3128	Alive	0	Alive		8.569863014	0	8.569863014	0		0	2		0	1	0	0	0			Normal	MB-0222	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		20
MB.0223	50 - 59 Years	50.45 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	12	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	4	Severe	Postmenopausal		6.04	2440	Dead	1	Dead of Disease		6.684931507	1	6.684931507	1		0	1		1	0	0	0	0			Luminal A	MB-0223	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0224	40 - 49 Years	44.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	4	Mild	Premenopausal		4.05	1008	Alive	0	Alive		2.761643836	0	2.761643836	0		0	2		0	1	0	0	0			Luminal A	MB-0224	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.0225	50 - 59 Years	59.15 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 2				Grade 2				4	1		Postmenopausal		3.04	4398	Alive	0	Alive		12.04931507	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-0225	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			19
MB.0226	50 - 59 Years	58.21 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	7	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 1				Grade 1				4	8		Postmenopausal		3.04	1361	Alive	0	Alive		3.728767123	0	3.728767123	0		0	2		0	1	0	0	0			Luminal A	MB-0226	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0227	50 - 59 Years	52.95 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Undefined	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	8		Postmenopausal		3.05	2102	Alive	0	Alive		5.75890411	0	5.75890411	0		0	2		0	1	0	0	0			Luminal A	MB-0227	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			24
MB.0229	40 - 49 Years	45.5 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	7		Premenopausal		3.04	1958	Alive	0	Alive		5.364383562	0	5.364383562	0		0	1		1	0	0	0	0			Luminal A	MB-0229	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			19
MB.0230	40 - 49 Years	41.98 Years	Ductal Breast Carcinoma	Ductal Breast Carcinoma in Situ	Primary Site	Ductal Breast Carcinoma in Situ		4	0	Ductal Breast Carcinoma in Situ	ERBB2 Positive	ERBB2 Positive							ERBB2 Positive									Estrogen Receptor Negative										Other	5		Premenopausal		1.07	2653	Alive	0	Alive		7.268493151	0	7.268493151	0		1	4		0	0	0	1	0			Her2	MB-0230	Progesterone Receptor Negative										Tissue Specimen	Validation	1	Stage 0									Alive at 1 Year		Alive at 3 Years					Alive at 5 Years																No Treatment	Other Biomarker Status					35
MB.0231	70 - 79 Years	71.57 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Low	2	0		ERBB2 Positive							ERBB2 Positive	ERBB2 Negative									Estrogen Receptor Positive										4	3		Postmenopausal		1.06	1366	Alive	0	Alive		3.742465753	0	3.742465753	0		0	1		1	0	0	0	0			Luminal A	MB-0231	Progesterone Receptor Negative							Progesterone Receptor Negative			Tissue Specimen	Validation	1										Alive at 1 Year		Alive at 3 Years				Alive at 3 Years																	No Treatment	Other Biomarker Status					30
MB.0232	40 - 49 Years	44.73 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	8		Premenopausal		3.03	1324	Alive	0	Alive		3.62739726	0	3.62739726	0		0	1		1	0	0	0	0			Luminal A	MB-0232	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			14
MB.0234	50 - 59 Years	56.27 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	4	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										4	8		Postmenopausal		3.05	2827	Dead	1	Dead of Other Causes		7.745205479	0	7.745205479	0		0	1		1	0	0	0	0			Luminal B	MB-0234	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		26
MB.0235	50 - 59 Years	52.55 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	8	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	8		Postmenopausal		4.04	4277	Dead	1	Dead of Disease		11.71780822	1	10	0		0	1		1	0	0	0	0			Luminal A	MB-0235	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0236	40 - 49 Years	43.63 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				4	5		Postmenopausal		4.05	3861	Alive	0	Alive		10.57808219	0	10	0		1	4		0	0	0	1	0			Luminal A	MB-0236	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			27
MB.0238	50 - 59 Years	52.19 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Postmenopausal		6.07	2083	Alive	0	Alive		5.706849315	0	5.706849315	0		0	5		0	0	0	0	1			Basal	MB-0238	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			35
MB.0239	70 - 79 Years	77.85 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	7	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1			Grade 1					4	3		Postmenopausal		2.09	2567	Dead	1	Dead of Other Causes		7.032876712	0	7.032876712	0		0	1		1	0	0	0	0			Luminal A	MB-0239	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage III			Stage III						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years						TP53 Mutation	TP53 Missense Mutation	TP53 Mutation					Hormone Therapy, Radiotherapy	Other Biomarker Status					46
MB.0242	50 - 59 Years	51.25 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative									Estrogen Receptor Positive		Grade 2				Grade 2				4	8		Postmenopausal		3.04	2198	Alive	0	Alive		6.021917808	0	6.021917808	0		0	1		1	0	0	0	0			Luminal B	MB-0242	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			18
MB.0243	50 - 59 Years	53.72 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	8		Postmenopausal		4.04	4028	Alive	0	Alive		11.03561644	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-0243	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0245	50 - 59 Years	54.76 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	0	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										4	3		Postmenopausal		1.03	3259	Alive	0	Alive		8.928767123	0	8.928767123	0		0	1		1	0	0	0	0			Luminal A	MB-0245	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	1	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		14
MB.0247	60 - 69 Years	66.75 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	4		Postmenopausal		4.03	2319	Alive	0	Alive		6.353424658	0	6.353424658	0		0	2		0	1	0	0	0			Luminal A	MB-0247	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.0248	40 - 49 Years	45.76 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	8		Premenopausal		4.04	2130	Alive	0	Alive		5.835616438	0	5.835616438	0		0	3		0	0	1	0	0			Luminal A	MB-0248	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0249	50 - 59 Years	53.45 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Postmenopausal		4.02	3628	Alive	0	Alive		9.939726027	0	9.939726027	0		1	4		0	0	0	1	0			Her2	MB-0249	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Radiotherapy	Other Biomarker Status		Other Biomarker Status			11
MB.0253	60 - 69 Years	69.19 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	4		Postmenopausal		3.02	2965	Alive	0	Alive		8.123287671	0	8.123287671	0		0	1		1	0	0	0	0			Normal	MB-0253	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			12
MB.0258	60 - 69 Years	62.7 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	7		Postmenopausal		4.02	1966	Alive	0	Alive		5.38630137	0	5.38630137	0		0	1		1	0	0	0	0			Luminal A	MB-0258	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			11
MB.0260	70 - 79 Years	78.26 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	15	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										4	3		Postmenopausal		1.02	3821	Alive	0	Alive		10.46849315	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-0260	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	1	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		12
MB.0261	60 - 69 Years	63.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	6	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1				Grade 1				4	8		Postmenopausal		4.05	2707	Dead	1	Dead of Disease		7.416438356	1	7.416438356	1		0	1		1	0	0	0	0			Luminal B	MB-0261	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			26
MB.0263	70 - 79 Years	76.49 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	6	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										4	7		Postmenopausal		1.05	2476	Alive	0	Alive		6.783561644	0	6.783561644	0		0	2		0	1	0	0	0			Luminal A	MB-0263	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	1	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		27
MB.0265	40 - 49 Years	46.44 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	18	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 2				Grade 2				4	4		Premenopausal		4.04	1701	Alive	0	Alive		4.660273973	0	4.660273973	0		0	2		0	1	0	0	0			Basal	MB-0265	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0269	40 - 49 Years	45.39 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	15	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	4		Premenopausal		5.05	1441	Alive	0	Alive		3.947945205	0	3.947945205	0		0	2		0	1	0	0	0			Basal	MB-0269	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			26
MB.0270	20 - 29 Years	29.98 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	10		Premenopausal		4.03	8220	Alive	0	Alive		22.52054795	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-0270	Progesterone Receptor Positive				Progesterone Receptor Positive					OddCluster	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			14
MB.0273	60 - 69 Years	68.66 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	17	3		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2			Grade 2					4	8		Postmenopausal		4.05	3874	Alive	0	Alive		10.61369863	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-0273	Progesterone Receptor Negative			Progesterone Receptor Negative						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years						TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					25
MB.0275	60 - 69 Years	61.94 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma		13	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive		Grade 1						Grade 1		4	4		Postmenopausal		2.02	2141	Alive	0	Alive		5.865753425	0	5.865753425	0		0	2		0	1	0	0	0			Normal	MB-0275	Progesterone Receptor Negative							Progesterone Receptor Negative			Tissue Specimen	Validation	1	Stage I							Stage I		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years									Hormone Therapy, Radiotherapy	Other Biomarker Status					9
MB.0279	60 - 69 Years	69.52 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma		10	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 1					Grade 1			4	4		Postmenopausal		2.04	3807	Alive	0	Alive		10.43013699	0	10	0		0	2		0	1	0	0	0			Normal	MB-0279	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		21
MB.0280	40 - 49 Years	47.64 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma		16	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive		Grade 2			Grade 2					4	7		Premenopausal		3.04	3406	Alive	0	Alive		9.331506849	0	9.331506849	0		0	3		0	0	1	0	0			Normal	MB-0280	Progesterone Receptor Positive			Progesterone Receptor Positive							Tissue Specimen	Validation	1	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years													Hormone Therapy, Radiotherapy	Other Biomarker Status					21
MB.0282	50 - 59 Years	51.81 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Low	28	8		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive		Grade 3						Grade 3		4	4		Postmenopausal		6.04	3819	Alive	0	Alive		10.4630137	0	10	0		0	2		0	1	0	0	0			Normal	MB-0282	Progesterone Receptor Positive							Progesterone Receptor Positive			Tissue Specimen	Validation	1	Stage II							Stage II		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years									Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					18
MB.0284	50 - 59 Years	51.42 Years		Benign Breast Neoplasm	Primary Site	Benign Breast Neoplasm	Moderate				ERBB2 Negative								ERBB2 Negative									Estrogen Receptor Negative										4	10		Postmenopausal		1		Alive	0	Alive		0	0	0	0		0	5		0	0	0	0	1			Basal	MB-0284	Progesterone Receptor Negative										Tissue Specimen	Validation	1																																	No Treatment						0
MB.0285	40 - 49 Years	48.07 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	22	14		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER-/HER2-	Grade 2			Grade 2					4	4	Mild	Premenopausal		5.06	101	Alive	0	Alive		0.276712329	0	0.276712329	0		0	2		0	1	0	0	0			Normal	MB-0285	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage II			Stage II																						TP53 Wild Type		TP53 Wild Type					No Treatment	Other Biomarker Status					28
MB.0286	60 - 69 Years	62.92 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER-/HER2-	Grade 3				Grade 3				4	4	Mild	Postmenopausal		4.05	1992	Alive	0	Alive		5.457534247	0	5.457534247	0		0	2		0	1	0	0	0			Luminal A	MB-0286	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			23
MB.0288	50 - 59 Years	55.22 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	27	25		ERBB2 Positive					ERBB2 Positive			ERBB2 Positive		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 2					Grade 2			4	1		Postmenopausal		5.06	1184	Dead	1	Dead of Disease		3.243835616	1	3.243835616	1		0	2		0	1	0	0	0			Normal	MB-0288	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											Chemotherapy, Hormone Therapy	Other Biomarker Status			Other Biomarker Status		30
MB.0290	40 - 49 Years	49.92 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	5	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive		Grade 1			Grade 1					4	8		Premenopausal		2.05	2767	Alive	0	Alive		7.580821918	0	7.580821918	0		0	2		0	1	0	0	0			Luminal A	MB-0290	Progesterone Receptor Positive			Progesterone Receptor Positive							Tissue Specimen	Validation	1										Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years													No Treatment	Other Biomarker Status					25
MB.0293	50 - 59 Years	51.62 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma		8	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive		Grade 1						Grade 1		4	4		Postmenopausal		2.03	1917	Alive	0	Alive		5.252054795	0	5.252054795	0		0	2		0	1	0	0	0			Normal	MB-0293	Progesterone Receptor Negative							Progesterone Receptor Negative			Tissue Specimen	Validation	1	Stage I							Stage I		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years									Hormone Therapy	Other Biomarker Status					13
MB.0294	40 - 49 Years	46.17 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	HER2+	Grade 2				Grade 2				4	4	Mild	Premenopausal		3.03	385	Alive	0	Alive		1.054794521	0	1.054794521	0		0	2		0	1	0	0	0			Normal	MB-0294	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			14
MB.0295	40 - 49 Years	47.13 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	Moderate	19	1		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1							Grade 1	4	4	Mild	Premenopausal		3.02	3037	Alive	0	Alive		8.320547945	0	8.320547945	0		0	2		0	1	0	0	0			Luminal A	MB-0295	Progesterone Receptor Positive								Progesterone Receptor Positive	European	Tissue Specimen	Discovery	1	Stage II								Stage II	Alive at 1 Year		Alive at 3 Years					Alive at 5 Years								Alive at 5 Years	TP53 Wild Type						TP53 Wild Type	Hormone Therapy	Other Biomarker Status					9
MB.0299	60 - 69 Years	68.83 Years	Ductal Breast Carcinoma	Ductal Breast Carcinoma in Situ	Primary Site	Ductal Breast Carcinoma in Situ	High	0	0	Ductal Breast Carcinoma in Situ	ERBB2 Negative	ERBB2 Negative							ERBB2 Negative									Estrogen Receptor Negative										Other	10		Postmenopausal		1.05	3684	Alive	0	Alive		10.09315068	0	10	0		0	5		0	0	0	0	1			Basal	MB-0299	Progesterone Receptor Negative										Tissue Specimen	Validation	1	Stage 0									Alive at 1 Year		Alive at 3 Years					Alive at 5 Years																Radiotherapy						25
MB.0301	80 - 89 Years	82.46 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	7		Postmenopausal		5.05	1778	Dead	1	Dead of Other Causes		4.871232877	0	4.871232877	0		0	1		1	0	0	0	0			Luminal A	MB-0301	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.0303	40 - 49 Years	47.71 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				4	10		Premenopausal		4.02	1778	Alive	0	Alive		4.871232877	0	4.871232877	0		0	5		0	0	0	0	1			Basal	MB-0303	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Hormone Therapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			11
MB.0306	80 - 89 Years	82.53 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	10	2		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3					Grade 3			4	3		Postmenopausal		5.07	1289	Dead	1	Dead of Disease		3.531506849	1	3.531506849	1		0	1		1	0	0	0	0			Luminal A	MB-0306	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years				TP53 Mutation	TP53 Missense Mutation			TP53 Mutation			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		35
MB.0307	40 - 49 Years	41.63 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	15	6	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				4	5		Premenopausal		6.02	3520	Alive	0	Alive		9.643835616	0	9.643835616	0		0	2		0	1	0	0	0			Luminal A	MB-0307	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.0308	50 - 59 Years	51.21 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	Low	18	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive		Grade 1							Grade 1	4	3		Postmenopausal		2.04	1885	Alive	0	Alive		5.164383562	0	5.164383562	0		0	2		0	1	0	0	0			Luminal A	MB-0308	Progesterone Receptor Negative								Progesterone Receptor Negative		Tissue Specimen	Validation	1	Stage I								Stage I	Alive at 1 Year		Alive at 3 Years					Alive at 5 Years								Alive at 5 Years								No Treatment	Other Biomarker Status					19
MB.0309	80 - 89 Years	89.43 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	12	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 1				Grade 1				4	8		Postmenopausal		3.04	1270	Dead	1	Dead of Other Causes		3.479452055	0	3.479452055	0		0	1		1	0	0	0	0			Luminal A	MB-0309	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			21
MB.0310	60 - 69 Years	67.38 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	24	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		4.03	1918	Alive	0	Alive		5.254794521	0	5.254794521	0		0	2		0	1	0	0	0			Luminal A	MB-0310	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.0311	70 - 79 Years	77.94 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1				Grade 1				4	8		Postmenopausal		2.09	2125	Alive	0	Alive		5.821917808	0	5.821917808	0		0	1		1	0	0	0	0			Luminal B	MB-0311	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			47
MB.0312	70 - 79 Years	70.49 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	15	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2			Grade 2					4	2		Postmenopausal		3.07	3576	Alive	0	Alive		9.797260274	0	9.797260274	0		0	1		1	0	0	0	0			Luminal B	MB-0312	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years						TP53 Wild Type		TP53 Wild Type					Hormone Therapy	Other Biomarker Status					33
MB.0313	50 - 59 Years	55.52 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	16	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	10		Postmenopausal		5.05	3325	Alive	0	Alive		9.109589041	0	9.109589041	0		0	1		1	0	0	0	0			Luminal B	MB-0313	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			23
MB.0315	50 - 59 Years	56.32 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	22	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	6		Postmenopausal		4.1	3625	Alive	0	Alive		9.931506849	0	9.931506849	0		0	2		0	1	0	0	0			Luminal A	MB-0315	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.0316	50 - 59 Years	50.82 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Postmenopausal		4.06	1828	Alive	0	Alive		5.008219178	0	5.008219178	0		0	5		0	0	0	0	1			Basal	MB-0316	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			30
MB.0318	50 - 59 Years	58.01 Years		Invasive Breast Carcinoma	Primary Site	Invasive Breast Carcinoma	High	0	0		ERBB2 Negative		ERBB2 Negative						ERBB2 Negative		Estrogen Receptor Negative	Estrogen Receptor Negative						Estrogen Receptor Negative										4	4		Postmenopausal		1.04	1918	Alive	0	Alive		5.254794521	0	5.254794521	0		0	5		0	0	0	0	1			Normal	MB-0318	Progesterone Receptor Negative		Progesterone Receptor Negative								Tissue Specimen	Validation	1	Stage I		Stage I							Alive at 1 Year		Alive at 3 Years					Alive at 5 Years		Alive at 5 Years														No Treatment	ERBB2/ER/PR Negative	ERBB2/ER/PR Negative				18
MB.0319	90+ Years	92.14 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	10	10		ERBB2 Positive			ERBB2 Positive					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2			Grade 2					4	2		Postmenopausal		5.06	1221	Dead	1	Dead of Disease		3.345205479	1	3.345205479	1		0	3		0	0	1	0	0			Luminal B	MB-0319	Progesterone Receptor Negative			Progesterone Receptor Negative						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Dead of Disease at 5 Years			Dead at 5 Years						TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					32
MB.0320	50 - 59 Years	50.98 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	11	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1					Grade 1			4	3		Postmenopausal		2.03	1968	Alive	0	Alive		5.391780822	0	5.391780822	0		0	2		0	1	0	0	0			Luminal A	MB-0320	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		17
MB.0321	40 - 49 Years	46.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	8		Premenopausal		5.06	1922	Alive	0	Alive		5.265753425	0	5.265753425	0		0	3		0	0	1	0	0			Luminal A	MB-0321	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.0324	40 - 49 Years	47.64 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	13	6	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	6		Premenopausal		6.06	3198	Alive	0	Alive		8.761643836	0	8.761643836	0		0	3		0	0	1	0	0			Luminal A	MB-0324	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			32
MB.0325	70 - 79 Years	79.34 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	22	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	10		Postmenopausal		4.09	2037	Alive	0	Alive		5.580821918	0	5.580821918	0		0	3		0	0	1	0	0			Luminal B	MB-0325	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			45
MB.0326	50 - 59 Years	51.45 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	3		Postmenopausal		4.02	3598	Alive	0	Alive		9.857534247	0	9.857534247	0		1	4		0	0	0	1	0			Normal	MB-0546 and MB-0326	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.0327	60 - 69 Years	66.73 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		3.05	1772	Alive	0	Alive		4.854794521	0	4.854794521	0		0	1		1	0	0	0	0			Luminal A	MB-0327 and MB-0547	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.0328	60 - 69 Years	69.62 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		5.07	3687	Alive	0	Alive		10.10136986	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-0328	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			34
MB.0329	70 - 79 Years	76.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	5		Postmenopausal		5.06	1048	Alive	0	Alive		2.871232877	0	2.871232877	0		0	2		0	1	0	0	0			Luminal A	MB-0549 and MB-0329	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year																						Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.0335	40 - 49 Years	47.71 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	24	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	7		Premenopausal		4.05	3602	Alive	0	Alive		9.868493151	0	9.868493151	0		0	3		0	0	1	0	0			Luminal B	MB-0559 and MB-0335	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.0336	70 - 79 Years	74.76 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	10		Postmenopausal		5.04	1828	Alive	0	Alive		5.008219178	0	5.008219178	0		0	1		1	0	0	0	0			Luminal B	MB-0336	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0340	70 - 79 Years	79.97 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	18	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 3				Grade 3				4	10		Postmenopausal		5.03	2925	Alive	0	Alive		8.01369863	0	8.01369863	0		0	5		0	0	0	0	1			Basal	MB-0340	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.0341	60 - 69 Years	67.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	13	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	8		Postmenopausal		4.05	1848	Alive	0	Alive		5.063013699	0	5.063013699	0		1	4		0	0	0	1	0			Luminal A	MB-0341	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			26
MB.0344	50 - 59 Years	59.75 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	29	2		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	3		Postmenopausal		4.06	3317	Alive	0	Alive		9.087671233	0	9.087671233	0		0	2		0	1	0	0	0			Normal	MB-0344	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		29
MB.0345	30 - 39 Years	37.3 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	21	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Premenopausal		4.06	202	Alive	0	Alive		0.553424658	0	0.553424658	0		0	2		0	1	0	0	0			Luminal A	MB-0345	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II																					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			28
MB.0347	50 - 59 Years	52.24 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	0	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER-/HER2-	Grade 3				Grade 3				4	4	Mild	Postmenopausal		4.08	6167	Dead	1	Dead of Disease		16.89589041	1	10	0		0	1		1	0	0	0	0			Basal	MB-0347	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.0348	80 - 89 Years	81.88 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				4	8		Postmenopausal		2.04	2338	Alive	0	Alive		6.405479452	0	6.405479452	0		0	3		0	0	1	0	0			Luminal A	MB-0348	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0349	70 - 79 Years	72.26 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	3		Postmenopausal		5.06	1848	Alive	0	Alive		5.063013699	0	5.063013699	0		0	1		1	0	0	0	0			Luminal B	MB-0349	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.0356	50 - 59 Years	58.16 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	13	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2			Grade 2					4	8		Postmenopausal		3.03	5359	Alive	0	Alive		14.68219178	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-0356	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years						TP53 Wild Type		TP53 Wild Type					No Treatment	Other Biomarker Status					16
MB.0358	50 - 59 Years	57.87 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		5.05	1524	Alive	0	Alive		4.175342466	0	4.175342466	0		0	2		0	1	0	0	0			Luminal A	MB-0358	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			26
MB.0359	40 - 49 Years	44.21 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	16	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Premenopausal		4.04	179	Alive	0	Alive		0.490410959	0	0.490410959	0		0	2		0	1	0	0	0			Luminal A	MB-0359	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II																					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0360	80 - 89 Years	83.58 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1				Grade 1				4	7		Postmenopausal		3.1	1256	Alive	0	Alive		3.44109589	0	3.44109589	0		0	1		1	0	0	0	0			Luminal B	MB-0360	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.0364	40 - 49 Years	48.67 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	6	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	4	Mild	Premenopausal		5.1	3385	Alive	0	Alive		9.273972603	0	9.273972603	0		0	2		0	1	0	0	0			Luminal A	MB-0364	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.0365	70 - 79 Years	76.84 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Low	10	0		ERBB2 Positive							ERBB2 Positive	ERBB2 Positive		Estrogen Receptor Positive							Estrogen Receptor Positive		Grade 2						Grade 2		4	4		Postmenopausal		3.03	2617	Dead	1	Dead of Other Causes		7.169863014	0	7.169863014	0		1	4		0	0	0	1	0			Her2	MB-0365	Progesterone Receptor Negative							Progesterone Receptor Negative			Tissue Specimen	Validation	1	Stage I							Stage I		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years									Hormone Therapy, Radiotherapy	Other Biomarker Status					15
MB.0366	50 - 59 Years	51.74 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	8		Premenopausal		3.04	1897	Alive	0	Alive		5.197260274	0	5.197260274	0		0	1		1	0	0	0	0			Luminal A	MB-0366	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			22
MB.0368	70 - 79 Years	74.79 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	10	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	2		Postmenopausal		6.06	1857	Dead	1	Dead of Disease		5.087671233	1	5.087671233	1		0	3		0	0	1	0	0			Luminal B	MB-0368	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			31
MB.0370	60 - 69 Years	64.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	23	16	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		6.09	1854	Alive	0	Alive		5.079452055	0	5.079452055	0		0	3		0	0	1	0	0			Luminal B	MB-0370	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			47
MB.0371	70 - 79 Years	78.41 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	24	6	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				4	5		Postmenopausal		6.04	1945	Alive	0	Alive		5.328767123	0	5.328767123	0		0	1		1	0	0	0	0			Luminal B	MB-0371	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0372	30 - 39 Years	39.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	20	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Premenopausal		4.04	1883	Dead	1	Dead of Disease		5.15890411	1	5.15890411	1		0	5		0	0	0	0	1			Basal	MB-0372	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			18
MB.0374	30 - 39 Years	34.68 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	28	15	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Premenopausal		6.05	43	Alive	0	Alive		0.117808219	0	0.117808219	0		0	1		1	0	0	0	0			Luminal B	MB-0374	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	1	Stage II				Stage II																					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.0375	70 - 79 Years	72.69 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	ER-/HER2-	Grade 3				Grade 3				3	10		Postmenopausal		5.05	1767	Alive	0	Alive		4.84109589	0	4.84109589	0		0	5		0	0	0	0	1			Normal	MB-0375	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.0377	60 - 69 Years	63.25 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	4	Mild	Postmenopausal		3.02	260	Alive	0	Alive		0.712328767	0	0.712328767	0		0	2		0	1	0	0	0			Luminal A	MB-0377	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I																					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.0378	50 - 59 Years	57.15 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Postmenopausal		5.06	1584	Alive	0	Alive		4.339726027	0	4.339726027	0		1	4		0	0	0	1	0			Her2	MB-0378	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.0379	40 - 49 Years	48.22 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	21	1		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2			Grade 2					4	7		Postmenopausal		4.06	255	Alive	0	Alive		0.698630137	0	0.698630137	0		0	2		0	1	0	0	0			Luminal A	MB-0379	Progesterone Receptor Negative			Progesterone Receptor Negative						European	Tissue Specimen	Discovery	1	Stage II			Stage II																						TP53 Wild Type		TP53 Wild Type					Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					29
MB.0380	80 - 89 Years	83.9 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		5.05	857	Dead	1	Dead of Other Causes		2.347945205	0	2.347945205	0		0	3		0	0	1	0	0			Luminal B	MB-0380	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.0381	30 - 39 Years	33.65 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	5		Premenopausal		4.04	2010	Alive	0	Alive		5.506849315	0	5.506849315	0		1	4		0	0	0	1	0			Her2	MB-0381	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0382	50 - 59 Years	59.05 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		4.04	313	Alive	0	Alive		0.857534247	0	0.857534247	0		0	2		0	1	0	0	0			Luminal A	MB-0382	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II																												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0383	60 - 69 Years	65.02 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	2	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Postmenopausal		4.04	2163	Alive	0	Alive		5.926027397	0	5.926027397	0		0	1		1	0	0	0	0			Luminal B	MB-0383	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			19
MB.0385	60 - 69 Years	66.58 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	High	16	11		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative	1	Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3						Grade 3		4	9		Postmenopausal		6.06	1093	Dead	1	Dead of Disease		2.994520548	1	2.994520548	1		0	3		0	0	1	0	0			Luminal B	MB-0385	Progesterone Receptor Negative							Progesterone Receptor Negative		European	Tissue Specimen	Discovery	1	Stage II							Stage II		Alive at 1 Year		Dead of Disease at 3 Years				Dead at 3 Years	Dead of Disease at 5 Years							Dead at 5 Years									Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					31
MB.0386	60 - 69 Years	66.83 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	8	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		6.03	2050	Alive	0	Alive		5.616438356	0	5.616438356	0		0	1		1	0	0	0	0			Luminal A	MB-0386	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.0388	40 - 49 Years	46.63 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	14	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	1		Premenopausal		5.06	1829	Alive	0	Alive		5.010958904	0	5.010958904	0		0	2		0	1	0	0	0			Normal	MB-0388	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.0389	40 - 49 Years	46.87 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	21	19	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				4	2		Premenopausal		6.1	335	Alive	0	Alive		0.917808219	0	0.917808219	0		0	1		1	0	0	0	0			Luminal B	MB-0389	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage III				Stage III																					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.0390	40 - 49 Years	40.68 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	16	5	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 3				Grade 3				4	5		Premenopausal		6.03	2166	Dead	1	Dead of Disease		5.934246575	1	5.934246575	1		1	4		0	0	0	1	0			Basal	MB-0390	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.0392	50 - 59 Years	56.28 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Postmenopausal		5.06	989	Dead	1	Dead of Disease		2.709589041	1	2.709589041	1		0	2		0	1	0	0	0			Normal	MB-0392	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage IV				Stage IV					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.0393	60 - 69 Years	68.74 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	20	16	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	2		Postmenopausal		6.11	625	Dead	1	Dead of Disease		1.712328767	1	1.712328767	1		0	2		0	1	0	0	0			Basal	MB-0393	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			53
MB.0394	50 - 59 Years	56.48 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Moderate	13	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2						Grade 2		4	2		Postmenopausal		3.04	1927	Alive	0	Alive		5.279452055	0	5.279452055	0		0	1		1	0	0	0	0			Luminal A	MB-0394	Progesterone Receptor Positive							Progesterone Receptor Positive		European	Tissue Specimen	Discovery	1	Stage I							Stage I		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years		TP53 Wild Type							Hormone Therapy, Radiotherapy	Other Biomarker Status					20
MB.0395	80 - 89 Years	80.38 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Postmenopausal		5.1	870	Dead	1	Dead of Disease		2.383561644	1	2.383561644	1		1	4		0	0	0	1	0			Her2	MB-0395	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.0396	50 - 59 Years	56.45 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				4	10		Postmenopausal		4.05	1820	Alive	0	Alive		4.98630137	0	4.98630137	0		0	5		0	0	0	0	1			Basal	MB-0396	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			27
MB.0397	50 - 59 Years	58.56 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	High	2	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1							Grade 1	4	4	Absent	Postmenopausal		2.02	1662	Alive	0	Alive		4.553424658	0	4.553424658	0		0	2		0	1	0	0	0			Luminal A	MB-0397	Progesterone Receptor Positive								Progesterone Receptor Positive	European	Tissue Specimen	Discovery	1	Stage I								Stage I	Alive at 1 Year		Alive at 3 Years														TP53 Wild Type						TP53 Wild Type	Hormone Therapy, Radiotherapy	Other Biomarker Status					11
MB.0399	60 - 69 Years	68.47 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	14	11	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	4		Postmenopausal		6.09	2038	Alive	0	Alive		5.583561644	0	5.583561644	0		1	4		0	0	0	1	0			Her2	MB-0399	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			45
MB.0401	40 - 49 Years	48.58 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Postmenopausal		4.04	788	Dead	1	Dead of Disease		2.15890411	1	2.15890411	1		0	5		0	0	0	0	1			Basal	MB-0401	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			20
MB.0402	70 - 79 Years	73.06 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	Low	21	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive		Grade 1							Grade 1	4	4		Postmenopausal		2.02	1840	Alive	0	Alive		5.04109589	0	5.04109589	0		0	2		0	1	0	0	0			Normal	MB-0402	Progesterone Receptor Positive								Progesterone Receptor Positive		Tissue Specimen	Validation	1	Stage I								Stage I	Alive at 1 Year		Alive at 3 Years					Alive at 5 Years								Alive at 5 Years								Hormone Therapy, Radiotherapy	Other Biomarker Status					11
MB.0403	50 - 59 Years	58.96 Years		Benign Breast Neoplasm	Primary Site	Benign Breast Neoplasm	High	0	0		ERBB2 Negative								ERBB2 Negative									Estrogen Receptor Negative										4	4		Postmenopausal		2	437	Alive	0	Alive		1.197260274	0	1.197260274	0		0	2		0	1	0	0	0			Basal	MB-0403	Progesterone Receptor Negative										Tissue Specimen	Validation	1	Stage I									Alive at 1 Year																							No Treatment						0
MB.0404	60 - 69 Years	60.71 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	1	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	8		Postmenopausal		5.03	1905	Alive	0	Alive		5.219178082	0	5.219178082	0		0	1		1	0	0	0	0			Luminal A	MB-0404	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.0405	70 - 79 Years	72.85 Years		Breast Carcinoma	Primary Site	Breast Carcinoma	High	26	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2	Grade 2							4	7		Postmenopausal		3.03	1772	Dead	1	Dead of Other Causes		4.854794521	0	4.854794521	0		0	3		0	0	1	0	0			Luminal B	MB-0405	Progesterone Receptor Positive	Progesterone Receptor Positive								European	Tissue Specimen	Discovery	1	Stage I	Stage I								Alive at 1 Year		Alive at 3 Years					Dead of Other Causes at 5 Years	Dead at 5 Years								TP53 Wild Type							Hormone Therapy, Radiotherapy	Other Biomarker Status					16
MB.0406	60 - 69 Years	69.32 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	17	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	2	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	2		Postmenopausal		6.36	1652	Alive	0	Alive		4.526027397	0	4.526027397	0		0	1		1	0	0	0	0			Luminal B	MB-0406	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			180
MB.0407	50 - 59 Years	51.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	20	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	7		Postmenopausal		3.02	2120	Alive	0	Alive		5.808219178	0	5.808219178	0		0	2		0	1	0	0	0			Normal	MB-0408 and MB-0407	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			12
MB.0408	50 - 59 Years	51.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	20	11	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	7		Postmenopausal		5.09	2120	Alive	0	Alive		5.808219178	0	5.808219178	0		0	2		0	1	0	0	0			Luminal A	MB-0408 and MB-0407	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			47
MB.0410	50 - 59 Years	57.41 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	18	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	3		Postmenopausal		3.04	1890	Alive	0	Alive		5.178082192	0	5.178082192	0		0	2		0	1	0	0	0			Luminal A	MB-0410	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		20
MB.0411	50 - 59 Years	54.6 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	15	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	6		Postmenopausal		4.04	1809	Alive	0	Alive		4.956164384	0	4.956164384	0		0	2		0	1	0	0	0			Luminal A	MB-0411	Progesterone Receptor Negative				Progesterone Receptor Negative					OddCluster	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.0412	50 - 59 Years	54.06 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	20	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	6		Postmenopausal		5.04	1647	Alive	0	Alive		4.512328767	0	4.512328767	0		0	1		1	0	0	0	0			Luminal B	MB-0412	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			19
MB.0413	50 - 59 Years	56.58 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	26	5	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	2		Postmenopausal		6.09	2081	Alive	0	Alive		5.701369863	0	5.701369863	0		0	1		1	0	0	0	0			Luminal A	MB-0413	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			47
MB.0414	70 - 79 Years	72.16 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				4	10		Postmenopausal		4.04	1876	Alive	0	Alive		5.139726027	0	5.139726027	0		0	5		0	0	0	0	1			Basal	MB-0414	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			21
MB.0417	50 - 59 Years	54.22 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	15	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	7		Postmenopausal		4.08	188	Dead	1	Dead of Disease		0.515068493	1	0.515068493	1		0	3		0	0	1	0	0			Her2	MB-0417	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Dead of Disease at 1 Year	Dead at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.0418	50 - 59 Years	58.72 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	20	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	9		Postmenopausal		5.06	1970	Alive	0	Alive		5.397260274	0	5.397260274	0		0	1		1	0	0	0	0			Her2	MB-0418	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			31
MB.0419	70 - 79 Years	77.92 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	18	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	8		Postmenopausal		4.04	511	Alive	0	Alive		1.4	0	1.4	0		0	1		1	0	0	0	0			Luminal A	MB-0419	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0420	30 - 39 Years	34.92 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Premenopausal		4.03	1938	Alive	0	Alive		5.309589041	0	5.309589041	0		0	5		0	0	0	0	1			Basal	MB-0420	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			16
MB.0421	70 - 79 Years	73.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	5		Postmenopausal		4.05	1938	Alive	0	Alive		5.309589041	0	5.309589041	0		0	1		1	0	0	0	0			Her2	MB-0421	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			24
MB.0422	60 - 69 Years	66.72 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	7	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	8		Postmenopausal		5.03	1014	Dead	1	Dead of Other Causes		2.778082192	0	2.778082192	0		0	1		1	0	0	0	0			Luminal A	MB-0422	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.0423	70 - 79 Years	71.1 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	13	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	3		Postmenopausal		3.07	1940	Alive	0	Alive		5.315068493	0	5.315068493	0		0	2		0	1	0	0	0			Luminal A	MB-0423	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy	Other Biomarker Status			Other Biomarker Status		35
MB.0424	40 - 49 Years	44.02 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	22	22	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	4	Absent	Premenopausal		6.12	295	Dead	1	Dead of Disease		0.808219178	1	0.808219178	1		0	2		0	1	0	0	0			Normal	MB-0424	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Dead of Disease at 1 Year	Dead at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			60
MB.0425	80 - 89 Years	83.17 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	27	6	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		5.04	732	Dead	1	Dead of Other Causes		2.005479452	0	2.005479452	0		0	1		1	0	0	0	0			Luminal A	MB-0425	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0426	50 - 59 Years	50.48 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		4.08	2166	Alive	0	Alive		5.934246575	0	5.934246575	0		0	2		0	1	0	0	0			Normal	MB-0426	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			42
MB.0427	80 - 89 Years	81.89 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	34	15		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2					Grade 2			4	7		Postmenopausal		5.04	1647	Alive	0	Alive		4.512328767	0	4.512328767	0		0	3		0	0	1	0	0			Luminal A	MB-0427	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years											TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		21
MB.0428	80 - 89 Years	85.21 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	25	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		6.04	1678	Alive	0	Alive		4.597260274	0	4.597260274	0		0	1		1	0	0	0	0			Luminal A	MB-0428	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0429	70 - 79 Years	78.86 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	19	4		ERBB2 Positive					ERBB2 Positive			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3					Grade 3			4	1		Postmenopausal		6.08	1910	Alive	0	Alive		5.232876712	0	5.232876712	0		0	3		0	0	1	0	0			Luminal B	MB-0429	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		40
MB.0431	60 - 69 Years	63.61 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	20	2		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	3		Postmenopausal		4.11	180	Alive	0	Alive		0.493150685	0	0.493150685	0		0	1		1	0	0	0	0			Luminal A	MB-0431	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	1	Stage II					Stage II																				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		57
MB.0432	60 - 69 Years	60.07 Years		Breast Carcinoma	Primary Site	Breast Carcinoma	Moderate	13	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Negative	ER-/HER2-	Grade 1	Grade 1							4	4	Mild	Postmenopausal		2.03	1655	Alive	0	Alive		4.534246575	0	4.534246575	0		0	2		0	1	0	0	0			Normal	MB-0432 and MB-0433	Progesterone Receptor Negative	Progesterone Receptor Negative								European	Tissue Specimen	Discovery	1	Stage II	Stage II								Alive at 1 Year		Alive at 3 Years														TP53 Wild Type							Hormone Therapy	Other Biomarker Status					14
MB.0433	60 - 69 Years	60.07 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	16	3		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										4	8		Postmenopausal		2.08	2566	Alive	0	Alive		7.030136986	0	7.030136986	0		0	2		0	1	0	0	0			Normal	MB-0432 and MB-0433	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		40
MB.0434	60 - 69 Years	69.79 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				4	5		Postmenopausal		5.04	1365	Dead	1	Dead of Disease		3.739726027	1	3.739726027	1		1	4		0	0	0	1	0			Luminal B	MB-0434	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.0436	80 - 89 Years	88.29 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				4	4		Postmenopausal		4.03	1885	Dead	1	Dead of Other Causes		5.164383562	0	5.164383562	0		1	4		0	0	0	1	0			Her2	MB-0436	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			13
MB.0437	80 - 89 Years	82.17 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	16	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	4		Postmenopausal		4.03	1851	Alive	0	Alive		5.071232877	0	5.071232877	0		0	3		0	0	1	0	0			Luminal B	MB-0437	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.0438	50 - 59 Years	57.41 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Postmenopausal		5.05	2178	Alive	0	Alive		5.967123288	0	5.967123288	0		1	4		0	0	0	1	0			Her2	MB-0438	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.0439	50 - 59 Years	50.32 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	High	10	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2						Grade 2		4	8		Postmenopausal		3.03	2143	Alive	0	Alive		5.871232877	0	5.871232877	0		0	3		0	0	1	0	0			Luminal B	MB-0439	Progesterone Receptor Positive							Progesterone Receptor Positive		European	Tissue Specimen	Discovery	1	Stage I							Stage I		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years		TP53 Wild Type							Hormone Therapy	Other Biomarker Status					15
MB.0440	50 - 59 Years	56.73 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Postmenopausal		5.05	2037	Alive	0	Alive		5.580821918	0	5.580821918	0		0	3		0	0	1	0	0			Luminal B	MB-0440	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			26
MB.0442	70 - 79 Years	71.58 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	15	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	4		Postmenopausal		4.03	1903	Alive	0	Alive		5.21369863	0	5.21369863	0		0	2		0	1	0	0	0			Normal	MB-0442	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			17
MB.0443	60 - 69 Years	61.67 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	20	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	7		Postmenopausal		3.05	387	Alive	0	Alive		1.060273973	0	1.060273973	0		0	1		1	0	0	0	0			Luminal A	MB-0443	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			26
MB.0444	40 - 49 Years	49.87 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	21	18		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	8		Premenopausal		5.07	1664	Dead	1	Dead of Disease		4.55890411	1	4.55890411	1		0	1		1	0	0	0	0			Luminal B	MB-0444	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage IV					Stage IV				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years				TP53 Mutation	TP53 Missense Mutation			TP53 Mutation			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		33
MB.0445	40 - 49 Years	40.07 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	7		Premenopausal		4.05	1678	Alive	0	Alive		4.597260274	0	4.597260274	0		0	1		1	0	0	0	0			Luminal A	MB-0445	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.0446	50 - 59 Years	56.96 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	19	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Postmenopausal		4.05	1768	Alive	0	Alive		4.843835616	0	4.843835616	0		0	5		0	0	0	0	1			Basal	MB-0446	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			24
MB.0449	50 - 59 Years	54.38 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	5	2		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1			Grade 1					4	3		Postmenopausal		3.07	2040	Alive	0	Alive		5.589041096	0	5.589041096	0		0	2		0	1	0	0	0			Luminal A	MB-0449	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years						TP53 Wild Type		TP53 Wild Type					Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					35
MB.0451	60 - 69 Years	63.2 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				4	8		Postmenopausal		2.03	1502	Alive	0	Alive		4.115068493	0	4.115068493	0		0	2		0	1	0	0	0			Luminal A	MB-0451	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			16
MB.0452	50 - 59 Years	54.43 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		4.05	1884	Alive	0	Alive		5.161643836	0	5.161643836	0		0	1		1	0	0	0	0			Luminal B	MB-0452	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.0453	60 - 69 Years	61.11 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	20	6	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	2		Postmenopausal		6.2	1294	Dead	1	Dead of Disease		3.545205479	1	3.545205479	1		1	4		0	0	0	1	0			Her2	MB-0453	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			100
MB.0454	90+ Years	90.02 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Moderate	13	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2						Grade 2		4	3		Postmenopausal		3.04	1405	Dead	1	Dead of Other Causes		3.849315068	0	3.849315068	0		0	3		0	0	1	0	0			Luminal A	MB-0454	Progesterone Receptor Positive							Progesterone Receptor Positive		European	Tissue Specimen	Discovery	1	Stage I							Stage I		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Dead of Other Causes at 5 Years							Dead at 5 Years		TP53 Wild Type							Hormone Therapy, Radiotherapy	Other Biomarker Status					20
MB.0455	50 - 59 Years	56.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	10		Postmenopausal		3.04	2006	Alive	0	Alive		5.495890411	0	5.495890411	0		0	1		1	0	0	0	0			Luminal B	MB-0455	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.0458	40 - 49 Years	49.28 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Low	14	2		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative	1	Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive		Grade 2			Grade 2					4	4		Premenopausal		4.1	2006	Alive	0	Alive		5.495890411	0	5.495890411	0		0	2		0	1	0	0	0			Normal	MB-0458	Progesterone Receptor Positive			Progesterone Receptor Positive							Tissue Specimen	Validation	1	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years													Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					50
MB.0459	80 - 89 Years	85.09 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	8	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	6		Postmenopausal		5.07	1068	Dead	1	Dead of Other Causes		2.926027397	0	2.926027397	0		0	1		1	0	0	0	0			Luminal B	MB-0459	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			34
MB.0460	80 - 89 Years	81.44 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	10	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	4	Mild	Postmenopausal		3.04	1838	Alive	0	Alive		5.035616438	0	5.035616438	0		0	2		0	1	0	0	0			Luminal A	MB-0460	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		22
MB.0462	60 - 69 Years	60.5 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 3				Grade 3				4	5		Postmenopausal		4.03	1835	Alive	0	Alive		5.02739726	0	5.02739726	0		0	2		0	1	0	0	0			Her2	MB-0462	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.0463	60 - 69 Years	60.48 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	4	Mild	Postmenopausal		3.04	1859	Alive	0	Alive		5.093150685	0	5.093150685	0		0	1		1	0	0	0	0			Luminal A	MB-0463	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0464	50 - 59 Years	58.98 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	20	17	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	9		Postmenopausal		6.03	1179	Dead	1	Dead of Disease		3.230136986	1	3.230136986	1		1	4		0	0	0	1	0			Basal	MB-0464	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			13
MB.0465	80 - 89 Years	87.18 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	13	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				4	5		Postmenopausal		5.05	858	Dead	1	Dead of Disease		2.350684932	1	2.350684932	1		1	4		0	0	0	1	0			Luminal B	MB-0465	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			26
MB.0466	30 - 39 Years	33.97 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	1		Premenopausal		5.14	1340	Alive	0	Alive		3.671232877	0	3.671232877	0		0	2		0	1	0	0	0			Luminal A	MB-0466	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			70
MB.0467	50 - 59 Years	58.35 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	1	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				4	5		Postmenopausal		4.03	1385	Alive	0	Alive		3.794520548	0	3.794520548	0		1	4		0	0	0	1	0			Her2	MB-0467	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy	Other Biomarker Status		Other Biomarker Status			13
MB.0469	60 - 69 Years	67.94 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	6		Postmenopausal		5.08	2015	Alive	0	Alive		5.520547945	0	5.520547945	0		0	3		0	0	1	0	0			Luminal B	MB-0469	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			39
MB.0471	70 - 79 Years	76.49 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	1		Postmenopausal		3.03	1967	Alive	0	Alive		5.389041096	0	5.389041096	0		0	3		0	0	1	0	0			Luminal A	MB-0471	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.0472	50 - 59 Years	59.34 Years		Invasive Breast Carcinoma	Primary Site	Invasive Breast Carcinoma	High	0	0		ERBB2 Negative		ERBB2 Negative						ERBB2 Negative		Estrogen Receptor Positive	Estrogen Receptor Positive						Estrogen Receptor Positive										4	7		Postmenopausal		1.02	764	Alive	0	Alive		2.093150685	0	2.093150685	0		0	3		0	0	1	0	0			Luminal B	MB-0472	Progesterone Receptor Positive		Progesterone Receptor Positive								Tissue Specimen	Validation	1	Stage 0		Stage 0							Alive at 1 Year																							Radiotherapy	Other Biomarker Status	Other Biomarker Status				11
MB.0474	50 - 59 Years	54.29 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	15	3		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative	1	Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3			Grade 3					4	9		Postmenopausal		5.16	1121	Alive	0	Alive		3.071232877	0	3.071232877	0		0	1		1	0	0	0	0			Luminal B	MB-0474	Progesterone Receptor Positive			Progesterone Receptor Positive						OddCluster	Tissue Specimen	Discovery	1	Stage III			Stage III						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years													TP53 Wild Type		TP53 Wild Type					Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					80
MB.0475	50 - 59 Years	54.15 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Premenopausal		4.04	1527	Alive	0	Alive		4.183561644	0	4.183561644	0		0	1		1	0	0	0	0			Luminal A	MB-0475	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0476	50 - 59 Years	54.62 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	ER-/HER2-	Grade 3				Grade 3				4	4	Severe	Postmenopausal		4.05	1440	Alive	0	Alive		3.945205479	0	3.945205479	0		0	2		0	1	0	0	0			Normal	MB-0476	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			25
MB.0478	70 - 79 Years	74.02 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	19	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	3		Postmenopausal		4.05	1561	Alive	0	Alive		4.276712329	0	4.276712329	0		0	2		0	1	0	0	0			Luminal A	MB-0478	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.0479	30 - 39 Years	33.83 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				4	5		Premenopausal		4.04	2354	Alive	0	Alive		6.449315068	0	6.449315068	0		1	4		0	0	0	1	0			Her2	MB-0479	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0480	50 - 59 Years	51.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	1	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	9		Premenopausal		4.03	1871	Alive	0	Alive		5.126027397	0	5.126027397	0		0	1		1	0	0	0	0			Luminal A	MB-0480	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			13
MB.0481	50 - 59 Years	54.22 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	1	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Postmenopausal		4.04	1092	Dead	1	Dead of Disease		2.991780822	1	2.991780822	1		0	5		0	0	0	0	1			Basal	MB-0481	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			19
MB.0482	30 - 39 Years	39.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Premenopausal		5.03	746	Dead	1	Dead of Disease		2.043835616	1	2.043835616	1		1	4		0	0	0	1	0			Normal	MB-0482	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.0483	40 - 49 Years	49.61 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	18	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	2	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Premenopausal		5.04	2226	Alive	0	Alive		6.098630137	0	6.098630137	0		0	3		0	0	1	0	0			Luminal B	MB-0483	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0484	30 - 39 Years	38.72 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	6		Premenopausal		5.04	1883	Alive	0	Alive		5.15890411	0	5.15890411	0		1	4		0	0	0	1	0			Her2	MB-0484	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0485	60 - 69 Years	60.78 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	18	7		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative	1	Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3			Grade 3					4	9		Postmenopausal		6.1	1103	Dead	1	Dead of Disease		3.021917808	1	3.021917808	1		0	1		1	0	0	0	0			Luminal A	MB-0485	Progesterone Receptor Negative			Progesterone Receptor Negative						European	Tissue Specimen	Discovery	1	Stage III			Stage III						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Dead of Disease at 5 Years			Dead at 5 Years						TP53 Wild Type		TP53 Wild Type					Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					50
MB.0486	50 - 59 Years	57.57 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	3		Postmenopausal		4.06	1651	Alive	0	Alive		4.523287671	0	4.523287671	0		0	1		1	0	0	0	0			Luminal A	MB-0486	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			32
MB.0487	50 - 59 Years	57.36 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	Low	2	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive		Grade 2							Grade 2	4	3		Postmenopausal		3.03	1918	Alive	0	Alive		5.254794521	0	5.254794521	0		0	2		0	1	0	0	0			Normal	MB-0487	Progesterone Receptor Positive								Progesterone Receptor Positive		Tissue Specimen	Validation	1	Stage I								Stage I	Alive at 1 Year		Alive at 3 Years					Alive at 5 Years								Alive at 5 Years								Radiotherapy	Other Biomarker Status					15
MB.0488	50 - 59 Years	50.64 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma		11	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive		Grade 1						Grade 1		4	4		Postmenopausal		2.05	2267	Alive	0	Alive		6.210958904	0	6.210958904	0		0	2		0	1	0	0	0			Basal	MB-0488	Progesterone Receptor Positive							Progesterone Receptor Positive			Tissue Specimen	Validation	1	Stage II							Stage II		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years									Hormone Therapy, Radiotherapy	Other Biomarker Status					25
MB.0489	40 - 49 Years	41.46 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				4	4		Premenopausal		4.02	1955	Alive	0	Alive		5.356164384	0	5.356164384	0		1	4		0	0	0	1	0			Normal	MB-0489	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			10
MB.0490	80 - 89 Years	81.9 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	12	10	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	4		Postmenopausal		5.06	684	Alive	0	Alive		1.873972603	0	1.873972603	0		0	2		0	1	0	0	0			Luminal A	MB-0490	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year																						Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.0491	40 - 49 Years	43.4 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	18	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2					Grade 2			4	4	Mild	Premenopausal		3.06	399	Alive	0	Alive		1.093150685	0	1.093150685	0		0	1		1	0	0	0	0			Luminal A	MB-0491	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage III					Stage III				Alive at 1 Year																TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		30
MB.0492	80 - 89 Years	85.21 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		23	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	8		Postmenopausal		4.06	1169	Alive	0	Alive		3.202739726	0	3.202739726	0		0	3		0	0	1	0	0			Luminal B	MB-0492	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.0494	70 - 79 Years	77.22 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	26	21	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	4	Absent	Postmenopausal		6.08	1099	Dead	1	Dead of Disease		3.010958904	1	3.010958904	1		1	4		0	0	0	1	0			Basal	MB-0494	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			40
MB.0495	60 - 69 Years	63.19 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	21	7	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 3				Grade 3				4	4		Postmenopausal		6.04	1883	Dead	1	Dead of Disease		5.15890411	1	5.15890411	1		0	2		0	1	0	0	0			Basal	MB-0495	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			19
MB.0496	60 - 69 Years	60 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	22	4		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative	1	Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1			Grade 1					4	3		Postmenopausal		4.05	475	Alive	0	Alive		1.301369863	0	1.301369863	0		0	2		0	1	0	0	0			Normal	MB-0496	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year																TP53 Wild Type		TP53 Wild Type					Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					26
MB.0497	50 - 59 Years	57.27 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	4	Mild	Postmenopausal		3.06	1847	Alive	0	Alive		5.060273973	0	5.060273973	0		0	3		0	0	1	0	0			Luminal A	MB-0497	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			29
MB.0499	50 - 59 Years	50.15 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low			Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 2				Grade 2				4	4		Postmenopausal		3.01	2225	Alive	0	Alive		6.095890411	0	6.095890411	0		0	2		0	1	0	0	0			Basal	MB-0499	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			4
MB.0500	30 - 39 Years	36.56 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Premenopausal		4.04	253	Alive	0	Alive		0.693150685	0	0.693150685	0		0	5		0	0	0	0	1			Basal	MB-0500	Progesterone Receptor Negative				Progesterone Receptor Negative					OddCluster	Tissue Specimen	Discovery	1	Stage II				Stage II																					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.0501	40 - 49 Years	48.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	8		Premenopausal		4.04	1790	Alive	0	Alive		4.904109589	0	4.904109589	0		0	1		1	0	0	0	0			Luminal A	MB-0501	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0502	50 - 59 Years	56.41 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	17	5	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 3				Grade 3				4	4		Postmenopausal		6.06	1871	Alive	0	Alive		5.126027397	0	5.126027397	0		0	2		0	1	0	0	0			Basal	MB-0502	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.0503	60 - 69 Years	60.77 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	2	0		ERBB2 Positive			ERBB2 Positive					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2			Grade 2					4	7		Postmenopausal		3.05	499	Alive	0	Alive		1.367123288	0	1.367123288	0		0	2		0	1	0	0	0			Luminal A	MB-0503	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year																TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					23
MB.0504	60 - 69 Years	68.16 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	11	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3			Grade 3					4	3		Postmenopausal		4.04	1930	Alive	0	Alive		5.287671233	0	5.287671233	0		0	2		0	1	0	0	0			Luminal A	MB-0504	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years						TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					21
MB.0505	50 - 59 Years	56.38 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	2	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				4	4	Absent	Postmenopausal		3.02	1821	Alive	0	Alive		4.989041096	0	4.989041096	0		0	2		0	1	0	0	0			Luminal A	MB-0505	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.0506	60 - 69 Years	60.74 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER+/HER2- High Proliferation	Grade 3				Grade 3				3	9		Postmenopausal		5.04	1351	Dead	1	Dead of Other Causes		3.701369863	0	3.701369863	0		1	4		0	0	0	1	0			Her2	MB-0506	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0507	50 - 59 Years	58.71 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	3		Postmenopausal		4.04	749	Alive	0	Alive		2.052054795	0	2.052054795	0		0	1		1	0	0	0	0			Luminal A	MB-0507	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.0508	40 - 49 Years	42.68 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	2		Premenopausal		3.02	1395	Alive	0	Alive		3.821917808	0	3.821917808	0		0	2		0	1	0	0	0			Normal	MB-0508	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Hormone Therapy	Other Biomarker Status		Other Biomarker Status			11
MB.0509	40 - 49 Years	41.48 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	3		Premenopausal		4.02	1876	Alive	0	Alive		5.139726027	0	5.139726027	0		0	1		1	0	0	0	0			Basal	MB-0509	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			11
MB.0510	70 - 79 Years	71.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	20	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	9		Postmenopausal		5.12	1592	Alive	0	Alive		4.361643836	0	4.361643836	0		0	2		0	1	0	0	0			Normal	MB-0510	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			60
MB.0511	50 - 59 Years	59.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	21	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		3.06	1851	Alive	0	Alive		5.071232877	0	5.071232877	0		0	2		0	1	0	0	0			Luminal A	MB-0511	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			31
MB.0513	70 - 79 Years	73.39 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	9		Postmenopausal		4.06	1667	Alive	0	Alive		4.567123288	0	4.567123288	0		0	3		0	0	1	0	0			Luminal A	MB-0513	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			32
MB.0514	40 - 49 Years	42.89 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	5	1		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative	1	Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2			Grade 2					4	3		Premenopausal		4.04	402	Alive	0	Alive		1.101369863	0	1.101369863	0		0	1		1	0	0	0	0			Luminal B	MB-0514	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year																TP53 Wild Type		TP53 Wild Type					Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					20
MB.0516	60 - 69 Years	62.81 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	2	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Postmenopausal		4.03	1482	Alive	0	Alive		4.060273973	0	4.060273973	0		0	5		0	0	0	0	1			Basal	MB-0516	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			15
MB.0517	40 - 49 Years	47.92 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	9		Premenopausal		3.03	1857	Alive	0	Alive		5.087671233	0	5.087671233	0		0	1		1	0	0	0	0			Luminal A	MB-0517	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.0519	60 - 69 Years	61.99 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	24	23	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	4		Postmenopausal		6.13	1637	Alive	0	Alive		4.484931507	0	4.484931507	0		0	2		0	1	0	0	0			Normal	MB-0519	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			65
MB.0521	50 - 59 Years	52.2 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	4	3		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	3		Postmenopausal		4.06	2964	Alive	0	Alive		8.120547945	0	8.120547945	0		0	2		0	1	0	0	0			Luminal A	MB-0521	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		30
MB.0524	40 - 49 Years	40.65 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	0	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	4	Mild	Premenopausal		4.02	2425	Alive	0	Alive		6.643835616	0	6.643835616	0		0	2		0	1	0	0	0			Normal	MB-0524	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			10
MB.0525	40 - 49 Years	48.47 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	4	Mild	Premenopausal		4.05	2922	Alive	0	Alive		8.005479452	0	8.005479452	0		0	5		0	0	0	0	1			Basal	MB-0525	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			25
MB.0528	50 - 59 Years	53.64 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				4	2		Postmenopausal		5.05	2317	Alive	0	Alive		6.347945205	0	6.347945205	0		0	1		1	0	0	0	0			Luminal A	MB-0528	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			26
MB.0532	50 - 59 Years	59.07 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				3	9		Postmenopausal		5.07	3986	Alive	0	Alive		10.92054795	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-0532	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.0535	40 - 49 Years	46.66 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	8		Premenopausal		3.02	3463	Alive	0	Alive		9.487671233	0	9.487671233	0		0	1		1	0	0	0	0			Luminal A	MB-0535	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.0536	60 - 69 Years	67.88 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Postmenopausal		4.04	3658	Alive	0	Alive		10.02191781	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-0536	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0537	50 - 59 Years	59.8 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		25	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 1				Grade 1				4	4		Postmenopausal		3.03	3512	Alive	0	Alive		9.621917808	0	9.621917808	0		0	2		0	1	0	0	0			Normal	MB-0537	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			14
MB.0539	60 - 69 Years	64.21 Years	Ductal Breast Carcinoma	Ductal Breast Carcinoma in Situ	Primary Site	Ductal Breast Carcinoma in Situ	Low	22	0	Ductal Breast Carcinoma in Situ	ERBB2 Positive	ERBB2 Positive							ERBB2 Positive									Estrogen Receptor Negative										Other	5		Postmenopausal		1.04	2565	Dead	1	Dead of Other Causes		7.02739726	0	7.02739726	0		1	4		0	0	0	1	0			Basal	MB-0539	Progesterone Receptor Negative										Tissue Specimen	Validation	1	Stage 0									Alive at 1 Year		Alive at 3 Years					Alive at 5 Years																No Treatment	Other Biomarker Status					20
MB.0540	60 - 69 Years	66.11 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	ER-/HER2-	Grade 1				Grade 1				4	4		Postmenopausal		2.02	3367	Alive	0	Alive		9.224657534	0	9.224657534	0		0	3		0	0	1	0	0			Normal	MB-0540	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.0541	30 - 39 Years	38.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	20	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Premenopausal		4.04	2273	Alive	0	Alive		6.22739726	0	6.22739726	0		0	3		0	0	1	0	0			Luminal A	MB-0541	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			19
MB.0542	30 - 39 Years	39.3 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	18	5	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Premenopausal		6.05	1458	Dead	1	Dead of Disease		3.994520548	1	3.994520548	1		1	4		0	0	0	1	0			Normal	MB-0542	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.0543	40 - 49 Years	45.9 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	27	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	1		Premenopausal		5.05	2082	Alive	0	Alive		5.704109589	0	5.704109589	0		0	5		0	0	0	0	1			Basal	MB-0543	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			27
MB.0544	70 - 79 Years	74.46 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Low	12	1		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive		Grade 3			Grade 3					4	8		Postmenopausal		5.1	2380	Dead	1	Dead of Other Causes		6.520547945	0	6.520547945	0		0	1		1	0	0	0	0			Luminal B	MB-0544	Progesterone Receptor Positive			Progesterone Receptor Positive							Tissue Specimen	Validation	1	Stage III			Stage III						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years													Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					52
MB.0546	50 - 59 Years	51.45 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		4.02	3598	Alive	0	Alive		9.857534247	0	9.857534247	0		0	2		0	1	0	0	0			Normal	MB-0546 and MB-0326	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.0547	60 - 69 Years	66.73 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	3		Postmenopausal		3.05	3961	Alive	0	Alive		10.85205479	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-0327 and MB-0547	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.0549	70 - 79 Years	76.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				4	5		Postmenopausal		5.06	839	Alive	0	Alive		2.298630137	0	2.298630137	0		0	1		1	0	0	0	0			Luminal B	MB-0549 and MB-0329	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year																						Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.0550	60 - 69 Years	60.12 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	8		Postmenopausal		4.03	394	Alive	0	Alive		1.079452055	0	1.079452055	0		0	1		1	0	0	0	0			Luminal B	MB-0550	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			15
MB.0552	60 - 69 Years	61.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Undefined	19	8	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	5		Postmenopausal		6.06	2042	Dead	1	Dead of Disease		5.594520548	1	5.594520548	1		1	4		0	0	0	1	0			Her2	MB-0552 and MB-0330	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			29
MB.0554	80 - 89 Years	82.35 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										4	8		Postmenopausal		2.03	3335	Dead	1	Dead of Other Causes		9.136986301	0	9.136986301	0		0	1		1	0	0	0	0			Luminal A	MB-0554	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			16
MB.0558	60 - 69 Years	69.88 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		29	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				4	10		Postmenopausal		4.06	2935	Dead	1	Dead of Other Causes		8.04109589	0	8.04109589	0		0	5		0	0	0	0	1			Basal	MB-0558	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			28
MB.0559	40 - 49 Years	47.71 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	24	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	7		Premenopausal		4.05	3602	Alive	0	Alive		9.868493151	0	9.868493151	0		0	3		0	0	1	0	0			Luminal A	MB-0559 and MB-0335	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.0568	60 - 69 Years	61.28 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	27	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	7		Postmenopausal		4.03	2352	Alive	0	Alive		6.443835616	0	6.443835616	0		0	2		0	1	0	0	0			Luminal A	MB-0568	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			17
MB.0569	70 - 79 Years	74.96 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	30	14	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	4	Severe	Postmenopausal		6.05	1785	Dead	1	Dead of Disease		4.890410959	1	4.890410959	1		0	1		1	0	0	0	0			Luminal B	MB-0569	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.0570	60 - 69 Years	68.99 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	6		Postmenopausal		4.04	6705	Alive	0	Alive		18.36986301	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-0570	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0571	60 - 69 Years	61.79 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1				Grade 1				4	7		Postmenopausal		2.04	2344	Alive	0	Alive		6.421917808	0	6.421917808	0		0	1		1	0	0	0	0			Luminal A	MB-0571	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0573	70 - 79 Years	76.22 Years		Breast Carcinoma	Primary Site	Breast Carcinoma	Moderate	25	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2	Grade 2							4	7		Postmenopausal		3.13	2382	Alive	0	Alive		6.526027397	0	6.526027397	0		0	2		0	1	0	0	0			Luminal A	MB-0573 and MB-0355	Progesterone Receptor Positive	Progesterone Receptor Positive								European	Tissue Specimen	Discovery	1	Stage 0	Stage 0								Alive at 1 Year		Alive at 3 Years					Alive at 5 Years	Alive at 5 Years								TP53 Wild Type							No Treatment	Other Biomarker Status					65
MB.0574	70 - 79 Years	71.21 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	2		Postmenopausal		5.04	427	Alive	0	Alive		1.169863014	0	1.169863014	0		0	1		1	0	0	0	0			Luminal A	MB-0574	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year															TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0575	40 - 49 Years	48.1 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	9	4		ERBB2 Positive			ERBB2 Positive					ERBB2 Negative	1	Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2			Grade 2					4	4	Absent	Postmenopausal		5.11	1482	Alive	0	Alive		4.060273973	0	4.060273973	0		0	2		0	1	0	0	0			Luminal A	MB-0575	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage III			Stage III						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years													TP53 Wild Type		TP53 Wild Type					Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					55
MB.0576	60 - 69 Years	68.47 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	5	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	2		Postmenopausal		6.04	930	Dead	1	Dead of Disease		2.547945205	1	2.547945205	1		0	1		1	0	0	0	0			Luminal B	MB-0576	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0577	50 - 59 Years	51.42 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Low	7	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive		Grade 2						Grade 2		4	7		Postmenopausal		3.02	1514	Alive	0	Alive		4.147945205	0	4.147945205	0		0	3		0	0	1	0	0			Luminal B	MB-0577	Progesterone Receptor Negative							Progesterone Receptor Negative			Tissue Specimen	Validation	1	Stage I							Stage I		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years																	Hormone Therapy, Radiotherapy	Other Biomarker Status					10
MB.0578	50 - 59 Years	59.64 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	14	6		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 2					Grade 2			4	4		Postmenopausal		5.08	1204	Alive	0	Alive		3.298630137	0	3.298630137	0		0	2		0	1	0	0	0			Normal	MB-0578	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	1	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years																		Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		42
MB.0579	70 - 79 Years	70.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	7		Postmenopausal		4.06	1577	Alive	0	Alive		4.320547945	0	4.320547945	0		0	1		1	0	0	0	0			Luminal B	MB-0579	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			29
MB.0580	30 - 39 Years	33.8 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	2	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	4	Mild	Premenopausal		5.08	2218	Alive	0	Alive		6.076712329	0	6.076712329	0		0	2		0	1	0	0	0			Luminal A	MB-0580	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.0583	70 - 79 Years	75.67 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		3.04	56	Alive	0	Alive		0.153424658	0	0.153424658	0		0	1		1	0	0	0	0			Luminal A	MB-0583	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II																					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			22
MB.0584	40 - 49 Years	41.31 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	7		Premenopausal		4.04	273	Alive	0	Alive		0.747945205	0	0.747945205	0		0	3		0	0	1	0	0			Luminal B	MB-0584	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I																					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.0585	70 - 79 Years	76.72 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	6		Postmenopausal		5.06	1525	Alive	0	Alive		4.178082192	0	4.178082192	0		0	1		1	0	0	0	0			Luminal B	MB-0585	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.0586	70 - 79 Years	77.99 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Low	9	1		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive		Grade 2			Grade 2					4	6		Postmenopausal		4.13	185	Alive	0	Alive		0.506849315	0	0.506849315	0		0	1		1	0	0	0	0			Luminal A	MB-0586	Progesterone Receptor Negative			Progesterone Receptor Negative							Tissue Specimen	Validation	1	Stage III			Stage III																													Hormone Therapy, Radiotherapy	Other Biomarker Status					65
MB.0587	50 - 59 Years	50.41 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Low	18	1		ERBB2 Positive			ERBB2 Positive					ERBB2 Negative	1	Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive		Grade 2			Grade 2					4	9		Postmenopausal		4.05	1995	Alive	0	Alive		5.465753425	0	5.465753425	0		0	3		0	0	1	0	0			Luminal A	MB-0587	Progesterone Receptor Positive			Progesterone Receptor Positive							Tissue Specimen	Validation	1	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years													Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					24
MB.0588	70 - 79 Years	76.35 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 2				Grade 2				4	4		Postmenopausal		3.04	1540	Alive	0	Alive		4.219178082	0	4.219178082	0		1	4		0	0	0	1	0			Normal	MB-0588	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			22
MB.0589	50 - 59 Years	59.96 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	30	25	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	5		Postmenopausal		5.07	1841	Alive	0	Alive		5.043835616	0	5.043835616	0		0	1		1	0	0	0	0			Luminal B	MB-0589	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage IV				Stage IV					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.0590	60 - 69 Years	60.27 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	35	15	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		6.06	1766	Alive	0	Alive		4.838356164	0	4.838356164	0		0	3		0	0	1	0	0			Luminal B	MB-0590	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.0591	80 - 89 Years	84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	18	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	8		Postmenopausal		4.03	978	Alive	0	Alive		2.679452055	0	2.679452055	0		0	1		1	0	0	0	0			Luminal B	MB-0591	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			17
MB.0592	70 - 79 Years	74.94 Years		Invasive Breast Carcinoma	Primary Site	Invasive Breast Carcinoma	Low	1	0		ERBB2 Negative		ERBB2 Negative						ERBB2 Negative		Estrogen Receptor Positive	Estrogen Receptor Positive						Estrogen Receptor Positive										4	8		Postmenopausal		1.11	487	Alive	0	Alive		1.334246575	0	1.334246575	0		0	3		0	0	1	0	0			Luminal B	MB-0592	Progesterone Receptor Positive		Progesterone Receptor Positive								Tissue Specimen	Validation	1	Stage 0		Stage 0							Alive at 1 Year																							No Treatment	Other Biomarker Status	Other Biomarker Status				55
MB.0593	60 - 69 Years	62.34 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	14	13		ERBB2 Positive					ERBB2 Positive			ERBB2 Positive	3	Estrogen Receptor Negative				Estrogen Receptor Negative			Estrogen Receptor Negative	HER2+	Grade 2					Grade 2			3	5		Postmenopausal		5.18	1040	Dead	1	Dead of Disease		2.849315068	1	2.849315068	1		1	4		0	0	0	1	0			Her2	MB-0593	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	1	Stage III					Stage III				Alive at 1 Year		Dead of Disease at 3 Years			Dead at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years				TP53 Wild Type				TP53 Wild Type			Chemotherapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		90
MB.0594	70 - 79 Years	77.96 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	4	Mild	Postmenopausal		5.09	1327	Alive	0	Alive		3.635616438	0	3.635616438	0		0	3		0	0	1	0	0			Luminal B	MB-0594	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			45
MB.0596	70 - 79 Years	77.48 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	1	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2			Grade 2					4	3		Postmenopausal		3.03	1079	Alive	0	Alive		2.956164384	0	2.956164384	0		0	1		1	0	0	0	0			Luminal A	MB-0596	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage I			Stage I						Alive at 1 Year																TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					16
MB.0597	60 - 69 Years	64.55 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		4.03	1648	Alive	0	Alive		4.515068493	0	4.515068493	0		0	2		0	1	0	0	0			Normal	MB-0597	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.0598	70 - 79 Years	77.48 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	25	9	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		5.05	1466	Alive	0	Alive		4.016438356	0	4.016438356	0		1	4		0	0	0	1	0			Luminal B	MB-0598	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			24
MB.0599	40 - 49 Years	46.85 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	21	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	4	Absent	Premenopausal		4.05	2004	Alive	0	Alive		5.490410959	0	5.490410959	0		0	2		0	1	0	0	0			Luminal A	MB-0599	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			24
MB.0600	70 - 79 Years	70.5 Years		Breast Carcinoma	Primary Site	Breast Carcinoma	Moderate	14	9		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3	Grade 3							4	6		Postmenopausal		6.05	1856	Alive	0	Alive		5.084931507	0	5.084931507	0		0	1		1	0	0	0	0			Luminal A	MB-0600	Progesterone Receptor Negative	Progesterone Receptor Negative								European	Tissue Specimen	Discovery	1	Stage II	Stage II								Alive at 1 Year		Alive at 3 Years					Alive at 5 Years	Alive at 5 Years								TP53 Wild Type							Hormone Therapy, Radiotherapy	Other Biomarker Status					27
MB.0601	30 - 39 Years	32.99 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	23	8	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	10		Premenopausal		6.05	880	Dead	1	Dead of Disease		2.410958904	1	2.410958904	1		0	1		1	0	0	0	0			Luminal B	MB-0601	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.0603	70 - 79 Years	79.52 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	7		Postmenopausal		4.04	1415	Alive	0	Alive		3.876712329	0	3.876712329	0		0	1		1	0	0	0	0			Luminal A	MB-0603	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Hormone Therapy	Other Biomarker Status		Other Biomarker Status			21
MB.0605	50 - 59 Years	58.08 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	9	0		ERBB2 Positive			ERBB2 Positive					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2			Grade 2					4	8		Postmenopausal		3.04	1704	Alive	0	Alive		4.668493151	0	4.668493151	0		0	2		0	1	0	0	0			Luminal A	MB-0605	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	1	Stage I			Stage I						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years													TP53 Wild Type		TP53 Wild Type					Hormone Therapy	Other Biomarker Status					18
MB.0606	80 - 89 Years	83.19 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Moderate	8	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2						Grade 2		4	3		Postmenopausal		3.04	824	Dead	1	Dead of Other Causes		2.257534247	0	2.257534247	0		0	3		0	0	1	0	0			Luminal B	MB-0606	Progesterone Receptor Negative							Progesterone Receptor Negative		European	Tissue Specimen	Discovery	1	Stage I							Stage I		Alive at 1 Year		Dead of Other Causes at 3 Years				Dead at 3 Years	Dead of Other Causes at 5 Years							Dead at 5 Years		TP53 Wild Type							Hormone Therapy	Other Biomarker Status					18
MB.0607	50 - 59 Years	53.1 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	4	Severe	Postmenopausal		5.06	1577	Alive	0	Alive		4.320547945	0	4.320547945	0		0	2		0	1	0	0	0			Luminal A	MB-0607	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.0608	70 - 79 Years	76.81 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	High	16	5		ERBB2 Negative						ERBB2 Negative		ERBB2 Negative	1	Estrogen Receptor Negative					Estrogen Receptor Negative		Estrogen Receptor Negative	ER-/HER2-	Grade 3								3	10		Postmenopausal		6.05	463	Alive	0	Alive		1.268493151	0	1.268493151	0		0	5		0	0	0	0	1			Basal	MB-0608	Progesterone Receptor Negative						Progesterone Receptor Negative			European	Tissue Specimen	Discovery	1	Stage II						Stage II			Alive at 1 Year																TP53 Wild Type					TP53 Wild Type		Radiotherapy	ERBB2/ER/PR Negative				ERBB2/ER/PR Negative	25
MB.0609	50 - 59 Years	51.15 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1				Grade 1				4	8		Postmenopausal		3.02	363	Alive	0	Alive		0.994520548	0	0.994520548	0		0	1		1	0	0	0	0			Luminal A	MB-0609	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II																					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			12
MB.0610	70 - 79 Years	71.3 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	4		Postmenopausal		4.04	1498	Alive	0	Alive		4.104109589	0	4.104109589	0		0	1		1	0	0	0	0			Luminal A	MB-0610	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.0611	70 - 79 Years	75.65 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				4	9		Postmenopausal		4.05	626	Alive	0	Alive		1.715068493	0	1.715068493	0		1	4		0	0	0	1	0			Luminal B	MB-0611	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year																						Hormone Therapy	Other Biomarker Status		Other Biomarker Status			24
MB.0613	60 - 69 Years	60.2 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	Moderate	13	0		ERBB2 Negative						ERBB2 Negative		ERBB2 Negative	1	Estrogen Receptor Negative					Estrogen Receptor Negative		Estrogen Receptor Negative	ER-/HER2-	Grade 2								4	4	Mild	Postmenopausal		3.12	1464	Alive	0	Alive		4.010958904	0	4.010958904	0		1	4		0	0	0	1	0			Basal	MB-0613	Progesterone Receptor Negative						Progesterone Receptor Negative			European	Tissue Specimen	Discovery	1	Stage III						Stage III			Alive at 1 Year		Alive at 3 Years														TP53 Mutation	TP53 Truncating Mutation				TP53 Mutation		Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative				ERBB2/ER/PR Negative	60
MB.0614	40 - 49 Years	48.99 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	6		Premenopausal		5.04	257	Alive	0	Alive		0.704109589	0	0.704109589	0		0	1		1	0	0	0	0			Luminal A	MB-0614	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II																					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			19
MB.0615	30 - 39 Years	38.75 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		4	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 2				Grade 2				4	5		Premenopausal		4.01	875	Alive	0	Alive		2.397260274	0	2.397260274	0		1	4		0	0	0	1	0			Normal	MB-0615	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1										Alive at 1 Year	Alive at 1 Year																						No Treatment	Other Biomarker Status		Other Biomarker Status			3
MB.0617	70 - 79 Years	72.14 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Low	8	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Negative		Grade 1						Grade 1		4	4		Postmenopausal		2.08	922	Alive	0	Alive		2.526027397	0	2.526027397	0		0	2		0	1	0	0	0			Normal	MB-0617	Progesterone Receptor Negative							Progesterone Receptor Negative			Tissue Specimen	Validation	1	Stage II							Stage II		Alive at 1 Year																							Hormone Therapy	Other Biomarker Status					40
MB.0618	60 - 69 Years	63.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		3.03	1561	Alive	0	Alive		4.276712329	0	4.276712329	0		0	1		1	0	0	0	0			Luminal B	MB-0618	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			17
MB.0619	30 - 39 Years	38.9 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Moderate	1	1		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative	1	Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3						Grade 3		4	4	Severe	Premenopausal		5.05	489	Alive	0	Alive		1.339726027	0	1.339726027	0		0	1		1	0	0	0	0			Normal	MB-0619	Progesterone Receptor Negative							Progesterone Receptor Negative		European	Tissue Specimen	Discovery	1	Stage II							Stage II		Alive at 1 Year																TP53 Wild Type							Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status					25
MB.0620	60 - 69 Years	62.97 Years		Invasive Breast Carcinoma	Primary Site	Invasive Breast Carcinoma		21	1		ERBB2 Negative		ERBB2 Negative						ERBB2 Negative	1	Estrogen Receptor Positive	Estrogen Receptor Positive						Estrogen Receptor Positive		Grade 3		Grade 3						4	4		Postmenopausal		5.03	501	Alive	0	Alive		1.37260274	0	1.37260274	0		0	2		0	1	0	0	0			Normal	MB-0620	Progesterone Receptor Negative		Progesterone Receptor Negative								Tissue Specimen	Validation	1	Stage II		Stage II							Alive at 1 Year																							Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status	Other Biomarker Status				14
MB.0621	70 - 79 Years	70.04 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	10	1		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	4	Absent	Postmenopausal		4.06	971	Alive	0	Alive		2.660273973	0	2.660273973	0		0	2		0	1	0	0	0			Luminal A	MB-0621	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	1	Stage II					Stage II				Alive at 1 Year																TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		30
MB.0624	60 - 69 Years	64.28 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	3	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		4.03	1291	Alive	0	Alive		3.536986301	0	3.536986301	0		0	2		0	1	0	0	0			Luminal A	MB-0624	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			16
MB.0627	50 - 59 Years	54.1 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate			Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	2	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				4	4		Postmenopausal		5.04	23	Alive	0	Alive		0.063013699	0	0.063013699	0		1	4		0	0	0	1	0			Basal	MB-0627	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1																																	No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			20
MB.0628	60 - 69 Years	63.98 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	7		Postmenopausal		3.02	1121	Alive	0	Alive		3.071232877	0	3.071232877	0		0	2		0	1	0	0	0			Normal	MB-0628	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.0630	30 - 39 Years	38.35 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Premenopausal		4.04	342	Alive	0	Alive		0.936986301	0	0.936986301	0		0	3		0	0	1	0	0			Luminal B	MB-0630	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I																					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0631	80 - 89 Years	84.41 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	4	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	8		Postmenopausal		4.05	1403	Dead	1	Dead of Disease		3.843835616	1	3.843835616	1		0	1		1	0	0	0	0			Luminal A	MB-0631	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.0632	50 - 59 Years	51.92 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	4	Absent	Postmenopausal		3.04	965	Alive	0	Alive		2.643835616	0	2.643835616	0		0	2		0	1	0	0	0			Luminal A	MB-0632	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0635	70 - 79 Years	76.5 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	4	Mild	Postmenopausal		4.03	1171	Alive	0	Alive		3.208219178	0	3.208219178	0		0	2		0	1	0	0	0			Basal	MB-0635	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			14
MB.0637	70 - 79 Years	75.71 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	10		Postmenopausal		4.06	787	Alive	0	Alive		2.156164384	0	2.156164384	0		0	1		1	0	0	0	0			Luminal B	MB-0637	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year															TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			31
MB.0640	60 - 69 Years	66.09 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	7		Postmenopausal		3.03	1112	Alive	0	Alive		3.046575342	0	3.046575342	0		0	2		0	1	0	0	0			Normal	MB-0640	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			13
MB.0641	50 - 59 Years	56.34 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	2	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	4	Mild	Postmenopausal		4.03	1227	Alive	0	Alive		3.361643836	0	3.361643836	0		0	2		0	1	0	0	0			Normal	MB-0641	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			14
MB.0642	70 - 79 Years	79.12 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				4	8		Postmenopausal		2.04	1010	Alive	0	Alive		2.767123288	0	2.767123288	0		0	1		1	0	0	0	0			Luminal A	MB-0642	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.0644	70 - 79 Years	71.06 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	5	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	4	Absent	Postmenopausal		5.06	1057	Alive	0	Alive		2.895890411	0	2.895890411	0		0	2		0	1	0	0	0			Luminal A	MB-0644	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.0649	60 - 69 Years	60.62 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	4	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				4	7		Postmenopausal		4.02	1065	Alive	0	Alive		2.917808219	0	2.917808219	0		0	2		0	1	0	0	0			Luminal A	MB-0649	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			8
MB.0650	70 - 79 Years	79.48 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	2		Postmenopausal		4.04	522	Alive	0	Alive		1.430136986	0	1.430136986	0		0	1		1	0	0	0	0			Luminal A	MB-0650	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.0653	60 - 69 Years	69.95 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	17	2		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Negative	ER+/HER2- High Proliferation	Grade 3			Grade 3					4	9		Postmenopausal		5.06	727	Dead	1	Dead of Disease		1.991780822	1	1.991780822	1		0	3		0	0	1	0	0			Her2	MB-0653	Progesterone Receptor Negative			Progesterone Receptor Negative						European	Tissue Specimen	Discovery	1	Stage II			Stage II						Alive at 1 Year		Dead of Disease at 3 Years	Dead at 3 Years				Dead of Disease at 5 Years			Dead at 5 Years						TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					28
MB.0654	80 - 89 Years	82.5 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				4	8		Postmenopausal		2.05	1283	Alive	0	Alive		3.515068493	0	3.515068493	0		0	1		1	0	0	0	0			Luminal A	MB-0654	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			24
MB.0655	60 - 69 Years	69.73 Years		Invasive Breast Carcinoma	Primary Site	Invasive Breast Carcinoma	Moderate	10	0		ERBB2 Negative		ERBB2 Negative						ERBB2 Negative		Estrogen Receptor Positive	Estrogen Receptor Positive						Estrogen Receptor Positive										4	4		Postmenopausal		1.12	1176	Alive	0	Alive		3.221917808	0	3.221917808	0		0	2		0	1	0	0	0			Normal	MB-0655	Progesterone Receptor Positive		Progesterone Receptor Positive								Tissue Specimen	Validation	1	Stage I		Stage I							Alive at 1 Year		Alive at 3 Years																					No Treatment	Other Biomarker Status	Other Biomarker Status				60
MB.0656	30 - 39 Years	35.9 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				4	5		Premenopausal		4.2	564	Dead	1	Dead of Disease		1.545205479	1	1.545205479	1		0	5		0	0	0	0	1			Basal	MB-0656	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			100
MB.0657	50 - 59 Years	58.65 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	2	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			4	4	Mild	Postmenopausal		3.2	126	Alive	0	Alive		0.345205479	0	0.345205479	0		0	2		0	1	0	0	0			Normal	MB-0657	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	1	Stage II					Stage II																				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		100
MB.0658	60 - 69 Years	60.89 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	16	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	2	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Postmenopausal		5.05	819	Alive	0	Alive		2.243835616	0	2.243835616	0		0	5		0	0	0	0	1			Basal	MB-0658	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			25
MB.0659	80 - 89 Years	82.87 Years		Breast Carcinoma	Primary Site	Breast Carcinoma	Moderate	0	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Negative							Estrogen Receptor Negative	ER-/HER2-	Grade 2	Grade 2							4	4	Absent	Postmenopausal		3.09	8	Dead	1	Dead of Other Causes		0.021917808	0	0.021917808	0		0	5		0	0	0	0	1			Normal	MB-0659	Progesterone Receptor Negative	Progesterone Receptor Negative								European	Tissue Specimen	Discovery	1	Stage 0	Stage 0								Dead of Other Causes at 1 Year		Dead of Other Causes at 3 Years					Dead of Other Causes at 5 Years	Dead at 5 Years								TP53 Wild Type							Radiotherapy	ERBB2/ER/PR Negative					45
MB.0660	50 - 59 Years	52.43 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	High	24	22		ERBB2 Positive						ERBB2 Positive		ERBB2 Negative	1	Estrogen Receptor Positive					Estrogen Receptor Positive		Estrogen Receptor Negative	ER+/HER2- High Proliferation	Grade 3								4	10		Premenopausal		6.32	560	Dead	1	Dead of Disease		1.534246575	1	1.534246575	1		1	4		0	0	0	1	0			Her2	MB-0660	Progesterone Receptor Negative						Progesterone Receptor Negative			European	Tissue Specimen	Discovery	1	Stage I						Stage I			Alive at 1 Year		Dead of Disease at 3 Years					Dead of Disease at 5 Years						Dead at 5 Years			TP53 Mutation	TP53 Missense Mutation				TP53 Mutation		Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status				Other Biomarker Status	160
MB.0661	70 - 79 Years	78.78 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	7		Postmenopausal		3.02	600	Dead	1	Dead of Disease		1.643835616	1	1.643835616	1		0	3		0	0	1	0	0			Luminal A	MB-0661	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			8
MB.0662	50 - 59 Years	50.94 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				4	5		Postmenopausal		4.03	760	Alive	0	Alive		2.082191781	0	2.082191781	0		1	4		0	0	0	1	0			Normal	MB-0662	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			14
MB.0663	50 - 59 Years	57.76 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				4	5		Postmenopausal		4.03	1661	Alive	0	Alive		4.550684932	0	4.550684932	0		1	4		0	0	0	1	0			Her2	MB-0663	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Chemotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.0664	70 - 79 Years	78.27 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	10	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Postmenopausal		6.17	318	Dead	1	Dead of Disease		0.871232877	1	0.871232877	1		0	5		0	0	0	0	1			Basal	MB-0664	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage III				Stage III					Dead of Disease at 1 Year	Dead at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			84
MB.0666	60 - 69 Years	61.31 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	9	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		6.05	730	Dead	1	Dead of Disease		2	1	2	1		1	4		0	0	0	1	0			Luminal A	MB-0666	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.0667	70 - 79 Years	76.24 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	31	11	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	1		Postmenopausal		6.07	2083	Alive	0	Alive		5.706849315	0	5.706849315	0		0	1		1	0	0	0	0			Luminal B	MB-0667 and MB-0025	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			34
MB.0869	50 - 59 Years	58.83 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	10		Postmenopausal		4.06	2957	Dead	1	Dead of Other Causes		8.101369863	0	8.101369863	0		0	5		0	0	0	0	1			Basal	MB-0869	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			29
MB.0872	80 - 89 Years	82.34 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		12	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				4	7		Postmenopausal		4.03	2533	Alive	0	Alive		6.939726027	0	6.939726027	0		0	2		0	1	0	0	0			Normal	MB-0872	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			14
MB.0874	50 - 59 Years	59.22 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	20	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				4	10		Postmenopausal		4.08	498	Dead	1	Dead of Disease		1.364383562	1	1.364383562	1		0	5		0	0	0	0	1			Basal	MB-0874	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			39
MB.0876	50 - 59 Years	54.85 Years	Ductal Breast Carcinoma	Ductal Breast Carcinoma in Situ	Primary Site	Ductal Breast Carcinoma in Situ	Moderate	0	0	Ductal Breast Carcinoma in Situ	ERBB2 Negative	ERBB2 Negative							ERBB2 Negative									Estrogen Receptor Negative										Other	4		Postmenopausal		1	2001	Alive	0	Alive		5.482191781	0	5.482191781	0		0	2		0	1	0	0	0			Basal	MB-0876	Progesterone Receptor Negative										Tissue Specimen	Validation	1	Stage 0									Alive at 1 Year		Alive at 3 Years					Alive at 5 Years																No Treatment						0
MB.0880	70 - 79 Years	73.64 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	19	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				4	7		Postmenopausal		2.06	37	Alive	0	Alive		0.101369863	0	0.101369863	0		0	1		1	0	0	0	0			Luminal A	MB-0880	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II																					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			30
MB.0884	50 - 59 Years	56.47 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	26	15	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				4	9		Postmenopausal		6.05	2810	Dead	1	Dead of Disease		7.698630137	1	7.698630137	1		0	3		0	0	1	0	0			Luminal B	MB-0884	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.0891	80 - 89 Years	83.68 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	Moderate	22	2		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1							Grade 1	4	3		Postmenopausal		3.07	3277	Alive	0	Alive		8.978082192	0	8.978082192	0		0	1		1	0	0	0	0			Luminal A	MB-0891	Progesterone Receptor Negative								Progesterone Receptor Negative	European	Tissue Specimen	Discovery	1	Stage II								Stage II	Alive at 1 Year		Alive at 3 Years					Alive at 5 Years								Alive at 5 Years	TP53 Wild Type						TP53 Wild Type	Hormone Therapy	Other Biomarker Status					37
MB.0893	50 - 59 Years	57.41 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	15	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				4	4	Mild	Postmenopausal		5.06	3241	Alive	0	Alive		8.879452055	0	8.879452055	0		0	2		0	1	0	0	0			Basal	MB-0893	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.0899	50 - 59 Years	50.62 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				4	8		Premenopausal		4.05	1655	Alive	0	Alive		4.534246575	0	4.534246575	0		0	2		0	1	0	0	0			Luminal A	MB-0899	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.0904	80 - 89 Years	83.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	26	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				4	3		Postmenopausal		4.04	2582	Alive	0	Alive		7.073972603	0	7.073972603	0		0	2		0	1	0	0	0			Luminal A	MB-0904	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	1	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			22
MB.0907	70 - 79 Years	72.14 Years	Ductal Breast Carcinoma	Ductal Breast Carcinoma in Situ	Primary Site	Ductal Breast Carcinoma in Situ	Low	0	0	Ductal Breast Carcinoma in Situ	ERBB2 Positive	ERBB2 Positive							ERBB2 Positive									Estrogen Receptor Negative										Other	4		Postmenopausal		2.07	1215	Alive	0	Alive		3.328767123	0	3.328767123	0		1	4		0	0	0	1	0			Normal	MB-0907	Progesterone Receptor Negative										Tissue Specimen	Validation	1	Stage I									Alive at 1 Year		Alive at 3 Years																					No Treatment	Other Biomarker Status					37
MB.4000	70 - 79 Years	76.96 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	High	10	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2						Grade 2		1	4	Mild	Postmenopausal		3.04	842	Dead	1	Dead of Other Causes		2.306849315	0	2.306849315	0		0	3		0	0	1	0	0			Luminal A	MB-4000	Progesterone Receptor Negative							Progesterone Receptor Negative		European	Tissue Specimen	Discovery	3	Stage 0							Stage 0		Alive at 1 Year		Dead of Other Causes at 3 Years				Dead at 3 Years	Dead of Other Causes at 5 Years							Dead at 5 Years		TP53 Wild Type							Radiotherapy	Other Biomarker Status					20
MB.4001	70 - 79 Years	74.51 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	0	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				2	7		Postmenopausal		3.08	1490	Dead	1	Dead of Disease		4.082191781	1	4.082191781	1		0	3		0	0	1	0	0			Luminal A	MB-4001	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.4003	70 - 79 Years	70.31 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	6		Postmenopausal		3.04	3197	Dead	1	Dead of Disease		8.75890411	1	8.75890411	1		0	3		0	0	1	0	0			Her2	MB-4003	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4004	60 - 69 Years	61.16 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	9		Postmenopausal		4.03	7495	Alive	0	Alive		20.53424658	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-4004	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.4011	70 - 79 Years	72.36 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma									ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	8		Postmenopausal		4.04	4978	Alive	0	Alive		13.63835616	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4011	Progesterone Receptor Negative				Progesterone Receptor Negative					European/Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.4012	60 - 69 Years	63.23 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	High	5	0		ERBB2 Negative						ERBB2 Negative		ERBB2 Positive		Estrogen Receptor Negative					Estrogen Receptor Negative		Estrogen Receptor Negative										1	8		Postmenopausal		3.05	8321	Dead	1	Dead of Other Causes		22.79726027	0	10	0		0	3		0	0	1	0	0			Her2	MB-4012	Progesterone Receptor Negative						Progesterone Receptor Negative				Tissue Specimen	Validation	3	Stage II						Stage II			Alive at 1 Year		Alive at 3 Years					Alive at 5 Years						Alive at 5 Years										Radiotherapy	ERBB2/ER/PR Negative				ERBB2/ER/PR Negative	25
MB.4017	70 - 79 Years	76.17 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	6		Postmenopausal		5.08	4179	Dead	1	Dead of Other Causes		11.44931507	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-4017	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.4018	70 - 79 Years	71.32 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	7		Postmenopausal		5.04	3170	Dead	1	Dead of Disease		8.684931507	1	8.684931507	1		0	1		1	0	0	0	0			Luminal A	MB-4018	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.4120	50 - 59 Years	56.19 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.02	6513	Dead	1	Dead of Other Causes		17.84383562	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4120	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			10
MB.4127	50 - 59 Years	54.35 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Postmenopausal		6.08	7745	Dead	1	Dead of Other Causes		21.21917808	0	10	0		0	3		0	0	1	0	0			Her2	MB-4127	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.4139	60 - 69 Years	63.05 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										1	8		Postmenopausal		2.04	4962	Dead	1	Dead of Other Causes		13.59452055	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-4139	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.4140	70 - 79 Years	71.17 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High		0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	8		Postmenopausal		4.05	3435	Dead	1	Dead of Other Causes		9.410958904	0	9.410958904	0		0	3		0	0	1	0	0			Luminal A	MB-4140	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.4141	50 - 59 Years	58.32 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	7		Postmenopausal		4.03	4435	Dead	1	Dead of Disease		12.15068493	1	10	0		0	3		0	0	1	0	0			Her2	MB-4141	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.4145	60 - 69 Years	60.33 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										1	4		Postmenopausal		1.04	6529	Dead	1	Dead of Other Causes		17.88767123	0	10	0		0	1		1	0	0	0	0			Her2	MB-4145	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4146	40 - 49 Years	43.06 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	29	4		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Negative				Estrogen Receptor Negative			Estrogen Receptor Negative	ER-/HER2-	Grade 3					Grade 3			3	4	Severe	Premenopausal		6.04	469	Dead	1	Dead of Disease		1.284931507	1	1.284931507	1		0	5		0	0	0	0	1			Basal	MB-4146	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Dead of Disease at 3 Years			Dead at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative			ERBB2/ER/PR Negative		20
MB.4148	50 - 59 Years	57.85 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	16	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	9		Postmenopausal		5.07	1891	Dead	1	Dead of Disease		5.180821918	1	5.180821918	1		0	3		0	0	1	0	0			Luminal B	MB-4148	Progesterone Receptor Positive				Progesterone Receptor Positive					European/Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.4154	50 - 59 Years	54.22 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	4	Severe	Premenopausal		4.06	1487	Dead	1	Dead of Other Causes		4.073972603	0	4.073972603	0		1	4		0	0	0	1	0			Luminal B	MB-4154	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.4171	60 - 69 Years	64.21 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High		0		ERBB2 Positive					ERBB2 Positive			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3					Grade 3			1	9		Postmenopausal		4.09	5541	Dead	1	Dead of Disease		15.18082192	1	10	0		0	3		0	0	1	0	0			Her2	MB-4171	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											No Treatment	Other Biomarker Status			Other Biomarker Status		43
MB.4173	70 - 79 Years	74.31 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	7		Postmenopausal		4.02	4810	Dead	1	Dead of Other Causes		13.17808219	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4173	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.4212	40 - 49 Years	45.5 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	0	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	4		Premenopausal		3.04	9218	Alive	0	Alive		25.25479452	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4212	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.4230	70 - 79 Years	75.87 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.1	3468	Dead	1	Dead of Other Causes		9.501369863	0	9.501369863	0		0	1		1	0	0	0	0			Luminal A	MB-4230	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.4233	50 - 59 Years	54.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	9		Postmenopausal		5.06	1091	Dead	1	Dead of Disease		2.989041096	1	2.989041096	1		0	3		0	0	1	0	0			Luminal B	MB-4233	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.4236	70 - 79 Years	73.91 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	28	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				2	9		Postmenopausal		5.04	6111	Dead	1	Dead of Other Causes		16.74246575	0	10	0		0	3		0	0	1	0	0			Her2	MB-4236	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.4264	70 - 79 Years	72.17 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	16	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				2	7		Postmenopausal		4.04	4896	Dead	1	Dead of Other Causes		13.41369863	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4264	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4266	20 - 29 Years	28.04 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	23	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	6		Premenopausal		4.09	1017	Dead	1	Dead of Disease		2.78630137	1	2.78630137	1		0	1		1	0	0	0	0			Luminal A	MB-4266	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			45
MB.4270	30 - 39 Years	37.85 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		14	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive		Grade 2				Grade 2				3	9		Premenopausal		5.04	2961	Dead	1	Dead of Disease		8.112328767	1	8.112328767	1		0	3		0	0	1	0	0			Her2	MB-4270	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.4274	70 - 79 Years	74.32 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				2	8		Postmenopausal		4.04	1798	Dead	1	Dead of Disease		4.926027397	1	4.926027397	1		0	3		0	0	1	0	0			Luminal B	MB-4274	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4276	50 - 59 Years	55.07 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 2				Grade 2				2	5		Postmenopausal		4.07	3966	Dead	1	Dead of Disease		10.86575342	1	10	0		1	4		0	0	0	1	0			Her2	MB-4276	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.4283	50 - 59 Years	55.62 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				2	8		Postmenopausal		4.08	5245	Alive	0	Alive		14.36986301	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4283	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.4289	60 - 69 Years	65.49 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	4	0		ERBB2 Positive					ERBB2 Positive			ERBB2 Positive		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1					Grade 1			1	2		Postmenopausal		2.04	2905	Dead	1	Dead of Disease		7.95890411	1	7.95890411	1		0	3		0	0	1	0	0			Her2	MB-4289	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		20
MB.4293	50 - 59 Years	54.16 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.06	6575	Dead	1	Dead of Other Causes		18.01369863	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-4293	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.4298	70 - 79 Years	70.24 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	13	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				2	9		Postmenopausal		4.04	1653	Dead	1	Dead of Disease		4.528767123	1	4.528767123	1		0	1		1	0	0	0	0			Luminal B	MB-4298	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4323	80 - 89 Years	80.04 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	8	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	8		Postmenopausal		3.06	3799	Dead	1	Dead of Other Causes		10.40821918	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4323	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.4342	70 - 79 Years	73.2 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	4		Postmenopausal		2.12	5692	Alive	0	Alive		15.59452055	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-4342	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			62
MB.4343	60 - 69 Years	68.09 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative									Estrogen Receptor Positive		Grade 3				Grade 3				1	4		Postmenopausal		4.05	5958	Dead	1	Dead of Other Causes		16.32328767	0	10	0		1	4		0	0	0	1	0			Her2	MB-4343	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment						25
MB.4357	70 - 79 Years	77.12 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	4	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	4	Severe	Postmenopausal		5.04	3421	Dead	1	Dead of Disease		9.37260274	1	9.37260274	1		0	3		0	0	1	0	0			Luminal A	MB-4357	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4408	70 - 79 Years	71.66 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	9		Postmenopausal		4.04	6197	Dead	1	Dead of Other Causes		16.97808219	0	10	0		0	5		0	0	0	0	1			Basal	MB-4408	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			20
MB.4421	60 - 69 Years	69.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.02	7943	Dead	1	Dead of Other Causes		21.76164384	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4421	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.4529	60 - 69 Years	61.21 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 1				Grade 1				1	3		Postmenopausal		2.03	3794	Dead	1	Dead of Other Causes		10.39452055	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-4529	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.4599	60 - 69 Years	63.83 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	8		Postmenopausal		5.08	5735	Alive	0	Alive		15.71232877	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4599	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.4616	70 - 79 Years	71.47 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.04	2704	Dead	1	Dead of Disease		7.408219178	1	7.408219178	1		0	3		0	0	1	0	0			Luminal A	MB-4616	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4618	40 - 49 Years	40.05 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	1		Premenopausal		3.02	7390	Alive	0	Alive		20.24657534	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-4618	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.4621	30 - 39 Years	39.51 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	8	6	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	10		Premenopausal		6.11	4257	Alive	0	Alive		11.6630137	0	10	0		0	5		0	0	0	0	1			Basal	MB-4621	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			53
MB.4622	40 - 49 Years	40.83 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.1	6852	Alive	0	Alive		18.77260274	0	10	0		0	5		0	0	0	0	1			Basal	MB-4622	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			50
MB.4623	60 - 69 Years	61.88 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	3		Postmenopausal		5.02	2680	Alive	0	Alive		7.342465753	0	7.342465753	0		0	1		1	0	0	0	0			Luminal A	MB-4623	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.4627	50 - 59 Years	55.65 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	15	4		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative	1	Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3			Grade 3					2	3		Postmenopausal		6.04	5599	Dead	1	Dead of Other Causes		15.33972603	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4627	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	3	Stage 0			Stage 0						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years													Hormone Therapy, Radiotherapy	Other Biomarker Status					20
MB.4630	60 - 69 Years	67.48 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	5	0		ERBB2 Positive					ERBB2 Positive			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										1	8		Postmenopausal		3.07	2875	Dead	1	Dead of Other Causes		7.876712329	0	7.876712329	0		0	3		0	0	1	0	0			Luminal B	MB-4630	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	3										Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											No Treatment	Other Biomarker Status			Other Biomarker Status		35
MB.4633	60 - 69 Years	67.03 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	19	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	4	Mild	Postmenopausal		5.05	5046	Alive	0	Alive		13.82465753	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4633	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.4634	60 - 69 Years	66.37 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	3		Postmenopausal		5.03	3288	Dead	1	Dead of Disease		9.008219178	1	9.008219178	1		0	1		1	0	0	0	0			Luminal A	MB-4634	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.4639	70 - 79 Years	71.17 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	9		Postmenopausal		4.06	3570	Dead	1	Dead of Disease		9.780821918	1	9.780821918	1		0	3		0	0	1	0	0			Luminal B	MB-4639	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.4640	60 - 69 Years	61.59 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	18	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	7		Postmenopausal		4.05	6018	Alive	0	Alive		16.48767123	0	10	0		1	4		0	0	0	1	0			Her2	MB-4640	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.4641	60 - 69 Years	64.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	3		Postmenopausal		5.03	4457	Dead	1	Dead of Other Causes		12.2109589	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4641	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.4642	60 - 69 Years	66.27 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	6		Postmenopausal		5.07	6808	Alive	0	Alive		18.65205479	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-4642	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.4643	70 - 79 Years	78.21 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	5		Postmenopausal		4.03	1244	Dead	1	Dead of Disease		3.408219178	1	3.408219178	1		1	4		0	0	0	1	0			Her2	MB-4643	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			15
MB.4644	50 - 59 Years	59.13 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 2				Grade 2				2	5		Postmenopausal		4.05	2700	Dead	1	Dead of Disease		7.397260274	1	7.397260274	1		0	3		0	0	1	0	0			Luminal B	MB-4644	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			23
MB.4648	70 - 79 Years	75.19 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	1		Postmenopausal		4.04	5056	Dead	1	Dead of Other Causes		13.85205479	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-4648	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.4649	60 - 69 Years	61.67 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.05	505	Dead	1	Dead of Other Causes		1.383561644	0	1.383561644	0		0	3		0	0	1	0	0			Luminal B	MB-4649	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.4651	60 - 69 Years	69.96 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	6		Postmenopausal		3.07	909	Dead	1	Dead of Disease		2.490410959	1	2.490410959	1		1	4		0	0	0	1	0			Luminal B	MB-4651	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.4653	40 - 49 Years	44.5 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	3		Premenopausal		4.06	1444	Dead	1	Dead of Disease		3.956164384	1	3.956164384	1		0	2		0	1	0	0	0			Normal	MB-4653	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			31
MB.4654	80 - 89 Years	80.82 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	8		Postmenopausal		4.04	1929	Dead	1	Dead of Other Causes		5.284931507	0	5.284931507	0		0	1		1	0	0	0	0			Luminal B	MB-4654	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4655	60 - 69 Years	64.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	3		Postmenopausal		5.03	2970	Dead	1	Dead of Other Causes		8.136986301	0	8.136986301	0		0	3		0	0	1	0	0			Luminal A	MB-4655	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			16
MB.4661	80 - 89 Years	81.11 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.05	7027	Alive	0	Alive		19.25205479	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4661	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			25
MB.4663	60 - 69 Years	61.97 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Postmenopausal		4.08	7180	Alive	0	Alive		19.67123288	0	10	0		0	5		0	0	0	0	1			Basal	MB-4663	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.4665	50 - 59 Years	54.27 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	4	Mild	Postmenopausal		4.04	7110	Alive	0	Alive		19.47945205	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4665	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			18
MB.4666	50 - 59 Years	57.98 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	16	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	7		Postmenopausal		6.03	3347	Dead	1	Dead of Disease		9.169863014	1	9.169863014	1		0	1		1	0	0	0	0			Luminal A	MB-4666	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			15
MB.4667	60 - 69 Years	65.58 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	7	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Negative				Estrogen Receptor Negative			Estrogen Receptor Negative	ER-/HER2-	Grade 3					Grade 3			1	4	Severe	Postmenopausal		4.04	4088	Alive	0	Alive		11.2	0	10	0		1	4		0	0	0	1	0			Her2	MB-4667	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Radiotherapy	ERBB2/ER/PR Negative			ERBB2/ER/PR Negative		20
MB.4669	60 - 69 Years	68.82 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	26	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	6		Postmenopausal		4.04	3584	Dead	1	Dead of Other Causes		9.819178082	0	9.819178082	0		0	3		0	0	1	0	0			Luminal B	MB-4669	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4670	60 - 69 Years	61 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	20	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.04	2034	Dead	1	Dead of Disease		5.57260274	1	5.57260274	1		0	3		0	0	1	0	0			Luminal A	MB-4670	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.4671	70 - 79 Years	72.48 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	2		Postmenopausal		4.06	1041	Dead	1	Dead of Disease		2.852054795	1	2.852054795	1		0	3		0	0	1	0	0			Luminal B	MB-4671	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.4672	50 - 59 Years	58.78 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	7		Postmenopausal		4.05	6628	Dead	1	Dead of Other Causes		18.15890411	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4672	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			25
MB.4673	60 - 69 Years	63.27 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	4	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				2	9		Postmenopausal		4.04	2610	Dead	1	Dead of Disease		7.150684932	1	7.150684932	1		0	3		0	0	1	0	0			Luminal B	MB-4673	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.4674	70 - 79 Years	75.26 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	4	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	7		Postmenopausal		4.08	2432	Dead	1	Dead of Disease		6.663013699	1	6.663013699	1		0	3		0	0	1	0	0			Luminal A	MB-4674	Progesterone Receptor Positive				Progesterone Receptor Positive					European/Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.4675	50 - 59 Years	59.23 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	8		Postmenopausal		4.04	7099	Alive	0	Alive		19.44931507	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4675	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.4679	60 - 69 Years	64.11 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	Low	17	0		ERBB2 Negative						ERBB2 Negative		ERBB2 Negative	1	Estrogen Receptor Negative					Estrogen Receptor Negative		Estrogen Receptor Negative		Grade 3								1	10		Postmenopausal		4.03	7049	Alive	0	Alive		19.31232877	0	10	0		0	5		0	0	0	0	1			Basal	MB-4679	Progesterone Receptor Negative						Progesterone Receptor Negative				Tissue Specimen	Validation	3	Stage I						Stage I			Alive at 1 Year		Alive at 3 Years					Alive at 5 Years						Alive at 5 Years										No Treatment	ERBB2/ER/PR Negative				ERBB2/ER/PR Negative	15
MB.4681	60 - 69 Years	60.66 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	13	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										1	3		Postmenopausal		1.03	7441	Alive	0	Alive		20.38630137	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4681	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	3	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											No Treatment	Other Biomarker Status			Other Biomarker Status		17
MB.4682	60 - 69 Years	65.5 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate		0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	9		Postmenopausal		4.04	4186	Dead	1	Dead of Disease		11.46849315	1	10	0		0	3		0	0	1	0	0			Luminal A	MB-4682	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.4685	70 - 79 Years	73.6 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	6		Postmenopausal		6.1	1299	Dead	1	Dead of Other Causes		3.55890411	0	3.55890411	0		0	3		0	0	1	0	0			Luminal B	MB-4685	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.4686	50 - 59 Years	53.03 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	3				5.07	1453	Dead	1	Dead of Disease		3.980821918	1	3.980821918	1		1	4		0	0	0	1	0			Luminal A	MB-4686	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.4687	80 - 89 Years	81.98 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	2	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	4	Severe	Postmenopausal		5.04	2223	Dead	1	Dead of Other Causes		6.090410959	0	6.090410959	0		0	2		0	1	0	0	0			Luminal A	MB-4687	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.4688	70 - 79 Years	71.17 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 2				Grade 2				2	5		Postmenopausal		5.09	2559	Dead	1	Dead of Disease		7.010958904	1	7.010958904	1		0	3		0	0	1	0	0			Luminal B	MB-4688	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			45
MB.4691	40 - 49 Years	49.76 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	7				4.02	3971	Alive	0	Alive		10.87945205	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4691	Progesterone Receptor Negative				Progesterone Receptor Negative					African/European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			10
MB.4692	50 - 59 Years	58.49 Years		Invasive Breast Carcinoma	Primary Site	Invasive Breast Carcinoma	High	8	0		ERBB2 Negative		ERBB2 Negative						ERBB2 Negative	1	Estrogen Receptor Positive	Estrogen Receptor Positive						Estrogen Receptor Positive		Grade 1		Grade 1						1	8		Postmenopausal		2.05	3218	Dead	1	Dead of Other Causes		8.816438356	0	8.816438356	0		0	3		0	0	1	0	0			Luminal A	MB-4692	Progesterone Receptor Positive		Progesterone Receptor Positive								Tissue Specimen	Validation	3										Alive at 1 Year		Alive at 3 Years					Alive at 5 Years		Alive at 5 Years														No Treatment	Other Biomarker Status	Other Biomarker Status				25
MB.4694	70 - 79 Years	76.06 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER-/HER2-	Grade 3				Grade 3				1	10		Postmenopausal		4.04	5949	Alive	0	Alive		16.29863014	0	10	0		0	5		0	0	0	0	1			Basal	MB-4694	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4695	60 - 69 Years	61.12 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	9	2		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 2					Grade 2			2	4		Postmenopausal		4.1	639	Dead	1	Dead of Other Causes		1.750684932	0	1.750684932	0		0	2		0	1	0	0	0			Normal	MB-4695	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	3	Stage II					Stage II				Alive at 1 Year		Dead of Other Causes at 3 Years			Dead at 3 Years		Dead of Other Causes at 5 Years					Dead at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		50
MB.4696	40 - 49 Years	49.98 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Premenopausal		4.09	6982	Alive	0	Alive		19.12876712	0	10	0		0	5		0	0	0	0	1			Basal	MB-4696	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			45
MB.4697	70 - 79 Years	79.01 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	21	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										1	3		Postmenopausal		1.06	3540	Dead	1	Dead of Other Causes		9.698630137	0	9.698630137	0		0	1		1	0	0	0	0				MB-4697	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	3										Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											No Treatment	Other Biomarker Status			Other Biomarker Status		30
MB.4698	50 - 59 Years	59.18 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	14	1		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3					Grade 3			2	3		Postmenopausal		5.04	5120	Dead	1	Dead of Disease		14.02739726	1	10	0		0	2		0	1	0	0	0			Luminal A	MB-4698	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		20
MB.4701	40 - 49 Years	47.62 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	8		Postmenopausal		4.05	3826	Alive	0	Alive		10.48219178	0	10	0		1	4		0	0	0	1	0			Luminal A	MB-4701	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.4702	50 - 59 Years	52.13 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	9		Postmenopausal		4.07	3808	Alive	0	Alive		10.43287671	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-4702	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.4704	60 - 69 Years	67.79 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	4	Mild	Postmenopausal		4.1	1920	Dead	1	Dead of Disease		5.260273973	1	5.260273973	1		0	2		0	1	0	0	0			Luminal A	MB-4704	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			49
MB.4705	60 - 69 Years	63.58 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	3		Postmenopausal		3.05	6393	Dead	1	Dead of Other Causes		17.51506849	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-4705	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			27
MB.4706	70 - 79 Years	75.48 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	3		Postmenopausal		4.03	1670	Dead	1	Dead of Other Causes		4.575342466	0	4.575342466	0		0	3		0	0	1	0	0			Luminal A	MB-4706	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.4707	50 - 59 Years	59.85 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Postmenopausal		4.05	6636	Alive	0	Alive		18.18082192	0	10	0		0	5		0	0	0	0	1			Basal	MB-4707	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			27
MB.4709	40 - 49 Years	49.02 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.04	4403	Alive	0	Alive		12.0630137	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4709	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4710	70 - 79 Years	77.12 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	3		Postmenopausal		4.04	1730	Alive	0	Alive		4.739726027	0	4.739726027	0		0	2		0	1	0	0	0			Luminal A	MB-4710	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Hormone Therapy	Other Biomarker Status		Other Biomarker Status			19
MB.4711	50 - 59 Years	56.07 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	12	11	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	5		Postmenopausal		6.2	944	Dead	1	Dead of Disease		2.58630137	1	2.58630137	1		1	4		0	0	0	1	0			Basal	MB-4711	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			99
MB.4712	40 - 49 Years	46.59 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	9		Premenopausal		4.1	6860	Alive	0	Alive		18.79452055	0	10	0		1	4		0	0	0	1	0			Normal	MB-4712	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			50
MB.4714	60 - 69 Years	64.68 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	27	11	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	10		Postmenopausal		6	2510	Dead	1	Dead of Other Causes		6.876712329	0	6.876712329	0		0	5		0	0	0	0	1			Basal	MB-4714	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			1
MB.4715	60 - 69 Years	67.8 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	8		Postmenopausal		5.09	1057	Dead	1	Dead of Disease		2.895890411	1	2.895890411	1		0	5		0	0	0	0	1			Basal	MB-4715	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			45
MB.4716	50 - 59 Years	52.98 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	6	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3					Grade 3			1	3		Premenopausal		4.06	2284	Dead	1	Dead of Disease		6.257534247	1	6.257534247	1		0	1		1	0	0	0	0			Luminal A	MB-4716	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Radiotherapy	Other Biomarker Status			Other Biomarker Status		28
MB.4717	40 - 49 Years	43.51 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High		0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	10		Premenopausal		4.05	1287	Dead	1	Dead of Disease		3.526027397	1	3.526027397	1		0	5		0	0	0	0	1			Basal	MB-4717	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			25
MB.4718	40 - 49 Years	44.27 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	5	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1					Grade 1			1	4	Mild	Premenopausal		2.2	5950	Dead	1	Dead of Disease		16.30136986	1	10	0		0	2		0	1	0	0	0			Normal	MB-4718	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		99
MB.4719	60 - 69 Years	67.27 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		5.04	2447	Dead	1	Dead of Other Causes		6.704109589	0	6.704109589	0		0	1		1	0	0	0	0			Luminal A	MB-4719	Progesterone Receptor Positive				Progesterone Receptor Positive					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			22
MB.4721	60 - 69 Years	66.39 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	12	4		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1					Grade 1			2	8		Postmenopausal		4.12	712	Dead	1	Dead of Disease		1.950684932	1	1.950684932	1		0	1		1	0	0	0	0			Luminal A	MB-4721	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Dead of Disease at 3 Years			Dead at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		60
MB.4722	60 - 69 Years	64.02 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1								Estrogen Receptor Positive										1	8		Postmenopausal		3.05	2583	Alive	0	Alive		7.076712329	0	7.076712329	0		0	3		0	0	1	0	0			Luminal A	MB-4722	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			25
MB.4723	60 - 69 Years	64.76 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	1		Postmenopausal		4.03	6359	Alive	0	Alive		17.42191781	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-4723	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.4724	60 - 69 Years	60.44 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				1	4	Severe	Postmenopausal		4.04	4382	Alive	0	Alive		12.00547945	0	10	0		1	4		0	0	0	1	0			Her2	MB-4724	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4725	60 - 69 Years	65.83 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	1	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				2	5		Postmenopausal		5.05	2963	Dead	1	Dead of Disease		8.117808219	1	8.117808219	1		0	1		1	0	0	0	0			Her2	MB-4725	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			26
MB.4729	70 - 79 Years	75.41 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				2	5		Postmenopausal		5.05	840	Dead	1	Dead of Other Causes		2.301369863	0	2.301369863	0		0	3		0	0	1	0	0			Luminal A	MB-4729	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.4730	50 - 59 Years	51.29 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	8		Premenopausal		4.14	3939	Dead	1	Dead of Other Causes		10.79178082	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4730	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			68
MB.4731	40 - 49 Years	49.43 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	4	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	5		Premenopausal		5.12	1346	Dead	1	Dead of Disease		3.687671233	1	3.687671233	1		1	4		0	0	0	1	0			Her2	MB-4731	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy	Other Biomarker Status		Other Biomarker Status			60
MB.4732	20 - 29 Years	26.72 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	20	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.09	4496	Alive	0	Alive		12.31780822	0	10	0		0	5		0	0	0	0	1			Basal	MB-4732	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			45
MB.4733	50 - 59 Years	56.27 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	4	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	4	Severe	Postmenopausal		6.04	592	Dead	1	Dead of Disease		1.621917808	1	1.621917808	1		0	5		0	0	0	0	1			Basal	MB-4733	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			18
MB.4735	50 - 59 Years	54.18 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.08	6974	Alive	0	Alive		19.10684932	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4735	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			40
MB.4737	50 - 59 Years	52.29 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	1		Postmenopausal		5.09	3666	Alive	0	Alive		10.04383562	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-4737	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			46
MB.4738	40 - 49 Years	42.27 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	Low	9	0		ERBB2 Negative								ERBB2 Negative	1	Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive		Grade 2							Grade 2	1	3		Premenopausal		3.04	5282	Alive	0	Alive		14.47123288	0	10	0		0	2		0	1	0	0	0			Normal	MB-4738	Progesterone Receptor Positive								Progesterone Receptor Positive		Tissue Specimen	Validation	3	Stage I								Stage I	Alive at 1 Year		Alive at 3 Years					Alive at 5 Years								Alive at 5 Years								No Treatment	Other Biomarker Status					20
MB.4739	50 - 59 Years	56.08 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	20	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.03	4850	Dead	1	Dead of Other Causes		13.28767123	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4739	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.4741	50 - 59 Years	53.02 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	6	1		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			2	8		Postmenopausal		4.04	1695	Dead	1	Dead of Disease		4.643835616	1	4.643835616	1		0	1		1	0	0	0	0			Luminal B	MB-4741	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy	Other Biomarker Status			Other Biomarker Status		20
MB.4742	70 - 79 Years	76.42 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	19	5	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	8		Postmenopausal		3.07	2494	Dead	1	Dead of Other Causes		6.832876712	0	6.832876712	0		0	3		0	0	1	0	0			Luminal A	MB-4742	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.4743	50 - 59 Years	52.61 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	6	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			1	4	Mild	Postmenopausal		3.03	6905	Alive	0	Alive		18.91780822	0	10	0		0	2		0	1	0	0	0			Normal	MB-4743	Progesterone Receptor Negative					Progesterone Receptor Negative				Asian	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			No Treatment	Other Biomarker Status			Other Biomarker Status		15
MB.4745	50 - 59 Years	50.08 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Postmenopausal		5.07	1280	Dead	1	Dead of Disease		3.506849315	1	3.506849315	1		1	4		0	0	0	1	0			Her2	MB-4745	Progesterone Receptor Negative				Progesterone Receptor Negative					OddCluster	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			37
MB.4746	30 - 39 Years	38.1 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	11	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive		Grade 3				Grade 3				3	3		Premenopausal		5.09	6690	Alive	0	Alive		18.32876712	0	10	0		0	1		1	0	0	0	0			Normal	MB-4746	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy	Other Biomarker Status		Other Biomarker Status			45
MB.4749	70 - 79 Years	70.57 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	8		Postmenopausal		4.04	1544	Dead	1	Dead of Other Causes		4.230136986	0	4.230136986	0		0	3		0	0	1	0	0			Luminal A	MB-4749	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			22
MB.4750	70 - 79 Years	73.21 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	3	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				2	8		Postmenopausal		4.05	1132	Dead	1	Dead of Disease		3.101369863	1	3.101369863	1		1	4		0	0	0	1	0			Luminal B	MB-4750	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.4752	60 - 69 Years	63.7 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	16	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	6		Postmenopausal		4.12	3758	Dead	1	Dead of Disease		10.29589041	1	10	0		0	1		1	0	0	0	0			Luminal A	MB-4752	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			60
MB.4757	30 - 39 Years	38.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.02	822	Dead	1	Dead of Disease		2.252054795	1	2.252054795	1		0	5		0	0	0	0	1			Basal	MB-4757	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense, Truncating Mutation		TP53 Mutation				Chemotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			10
MB.4758	40 - 49 Years	45.77 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	10		Premenopausal		4.02	6358	Alive	0	Alive		17.41917808	0	10	0		0	5		0	0	0	0	1			Basal	MB-4758	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			10
MB.4760	40 - 49 Years	48.41 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	4		Premenopausal		2.03	3744	Dead	1	Dead of Disease		10.25753425	1	10	0		0	2		0	1	0	0	0			Luminal A	MB-4760	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			15
MB.4762	60 - 69 Years	67.82 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	High	14	0		ERBB2 Negative								ERBB2 Negative	1	Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2							Grade 2	1	7		Postmenopausal		3.03	6828	Alive	0	Alive		18.70684932	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4762	Progesterone Receptor Positive								Progesterone Receptor Positive	European	Tissue Specimen	Discovery	3	Stage 0								Stage 0	Alive at 1 Year		Alive at 3 Years					Alive at 5 Years								Alive at 5 Years	TP53 Wild Type						TP53 Wild Type	Radiotherapy	Other Biomarker Status					15
MB.4763	40 - 49 Years	44.07 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Premenopausal		5.06	3063	Alive	0	Alive		8.391780822	0	8.391780822	0		1	4		0	0	0	1	0			Her2	MB-4763	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.4764	50 - 59 Years	57.95 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	20	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3					Grade 3			1	3		Postmenopausal		4.1	6660	Alive	0	Alive		18.24657534	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-4764	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		50
MB.4767	70 - 79 Years	74.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	9		Postmenopausal		5.08	1414	Dead	1	Dead of Disease		3.873972603	1	3.873972603	1		0	3		0	0	1	0	0			Luminal B	MB-4767	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.4769	60 - 69 Years	65.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	1		Postmenopausal		4.07	651	Dead	1	Dead of Disease		1.783561644	1	1.783561644	1		0	5		0	0	0	0	1			Basal	MB-4769	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			35
MB.4770	70 - 79 Years	70.22 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	10		Postmenopausal		4.03	4562	Dead	1	Dead of Other Causes		12.49863014	0	10	0		1	4		0	0	0	1	0			Her2	MB-4770	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				No Treatment	Other Biomarker Status		Other Biomarker Status			13
MB.4771	40 - 49 Years	47.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	18	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Premenopausal		3.06	6950	Alive	0	Alive		19.04109589	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4771	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.4779	50 - 59 Years	53.39 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	21	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	3		Premenopausal		4.03	3047	Alive	0	Alive		8.347945205	0	8.347945205	0		0	1		1	0	0	0	0			Luminal A	MB-4779	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			13
MB.4782	40 - 49 Years	43.85 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma		14	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative									Estrogen Receptor Positive		Grade 2			Grade 2					1	4		Premenopausal		5	6889	Alive	0	Alive		18.8739726	0	10	0		0	2		0	1	0	0	0			Normal	MB-4782	Progesterone Receptor Positive			Progesterone Receptor Positive							Tissue Specimen	Validation	3										Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years													No Treatment	Other Biomarker Status					
MB.4784	60 - 69 Years	63.35 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	1		Postmenopausal		4.04	4372	Dead	1	Dead of Other Causes		11.97808219	0	10	0		0	3		0	0	1	0	0			Normal	MB-4784	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.4785	70 - 79 Years	75.46 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.06	3650	Dead	1	Dead of Disease		10	1	10	1		0	1		1	0	0	0	0			Luminal A	MB-4785	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.4787	60 - 69 Years	68.85 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	6		Postmenopausal		3.06	2432	Dead	1	Dead of Other Causes		6.663013699	0	6.663013699	0		1	4		0	0	0	1	0			Luminal A	MB-4787	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			30
MB.4790	40 - 49 Years	43.73 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	7		Premenopausal		3.06	2090	Dead	1	Dead of Disease		5.726027397	1	5.726027397	1		0	2		0	1	0	0	0			Luminal A	MB-4790	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			28
MB.4791	80 - 89 Years	83.49 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1				Grade 1				1	4	Severe	Postmenopausal		2.04	5215	Dead	1	Dead of Other Causes		14.28767123	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-4791	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.4792	40 - 49 Years	49.92 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	14	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	10		Premenopausal		5.04	1219	Dead	1	Dead of Disease		3.339726027	1	3.339726027	1		0	5		0	0	0	0	1			Basal	MB-4792	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			20
MB.4794	80 - 89 Years	89 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	7		Postmenopausal		2.07	1365	Dead	1	Dead of Other Causes		3.739726027	0	3.739726027	0		0	3		0	0	1	0	0			Luminal A	MB-4794	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.4796	50 - 59 Years	53.18 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 2				Grade 2				1	5		Postmenopausal		3.05	3848	Alive	0	Alive		10.54246575	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-4796	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			25
MB.4797	80 - 89 Years	81.06 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	9	0		ERBB2 Positive					ERBB2 Positive			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2					Grade 2			1	2		Postmenopausal		3.04	2981	Dead	1	Dead of Other Causes		8.167123288	0	8.167123288	0		0	3		0	0	1	0	0			Luminal A	MB-4797	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		20
MB.4800	60 - 69 Years	61.3 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	6		Postmenopausal		4.05	3328	Dead	1	Dead of Disease		9.117808219	1	9.117808219	1		0	1		1	0	0	0	0			Luminal A	MB-4800	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			25
MB.4801	60 - 69 Years	65.83 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	8		Postmenopausal		6.07	3911	Dead	1	Dead of Other Causes		10.71506849	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4801	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.4802	70 - 79 Years	71.67 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	7	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1								Estrogen Receptor Positive		Grade 2					Grade 2			1	8		Postmenopausal		3.08	1317	Dead	1	Dead of Disease		3.608219178	1	3.608219178	1		0	3		0	0	1	0	0			Luminal B	MB-4802	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	3	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											No Treatment						40
MB.4805	40 - 49 Years	45.39 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	7		Postmenopausal		4.07	3894	Dead	1	Dead of Disease		10.66849315	1	10	0		0	1		1	0	0	0	0			Luminal A	MB-4805	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.4806	40 - 49 Years	49.77 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	18	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	3		Postmenopausal		4.02	6053	Dead	1	Dead of Other Causes		16.58356164	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-4806	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			10
MB.4809	40 - 49 Years	43.77 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	ER-/HER2-	Grade 3				Grade 3				1	10		Premenopausal		4.03	5958	Alive	0	Alive		16.32328767	0	10	0		0	5		0	0	0	0	1			Basal	MB-4809	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				No Treatment	Other Biomarker Status		Other Biomarker Status			14
MB.4814	30 - 39 Years	39.92 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Mild	Premenopausal		3.1	2204	Dead	1	Dead of Disease		6.038356164	1	6.038356164	1		0	2		0	1	0	0	0			Normal	MB-4814	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			50
MB.4818	70 - 79 Years	75.74 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	3		Postmenopausal		4.11	2287	Dead	1	Dead of Other Causes		6.265753425	0	6.265753425	0		0	3		0	0	1	0	0			Luminal B	MB-4818	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			57
MB.4820	60 - 69 Years	67.19 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	2		Postmenopausal		2.03	1719	Dead	1	Dead of Disease		4.709589041	1	4.709589041	1		0	3		0	0	1	0	0			Luminal A	MB-4820	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.4822	70 - 79 Years	76.88 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.02	2749	Dead	1	Dead of Disease		7.531506849	1	7.531506849	1		0	1		1	0	0	0	0			Luminal A	MB-4822	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			10
MB.4823	60 - 69 Years	64.15 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		17	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 2				Grade 2				1	5		Postmenopausal		3	2577	Alive	0	Alive		7.060273973	0	7.060273973	0		0	5		0	0	0	0	1			Her2	MB-4823	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			1
MB.4825	60 - 69 Years	65.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.02	5698	Alive	0	Alive		15.6109589	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4825	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			10
MB.4827	70 - 79 Years	78.54 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.04	1371	Dead	1	Dead of Other Causes		3.756164384	0	3.756164384	0		0	1		1	0	0	0	0			Luminal A	MB-4827	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			22
MB.4828	70 - 79 Years	78.87 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	2	2		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 3					Grade 3			2	1		Postmenopausal		5.16	1275	Dead	1	Dead of Disease		3.493150685	1	3.493150685	1		0	1		1	0	0	0	0			Luminal B	MB-4828	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	3	Stage III					Stage III				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		80
MB.4829	80 - 89 Years	83.27 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	7		Postmenopausal		2.02	5288	Dead	1	Dead of Other Causes		14.48767123	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-4829	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.4832	40 - 49 Years	45.44 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				1	3		Premenopausal		2.02	4252	Dead	1	Dead of Disease		11.64931507	1	10	0		0	2		0	1	0	0	0			Luminal A	MB-4832	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			11
MB.4834	40 - 49 Years	49.61 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	1		Premenopausal		5.05	1085	Dead	1	Dead of Disease		2.97260274	1	2.97260274	1		0	1		1	0	0	0	0			Luminal B	MB-4834	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.4836	50 - 59 Years	55.66 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	4		Postmenopausal		4.03	703	Dead	1	Dead of Disease		1.926027397	1	1.926027397	1		0	3		0	0	1	0	0			Her2	MB-4836	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.4839	60 - 69 Years	67.26 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1								Estrogen Receptor Positive										1	3		Postmenopausal		1.02	6990	Alive	0	Alive		19.15068493	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-4839	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			12
MB.4843	50 - 59 Years	54.35 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										1	8		Postmenopausal		2.06	3509	Alive	0	Alive		9.61369863	0	9.61369863	0		0	2		0	1	0	0	0			Luminal A	MB-4843	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.4845	80 - 89 Years	86.75 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	24	19		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										2	8		Postmenopausal		3.04	764	Dead	1	Dead of Disease		2.093150685	1	2.093150685	1		0	3		0	0	1	0	0			Luminal A	MB-4845	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	3	Stage II					Stage II				Alive at 1 Year		Dead of Disease at 3 Years			Dead at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		20
MB.4846	60 - 69 Years	63.07 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	5		Postmenopausal		3.05	3049	Dead	1	Dead of Disease		8.353424658	1	8.353424658	1		0	1		1	0	0	0	0			Luminal B	MB-4846	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.4849	80 - 89 Years	81.52 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	8		Postmenopausal		4.06	1360	Dead	1	Dead of Disease		3.726027397	1	3.726027397	1		0	3		0	0	1	0	0			Luminal A	MB-4849	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.4851	70 - 79 Years	73.95 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	2		Postmenopausal		4.05	2708	Dead	1	Dead of Disease		7.419178082	1	7.419178082	1		0	3		0	0	1	0	0			Luminal A	MB-4851	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.4853	60 - 69 Years	62.35 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	6	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative	1	Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive										1	8		Postmenopausal		3.03	7351	Alive	0	Alive		20.13972603	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-4853	Progesterone Receptor Positive			Progesterone Receptor Positive							Tissue Specimen	Validation	3	Stage I			Stage I						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years													No Treatment	Other Biomarker Status					16
MB.4855	70 - 79 Years	74.8 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	7		Postmenopausal		5.06	1244	Dead	1	Dead of Other Causes		3.408219178	0	3.408219178	0		0	1		1	0	0	0	0			Luminal A	MB-4855	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.4858	70 - 79 Years	74.56 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				1	5		Postmenopausal		4.03	3880	Dead	1	Dead of Other Causes		10.63013699	0	10	0		1	4		0	0	0	1	0			Luminal A	MB-4858	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				No Treatment	Other Biomarker Status		Other Biomarker Status			15
MB.4859	70 - 79 Years	74.29 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 2				Grade 2				1	4		Postmenopausal		3.03	4734	Dead	1	Dead of Other Causes		12.96986301	0	10	0		0	2		0	1	0	0	0			Normal	MB-4859	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.4860	40 - 49 Years	44.95 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	13	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 2					Grade 2			1	3		Premenopausal		3.02	6239	Alive	0	Alive		17.09315068	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4860	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	3	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Radiotherapy	Other Biomarker Status			Other Biomarker Status		10
MB.4862	60 - 69 Years	64.32 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	1		Postmenopausal		4.05	5619	Alive	0	Alive		15.39452055	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-4862	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.4865	50 - 59 Years	50.7 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Postmenopausal		4.07	6315	Alive	0	Alive		17.30136986	0	10	0		0	5		0	0	0	0	1			Basal	MB-4865	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			35
MB.4866	40 - 49 Years	43.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 1				Grade 1				1	4	Mild	Premenopausal		2.04	6404	Alive	0	Alive		17.54520548	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4866	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.4867	40 - 49 Years	47.03 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Premenopausal		3.05	6261	Alive	0	Alive		17.15342466	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-4867	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			25
MB.4869	60 - 69 Years	67.12 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	20	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.06	879	Dead	1	Dead of Disease		2.408219178	1	2.408219178	1		0	1		1	0	0	0	0			Luminal A	MB-4869	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.4870	50 - 59 Years	57.33 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 1				Grade 1				1	3		Postmenopausal		2.05	6118	Alive	0	Alive		16.76164384	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-4870	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.4871	70 - 79 Years	74.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 2				Grade 2				1	5		Postmenopausal		3.08	1194	Dead	1	Dead of Disease		3.271232877	1	3.271232877	1		0	5		0	0	0	0	1			Normal	MB-4871	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			40
MB.4872	50 - 59 Years	58.69 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	3		Postmenopausal		4.04	4713	Alive	0	Alive		12.91232877	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4872	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.4876	40 - 49 Years	42.45 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	4		Premenopausal		3.06	4518	Dead	1	Dead of Disease		12.37808219	1	10	0		0	1		1	0	0	0	0			Basal	MB-4876	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.4878	70 - 79 Years	79.35 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 2				Grade 2				1	5		Postmenopausal		3.05	674	Dead	1	Dead of Disease		1.846575342	1	1.846575342	1		0	2		0	1	0	0	0			Luminal A	MB-4878	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			25
MB.4879	40 - 49 Years	49.34 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3								Estrogen Receptor Negative		Grade 3				Grade 3				1	5		Premenopausal		4.04	2399	Dead	1	Dead of Other Causes		6.57260274	0	6.57260274	0		1	4		0	0	0	1	0			Her2	MB-4879	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.4880	60 - 69 Years	69.68 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	5	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative									Estrogen Receptor Negative		Grade 3			Grade 3					1	9		Postmenopausal		4.05	6329	Alive	0	Alive		17.33972603	0	10	0		0	5		0	0	0	0	1			Basal	MB-4880	Progesterone Receptor Negative			Progesterone Receptor Negative							Tissue Specimen	Validation	3	Stage II			Stage II						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years													No Treatment						27
MB.4881	30 - 39 Years	37.05 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Premenopausal		4.07	6050	Alive	0	Alive		16.57534247	0	10	0		0	5		0	0	0	0	1			Basal	MB-4881	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			35
MB.4882	70 - 79 Years	76.71 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative									Estrogen Receptor Positive		Grade 1				Grade 1				1	3		Postmenopausal		2.01	6083	Alive	0	Alive		16.66575342	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4882	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			7
MB.4883	50 - 59 Years	57.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1								Estrogen Receptor Positive		Grade 2				Grade 2				1	7		Postmenopausal		3.04	6048	Alive	0	Alive		16.56986301	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4883	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4886	40 - 49 Years	43.42 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Postmenopausal		5.09	1445	Dead	1	Dead of Disease		3.95890411	1	3.95890411	1		1	4		0	0	0	1	0			Her2	MB-4886	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy	Other Biomarker Status		Other Biomarker Status			45
MB.4887	50 - 59 Years	52.09 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	4	Mild	Postmenopausal		5.07	1062	Dead	1	Dead of Disease		2.909589041	1	2.909589041	1		0	2		0	1	0	0	0			Normal	MB-4887	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			33
MB.4888	60 - 69 Years	63.95 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	4	Severe	Postmenopausal		4.03	6015	Alive	0	Alive		16.47945205	0	10	0		0	5		0	0	0	0	1			Basal	MB-4888	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			16
MB.4893	30 - 39 Years	33.04 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	4	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	10		Premenopausal		5.04	5301	Alive	0	Alive		14.52328767	0	10	0		0	5		0	0	0	0	1			Basal	MB-4893	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			20
MB.4894	40 - 49 Years	47.71 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	8		Premenopausal		4.07	6269	Alive	0	Alive		17.17534247	0	10	0		1	4		0	0	0	1	0			Luminal A	MB-4894	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				No Treatment	Other Biomarker Status		Other Biomarker Status			35
MB.4896	40 - 49 Years	41.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	5		Premenopausal		4.06	1946	Dead	1	Dead of Disease		5.331506849	1	5.331506849	1		1	4		0	0	0	1	0			Basal	MB-4896	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			30
MB.4897	40 - 49 Years	40.04 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	Low	11	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive		Grade 1							Grade 1	1	4		Premenopausal		2	5923	Alive	0	Alive		16.22739726	0	10	0		0	2		0	1	0	0	0			Normal	MB-4897	Progesterone Receptor Positive								Progesterone Receptor Positive		Tissue Specimen	Validation	3	Stage I								Stage I	Alive at 1 Year		Alive at 3 Years					Alive at 5 Years								Alive at 5 Years								No Treatment	Other Biomarker Status					1
MB.4898	60 - 69 Years	63.63 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.02	3537	Dead	1	Dead of Disease		9.690410959	1	9.690410959	1		0	3		0	0	1	0	0			Luminal A	MB-4898	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.4899	40 - 49 Years	40.25 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Premenopausal		3.04	5678	Alive	0	Alive		15.55616438	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4899	Progesterone Receptor Positive				Progesterone Receptor Positive					OddCluster	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4900	40 - 49 Years	47.61 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	6		Postmenopausal		3.04	6185	Alive	0	Alive		16.94520548	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-4900	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			18
MB.4904	60 - 69 Years	64.3 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	1	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	5		Postmenopausal		5	3877	Dead	1	Dead of Other Causes		10.62191781	0	10	0		1	4		0	0	0	1	0			Her2	MB-4904	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			
MB.4906	70 - 79 Years	73.03 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1				Grade 1				2	9		Postmenopausal		3.05	5933	Alive	0	Alive		16.25479452	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4906	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			26
MB.4908	60 - 69 Years	69.87 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				2	5		Postmenopausal		5.08	1437	Dead	1	Dead of Disease		3.936986301	1	3.936986301	1		0	1		1	0	0	0	0			Luminal B	MB-4908	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.4911	40 - 49 Years	43.51 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.03	943	Dead	1	Dead of Disease		2.583561644	1	2.583561644	1		0	5		0	0	0	0	1			Basal	MB-4911	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			15
MB.4912	70 - 79 Years	78.19 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	20	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.06	1500	Dead	1	Dead of Disease		4.109589041	1	4.109589041	1		0	3		0	0	1	0	0			Luminal B	MB-4912	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.4929	50 - 59 Years	59.49 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	15	4		ERBB2 Positive					ERBB2 Positive			ERBB2 Positive		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Negative	HER2+	Grade 3					Grade 3			2	5		Postmenopausal		6.05	1200	Dead	1	Dead of Disease		3.287671233	1	3.287671233	1		0	1		1	0	0	0	0			Her2	MB-4929	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years				TP53 Mutation	TP53 Truncating Mutation			TP53 Mutation			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		26
MB.4930	60 - 69 Years	62.43 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				2	9		Postmenopausal		5.06	1753	Alive	0	Alive		4.802739726	0	4.802739726	0		0	3		0	0	1	0	0			Luminal B	MB-4930	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.4933	50 - 59 Years	50.78 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	4	Severe	Premenopausal		3.06	5981	Alive	0	Alive		16.38630137	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4933	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			30
MB.4934	70 - 79 Years	74.85 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	7		Postmenopausal		5.06	2107	Alive	0	Alive		5.77260274	0	5.77260274	0		0	3		0	0	1	0	0			Luminal B	MB-4934	Progesterone Receptor Positive				Progesterone Receptor Positive					OddCluster	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.4935	30 - 39 Years	36.35 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	24	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Premenopausal		5.05	5826	Alive	0	Alive		15.96164384	0	10	0		1	4		0	0	0	1	0			Her2	MB-4935	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy	Other Biomarker Status		Other Biomarker Status			23
MB.4937	40 - 49 Years	41.09 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	6		Premenopausal		4.04	2317	Dead	1	Dead of Disease		6.347945205	1	6.347945205	1		1	4		0	0	0	1	0			Luminal B	MB-4937	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.4938	30 - 39 Years	33.92 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 2				Grade 2				3	10				4.05	2118	Dead	1	Dead of Disease		5.802739726	1	5.802739726	1		0	5		0	0	0	0	1			Basal	MB-4938	Progesterone Receptor Negative				Progesterone Receptor Negative					African/European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			25
MB.4941	50 - 59 Years	57.32 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.04	1759	Dead	1	Dead of Disease		4.819178082	1	4.819178082	1		0	2		0	1	0	0	0			Luminal A	MB-4941	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.4942	60 - 69 Years	60.31 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	Low	14	0		ERBB2 Positive						ERBB2 Positive		ERBB2 Negative	1	Estrogen Receptor Negative					Estrogen Receptor Negative		Estrogen Receptor Negative		Grade 3								1	10		Postmenopausal		4.05	3724	Dead	1	Dead of Other Causes		10.20273973	0	10	0		0	5		0	0	0	0	1			Basal	MB-4942	Progesterone Receptor Negative						Progesterone Receptor Negative				Tissue Specimen	Validation	3	Stage II						Stage II			Alive at 1 Year		Alive at 3 Years					Alive at 5 Years						Alive at 5 Years										Radiotherapy	Other Biomarker Status				Other Biomarker Status	27
MB.4944	70 - 79 Years	77.77 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	2		Postmenopausal		3.04	5159	Alive	0	Alive		14.13424658	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-4944	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.4945	60 - 69 Years	65.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	9		Postmenopausal		5.04	604	Dead	1	Dead of Disease		1.654794521	1	1.654794521	1		0	5		0	0	0	0	1			Basal	MB-4945	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			19
MB.4950	60 - 69 Years	69.99 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	24	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	3		Postmenopausal		6.06	4518	Dead	1	Dead of Disease		12.37808219	1	10	0		0	1		1	0	0	0	0			Luminal A	MB-4950	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.4952	60 - 69 Years	67.15 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				1	4	Severe	Postmenopausal		4.04	5532	Alive	0	Alive		15.15616438	0	10	0		1	4		0	0	0	1	0			Her2	MB-4952	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			21
MB.4956	60 - 69 Years	69.31 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	1		Postmenopausal		6.12	2079	Dead	1	Dead of Disease		5.695890411	1	5.695890411	1		0	3		0	0	1	0	0			Luminal B	MB-4956	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			60
MB.4959	70 - 79 Years	76.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				1	3		Postmenopausal		2.03	3527	Dead	1	Dead of Disease		9.663013699	1	9.663013699	1		0	1		1	0	0	0	0			Luminal A	MB-4959	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			13
MB.4961	50 - 59 Years	56.94 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	19	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.05	6080	Alive	0	Alive		16.65753425	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4961	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.4962	70 - 79 Years	72.44 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.03	4743	Alive	0	Alive		12.99452055	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4962	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			14
MB.4965	60 - 69 Years	69.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.06	1494	Alive	0	Alive		4.093150685	0	4.093150685	0		0	3		0	0	1	0	0			Luminal A	MB-4965	Progesterone Receptor Positive				Progesterone Receptor Positive					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.4966	50 - 59 Years	55.83 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	7	4		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1					Grade 1			2	3		Postmenopausal		4.1	1479	Dead	1	Dead of Disease		4.052054795	1	4.052054795	1		0	1		1	0	0	0	0			Luminal B	MB-4966	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy	Other Biomarker Status			Other Biomarker Status		50
MB.4967	60 - 69 Years	61.16 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	3		Postmenopausal		4.03	3921	Dead	1	Dead of Other Causes		10.74246575	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-4967	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.4968	50 - 59 Years	56.03 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	8	4		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			2	4	Mild			5.05	2361	Alive	0	Alive		6.468493151	0	6.468493151	0		0	3		0	0	1	0	0			Luminal A	MB-4968	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		25
MB.4970	70 - 79 Years	77.45 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.06	2664	Dead	1	Dead of Disease		7.298630137	1	7.298630137	1		0	3		0	0	1	0	0			Luminal B	MB-4970	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			30
MB.4977	70 - 79 Years	72.54 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	8		Postmenopausal		6.04	6077	Alive	0	Alive		16.64931507	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4977	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.4978	50 - 59 Years	58.89 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	14	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										1	3		Postmenopausal		2.04	5953	Alive	0	Alive		16.30958904	0	10	0		1	4		0	0	0	1	0			Normal	MB-4978	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	3	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		20
MB.4981	60 - 69 Years	69.67 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	3		Postmenopausal		6.06	5423	Dead	1	Dead of Disease		14.85753425	1	10	0		0	2		0	1	0	0	0			Luminal A	MB-4981	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.4982	60 - 69 Years	62.99 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				2	4	Mild	Postmenopausal		6.03	575	Dead	1	Dead of Disease		1.575342466	1	1.575342466	1		1	4		0	0	0	1	0			Her2	MB-4982	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.4986	40 - 49 Years	41 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	9		Premenopausal		3.1	2394	Dead	1	Dead of Disease		6.55890411	1	6.55890411	1		0	2		0	1	0	0	0			Luminal A	MB-4986	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.4987	70 - 79 Years	76.37 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	10	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Negative				Estrogen Receptor Negative			Estrogen Receptor Positive		Grade 2					Grade 2			1	8		Postmenopausal		3.04	5603	Alive	0	Alive		15.35068493	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4987	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	3	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											No Treatment	ERBB2/ER/PR Negative			ERBB2/ER/PR Negative		20
MB.4991	70 - 79 Years	77.13 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	6		Postmenopausal		5.08	3806	Alive	0	Alive		10.42739726	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-4991	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.4992	60 - 69 Years	66.47 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	10	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Negative				Estrogen Receptor Negative			Estrogen Receptor Negative	ER+/HER2- Low Proliferation	Grade 2					Grade 2			1	3		Postmenopausal		3.07	4961	Alive	0	Alive		13.59178082	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-4992	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			No Treatment	ERBB2/ER/PR Negative			ERBB2/ER/PR Negative		33
MB.4993	30 - 39 Years	33.55 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	4	Mild	Premenopausal		6.1	2257	Dead	1	Dead of Disease		6.183561644	1	6.183561644	1		1	4		0	0	0	1	0			Her2	MB-4993	Progesterone Receptor Negative				Progesterone Receptor Negative					African/European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			50
MB.4996	60 - 69 Years	69.65 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	17	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 1				Grade 1				2	7		Postmenopausal		3.04	2993	Dead	1	Dead of Other Causes		8.2	0	8.2	0		0	3		0	0	1	0	0			Luminal A	MB-4996	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			18
MB.4998	70 - 79 Years	75.27 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	13	4		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3					Grade 3			2	8		Postmenopausal		6.06	1967	Dead	1	Dead of Disease		5.389041096	1	5.389041096	1		0	3		0	0	1	0	0			Luminal B	MB-4998	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy	Other Biomarker Status			Other Biomarker Status		32
MB.4999	40 - 49 Years	44.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	7		Premenopausal		3.06	5638	Alive	0	Alive		15.44657534	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-4999	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5001	70 - 79 Years	71.61 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	4	Mild	Postmenopausal		4.04	2454	Dead	1	Dead of Disease		6.723287671	1	6.723287671	1		0	3		0	0	1	0	0			Luminal A	MB-5001	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			21
MB.5004	40 - 49 Years	42.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				3	4	Mild	Premenopausal		5.07	5782	Alive	0	Alive		15.84109589	0	10	0		0	1		1	0	0	0	0			Her2	MB-5004	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			37
MB.5008	60 - 69 Years	65.76 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	23	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	10		Postmenopausal		5.12	5762	Alive	0	Alive		15.78630137	0	10	0		0	3		0	0	1	0	0			Her2	MB-5008	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			60
MB.5011	60 - 69 Years	67.68 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.05	2415	Dead	1	Dead of Other Causes		6.616438356	0	6.616438356	0		0	1		1	0	0	0	0			Luminal A	MB-5011	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.5013	60 - 69 Years	68.56 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	3		Postmenopausal		4.04	5637	Alive	0	Alive		15.44383562	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5013	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5014	60 - 69 Years	69.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	6		Postmenopausal		5.04	5688	Alive	0	Alive		15.58356164	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5014	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5015	40 - 49 Years	44.36 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	8		Premenopausal		4.04	5221	Alive	0	Alive		14.30410959	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5015	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.5017	60 - 69 Years	65.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	4	Severe	Postmenopausal		6.03	4348	Alive	0	Alive		11.91232877	0	10	0		0	1		1	0	0	0	0			Her2	MB-5017	Progesterone Receptor Negative				Progesterone Receptor Negative					European/Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			14
MB.5018	70 - 79 Years	72.12 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.06	3258	Dead	1	Dead of Other Causes		8.926027397	0	8.926027397	0		0	3		0	0	1	0	0			Luminal A	MB-5018	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.5019	40 - 49 Years	49.88 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				1	5		Premenopausal		4.02	1134	Dead	1	Dead of Disease		3.106849315	1	3.106849315	1		1	4		0	0	0	1	0			Normal	MB-5019	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.5020	60 - 69 Years	62.68 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	8		Postmenopausal		6.03	2545	Dead	1	Dead of Disease		6.97260274	1	6.97260274	1		0	1		1	0	0	0	0			Luminal A	MB-5020	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.5022	70 - 79 Years	70.71 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				2	5		Postmenopausal		5.06	3558	Dead	1	Dead of Disease		9.747945205	1	9.747945205	1		0	1		1	0	0	0	0			Her2	MB-5022	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			31
MB.5027	40 - 49 Years	46.95 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	3		Premenopausal		4.05	5696	Alive	0	Alive		15.60547945	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5027	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5033	60 - 69 Years	63.92 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Moderate	7	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative	1	Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1						Grade 1		1	1		Postmenopausal		2.09	1582	Dead	1	Dead of Disease		4.334246575	1	4.334246575	1		0	3		0	0	1	0	0			Luminal B	MB-5033	Progesterone Receptor Negative							Progesterone Receptor Negative		European	Tissue Specimen	Discovery	3	Stage 0							Stage 0		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Dead of Disease at 5 Years							Dead at 5 Years		TP53 Wild Type							Radiotherapy	Other Biomarker Status					43
MB.5035	50 - 59 Years	56.47 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	17	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3					Grade 3			1	3		Postmenopausal		4.11	3176	Alive	0	Alive		8.701369863	0	8.701369863	0		0	2		0	1	0	0	0			Luminal A	MB-5035	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			No Treatment	Other Biomarker Status			Other Biomarker Status		55
MB.5039	60 - 69 Years	67.7 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	3	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				2	1		Postmenopausal		5.11	1864	Dead	1	Dead of Disease		5.106849315	1	5.106849315	1		0	3		0	0	1	0	0			Luminal B	MB-5039	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			55
MB.5040	70 - 79 Years	72.73 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	6		Postmenopausal		4.08	2375	Dead	1	Dead of Other Causes		6.506849315	0	6.506849315	0		1	4		0	0	0	1	0			Luminal B	MB-5040	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.5041	40 - 49 Years	45.4 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	2		Premenopausal		4.04	3674	Alive	0	Alive		10.06575342	0	10	0		1	4		0	0	0	1	0			Her2	MB-5041	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5043	70 - 79 Years	70.42 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	8		Postmenopausal		6.08	3851	Dead	1	Dead of Disease		10.55068493	1	10	0		0	1		1	0	0	0	0			Luminal A	MB-5043	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.5044	50 - 59 Years	55.56 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.03	4183	Alive	0	Alive		11.46027397	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5044	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.5045	70 - 79 Years	70.11 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	4	Mild	Postmenopausal		4.05	5049	Dead	1	Dead of Other Causes		13.83287671	0	10	0		1	4		0	0	0	1	0			Luminal A	MB-5045	Progesterone Receptor Positive				Progesterone Receptor Positive					OddCluster	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5048	40 - 49 Years	44.12 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	7		Premenopausal		3.03	2591	Dead	1	Dead of Disease		7.098630137	1	7.098630137	1		0	1		1	0	0	0	0			Luminal A	MB-5048	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.5049	60 - 69 Years	61.76 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.03	5920	Alive	0	Alive		16.21917808	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-5049	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			17
MB.5050	50 - 59 Years	55.04 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.03	5530	Alive	0	Alive		15.15068493	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5050	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5052	70 - 79 Years	76.66 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				2	4	Severe	Postmenopausal		5.07	1037	Dead	1	Dead of Other Causes		2.84109589	0	2.84109589	0		1	4		0	0	0	1	0			Her2	MB-5052	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.5053	60 - 69 Years	68.21 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.04	4518	Dead	1	Dead of Other Causes		12.37808219	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5053	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			21
MB.5054	50 - 59 Years	52.57 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	5		Postmenopausal		4	5631	Alive	0	Alive		15.42739726	0	10	0		1	4		0	0	0	1	0			Basal	MB-5054	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			1
MB.5057	30 - 39 Years	39.25 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Premenopausal		4.03	1690	Dead	1	Dead of Disease		4.630136986	1	4.630136986	1		0	5		0	0	0	0	1			Basal	MB-5057	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			15
MB.5058	60 - 69 Years	61.04 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	7		Postmenopausal		6.03	5362	Dead	1	Dead of Disease		14.69041096	1	10	0		1	4		0	0	0	1	0			Normal	MB-5058	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			15
MB.5059	50 - 59 Years	53.69 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Premenopausal		3.03	21	Alive	0	Alive		0.057534247	0	0.057534247	0		0	1		1	0	0	0	0			Luminal A	MB-5059	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0																					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			17
MB.5060	70 - 79 Years	75.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.05	4503	Dead	1	Dead of Other Causes		12.3369863	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-5060	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5061	70 - 79 Years	71.05 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	7		Postmenopausal		4.05	1183	Alive	0	Alive		3.24109589	0	3.24109589	0		0	3		0	0	1	0	0			Luminal B	MB-5061	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5062	70 - 79 Years	75.55 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				2	1		Postmenopausal		5.04	5048	Alive	0	Alive		13.83013699	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5062	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5063	40 - 49 Years	41.54 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	5		Premenopausal		5.04	5715	Alive	0	Alive		15.65753425	0	10	0		1	4		0	0	0	1	0			Her2	MB-5063	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5064	60 - 69 Years	63.4 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Absent	Postmenopausal		3.04	2745	Alive	0	Alive		7.520547945	0	7.520547945	0		0	3		0	0	1	0	0			Luminal A	MB-5064	Progesterone Receptor Positive				Progesterone Receptor Positive					OddCluster	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.5065	60 - 69 Years	68.66 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	4	Severe	Postmenopausal		4.03	5544	Alive	0	Alive		15.1890411	0	10	0		0	5		0	0	0	0	1			Basal	MB-5065	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			16
MB.5066	50 - 59 Years	53.58 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	3		Postmenopausal		4.05	2841	Alive	0	Alive		7.783561644	0	7.783561644	0		0	1		1	0	0	0	0			Luminal A	MB-5066	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5068	70 - 79 Years	71.19 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.03	5475	Alive	0	Alive		15	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5068	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5070	40 - 49 Years	47.38 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.06	5731	Alive	0	Alive		15.70136986	0	10	0		0	5		0	0	0	0	1			Basal	MB-5070	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			30
MB.5072	50 - 59 Years	52.23 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	4	Mild	Postmenopausal		5.06	1507	Dead	1	Dead of Disease		4.128767123	1	4.128767123	1		1	4		0	0	0	1	0			Her2	MB-5072	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			30
MB.5073	60 - 69 Years	67.87 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	Moderate	0	0		ERBB2 Negative						ERBB2 Negative		ERBB2 Negative	1	Estrogen Receptor Positive					Estrogen Receptor Positive		Estrogen Receptor Positive										2	4		Postmenopausal		3.1	2245	Alive	0	Alive		6.150684932	0	6.150684932	0		0	1		1	0	0	0	0			Luminal A	MB-5073	Progesterone Receptor Positive						Progesterone Receptor Positive				Tissue Specimen	Validation	3	Stage II						Stage II			Alive at 1 Year		Alive at 3 Years					Alive at 5 Years						Alive at 5 Years										Hormone Therapy	Other Biomarker Status				Other Biomarker Status	50
MB.5074	70 - 79 Years	70.59 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	13	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3					Grade 3			1	3		Postmenopausal		4.05	5908	Alive	0	Alive		16.18630137	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5074	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		25
MB.5076	20 - 29 Years	28.05 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	1	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.07	806	Dead	1	Dead of Disease		2.208219178	1	2.208219178	1		0	5		0	0	0	0	1			Basal	MB-5076	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			35
MB.5078	50 - 59 Years	56.33 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 2				Grade 2				2	5		Postmenopausal		4.05	2613	Dead	1	Dead of Disease		7.15890411	1	7.15890411	1		1	4		0	0	0	1	0			Luminal B	MB-5078	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			24
MB.5079	60 - 69 Years	66.38 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	8		Postmenopausal		3.03	5736	Alive	0	Alive		15.71506849	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5079	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5081	40 - 49 Years	43.63 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	9		Premenopausal		3.03	1740	Dead	1	Dead of Disease		4.767123288	1	4.767123288	1		0	2		0	1	0	0	0			Normal	MB-5081	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			16
MB.5084	40 - 49 Years	49 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.04	5936	Alive	0	Alive		16.2630137	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5084	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.5088	70 - 79 Years	72.38 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	18	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.06	3696	Alive	0	Alive		10.1260274	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5088	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.5093	60 - 69 Years	69.95 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	1		Postmenopausal		3.06	4273	Dead	1	Dead of Other Causes		11.70684932	0	10	0		0	1		1	0	0	0	0			Her2	MB-5093	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.5097	50 - 59 Years	56.33 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	1		Premenopausal		3.04	1848	Alive	0	Alive		5.063013699	0	5.063013699	0		0	1		1	0	0	0	0			Luminal B	MB-5097	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			22
MB.5100	30 - 39 Years	32.74 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	18	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		6.04	597	Dead	1	Dead of Disease		1.635616438	1	1.635616438	1		0	5		0	0	0	0	1			Basal	MB-5100	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			20
MB.5101	60 - 69 Years	67.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	6		Postmenopausal		5.1	1030	Dead	1	Dead of Disease		2.821917808	1	2.821917808	1		0	3		0	0	1	0	0			Luminal B	MB-5101	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.5104	70 - 79 Years	73.81 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.03	3675	Dead	1	Dead of Disease		10.06849315	1	10	0		0	1		1	0	0	0	0			Luminal A	MB-5104	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			15
MB.5105	60 - 69 Years	63.24 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	8		Postmenopausal		3.02	5865	Alive	0	Alive		16.06849315	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5105	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			11
MB.5106	50 - 59 Years	59.5 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	2	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	6		Postmenopausal		4.03	5354	Alive	0	Alive		14.66849315	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5106	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5107	60 - 69 Years	61.06 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	15	0		ERBB2 Positive					ERBB2 Positive			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3					Grade 3			1	1		Postmenopausal		4.08	2479	Dead	1	Dead of Disease		6.791780822	1	6.791780822	1		0	3		0	0	1	0	0			Luminal B	MB-5107	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		41
MB.5109	60 - 69 Years	64.94 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.03	3752	Dead	1	Dead of Other Causes		10.27945205	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5109	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5110	50 - 59 Years	59.12 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	9	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										1	3		Postmenopausal		1.05	657	Dead	1	Dead of Disease		1.8	1	1.8	1		0	2		0	1	0	0	0			Normal	MB-5110	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	3	Stage II					Stage II				Alive at 1 Year		Dead of Disease at 3 Years			Dead at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		25
MB.5113	40 - 49 Years	43.8 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	1		Premenopausal		3.03	5269	Alive	0	Alive		14.43561644	0	10	0		0	2		0	1	0	0	0			Normal	MB-5113	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.5114	50 - 59 Years	57.87 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				1	5		Postmenopausal		4.08	461	Dead	1	Dead of Disease		1.263013699	1	1.263013699	1		1	4		0	0	0	1	0			Basal	MB-5114	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.5115	40 - 49 Years	40.57 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.06	2322	Alive	0	Alive		6.361643836	0	6.361643836	0		0	5		0	0	0	0	1			Basal	MB-5115	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			30
MB.5116	70 - 79 Years	74.71 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	18	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	2		Postmenopausal		5.04	2153	Dead	1	Dead of Disease		5.898630137	1	5.898630137	1		0	3		0	0	1	0	0			Luminal B	MB-5116	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.5117	50 - 59 Years	51.09 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.06	5758	Alive	0	Alive		15.77534247	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5117	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5118	70 - 79 Years	72.14 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.02	5615	Alive	0	Alive		15.38356164	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5118	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.5119	70 - 79 Years	75.33 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.04	1793	Alive	0	Alive		4.912328767	0	4.912328767	0		0	1		1	0	0	0	0			Luminal A	MB-5119	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.5120	40 - 49 Years	47.24 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Premenopausal		5.06	834	Dead	1	Dead of Disease		2.284931507	1	2.284931507	1		1	4		0	0	0	1	0			Her2	MB-5120	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5121	70 - 79 Years	72.02 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	16	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3					Grade 3			1	8		Postmenopausal		4.04	3447	Dead	1	Dead of Disease		9.443835616	1	9.443835616	1		0	3		0	0	1	0	0			Luminal B	MB-5121	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy	Other Biomarker Status			Other Biomarker Status		18
MB.5122	70 - 79 Years	77.66 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	5	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	8		Postmenopausal		3.08	3771	Dead	1	Dead of Other Causes		10.33150685	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5122	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.5123	60 - 69 Years	69.72 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	7		Postmenopausal		4.04	2709	Dead	1	Dead of Disease		7.421917808	1	7.421917808	1		0	1		1	0	0	0	0			Luminal A	MB-5123	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.5124	80 - 89 Years	83.96 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	6		Postmenopausal		3.05	3726	Dead	1	Dead of Disease		10.20821918	1	10	0		0	1		1	0	0	0	0			Luminal B	MB-5124	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			26
MB.5126	60 - 69 Years	63.48 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	1	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Postmenopausal		5.02	819	Dead	1	Dead of Disease		2.243835616	1	2.243835616	1		0	5		0	0	0	0	1			Basal	MB-5126	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			10
MB.5127	70 - 79 Years	74.98 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	14	0	Invasive Ductal Breast Carcinoma									ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	1		Postmenopausal		4.06	3615	Alive	0	Alive		9.904109589	0	9.904109589	0		0	3		0	0	1	0	0			Luminal B	MB-5127	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5130	50 - 59 Years	58.61 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	7		Postmenopausal		4.03	5718	Alive	0	Alive		15.66575342	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5130	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5131	60 - 69 Years	64.08 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.01	5910	Alive	0	Alive		16.19178082	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5131	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			3
MB.5134	40 - 49 Years	46.58 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	3		Premenopausal		3.02	5469	Alive	0	Alive		14.98356164	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5134	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.5136	60 - 69 Years	63.22 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	11	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3					Grade 3			1	4	Severe	Postmenopausal		4.04	5362	Alive	0	Alive		14.69041096	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5136	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		20
MB.5137	30 - 39 Years	36.04 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	3	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.05	1298	Alive	0	Alive		3.556164384	0	3.556164384	0		0	5		0	0	0	0	1			Basal	MB-5137	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5138	40 - 49 Years	44.59 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High		2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.03	1110	Dead	1	Dead of Disease		3.04109589	1	3.04109589	1		0	5		0	0	0	0	1			Basal	MB-5138	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			15
MB.5139	60 - 69 Years	69.16 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	1		Postmenopausal		6.06	2699	Dead	1	Dead of Other Causes		7.394520548	0	7.394520548	0		0	3		0	0	1	0	0			Luminal B	MB-5139	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			29
MB.5140	70 - 79 Years	77.31 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	19	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	1		Postmenopausal		5.1	4042	Dead	1	Dead of Disease		11.0739726	1	10	0		0	3		0	0	1	0	0			Luminal B	MB-5140	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.5143	70 - 79 Years	78.8 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.04	3838	Dead	1	Dead of Other Causes		10.51506849	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5143	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5144	50 - 59 Years	57.14 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	9				3.03	2502	Alive	0	Alive		6.854794521	0	6.854794521	0		0	1		1	0	0	0	0			Luminal B	MB-5144	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.5145	60 - 69 Years	61.55 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	9		Postmenopausal		4.05	4777	Dead	1	Dead of Disease		13.08767123	1	10	0		0	5		0	0	0	0	1			Normal	MB-5145	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5147	50 - 59 Years	54.61 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				1	5		Postmenopausal		4.05	608	Alive	0	Alive		1.665753425	0	1.665753425	0		0	1		1	0	0	0	0			Luminal A	MB-5147	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5148	70 - 79 Years	76.72 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 3				Grade 3				1	4		Postmenopausal		4.04	5820	Alive	0	Alive		15.94520548	0	10	0		0	2		0	1	0	0	0			Her2	MB-5148	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5150	60 - 69 Years	69.29 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	4		Postmenopausal		3	3325	Dead	1	Dead of Disease		9.109589041	1	9.109589041	1		0	3		0	0	1	0	0			Normal	MB-5150	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			1
MB.5152	70 - 79 Years	76.19 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	18	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	7		Postmenopausal		4.03	3478	Dead	1	Dead of Other Causes		9.528767123	0	9.528767123	0		0	1		1	0	0	0	0			Luminal A	MB-5152	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			17
MB.5154	30 - 39 Years	31.87 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	3		Premenopausal		4	5125	Alive	0	Alive		14.04109589	0	10	0		1	4		0	0	0	1	0			Normal	MB-5154	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			1
MB.5157	70 - 79 Years	70.68 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER-/HER2-	Grade 3				Grade 3				2	4	Severe	Postmenopausal		6.02	547	Dead	1	Dead of Disease		1.498630137	1	1.498630137	1		1	4		0	0	0	1	0			Normal	MB-5157	Progesterone Receptor Positive				Progesterone Receptor Positive					European/Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.5158	60 - 69 Years	66.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.04	5812	Alive	0	Alive		15.92328767	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5158	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5160	60 - 69 Years	68.52 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.05	2632	Dead	1	Dead of Disease		7.210958904	1	7.210958904	1		0	3		0	0	1	0	0			Luminal B	MB-5160	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5161	40 - 49 Years	44.41 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Severe	Premenopausal		3.02	5260	Alive	0	Alive		14.4109589	0	10	0		0	2		0	1	0	0	0			Normal	MB-5161	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.5162	50 - 59 Years	53.38 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	12	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative									Estrogen Receptor Negative		Grade 2					Grade 2			1	4		Postmenopausal		3.03	4930	Alive	0	Alive		13.50684932	0	10	0		0	2		0	1	0	0	0			Basal	MB-5162	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	3	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											No Treatment						15
MB.5163	60 - 69 Years	69.04 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	3		Postmenopausal		4.04	5553	Alive	0	Alive		15.21369863	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5163	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.5164	40 - 49 Years	48.76 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	5		Premenopausal		4.03	2415	Alive	0	Alive		6.616438356	0	6.616438356	0		0	2		0	1	0	0	0			Normal	MB-5164	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			13
MB.5166	60 - 69 Years	69.23 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				2	5		Postmenopausal		6.06	2422	Dead	1	Dead of Disease		6.635616438	1	6.635616438	1		0	3		0	0	1	0	0			Luminal B	MB-5166	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5167	60 - 69 Years	60.46 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	14	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										1	8		Postmenopausal		1.06	5637	Alive	0	Alive		15.44383562	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5167	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	3	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		30
MB.5169	60 - 69 Years	62.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	3		Postmenopausal		4.05	1559	Dead	1	Dead of Disease		4.271232877	1	4.271232877	1		0	1		1	0	0	0	0			Luminal B	MB-5169	Progesterone Receptor Positive				Progesterone Receptor Positive					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			25
MB.5171	40 - 49 Years	46.79 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	4		Premenopausal		3.02	5550	Dead	1	Dead of Disease		15.20547945	1	10	0		0	2		0	1	0	0	0			Normal	MB-5171	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			11
MB.5172	40 - 49 Years	49.57 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Postmenopausal		6.08	5528	Alive	0	Alive		15.14520548	0	10	0		0	1		1	0	0	0	0			Her2	MB-5172	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.5173	60 - 69 Years	69.05 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Postmenopausal		4.1	664	Dead	1	Dead of Disease		1.819178082	1	1.819178082	1		0	5		0	0	0	0	1			Basal	MB-5173	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			50
MB.5174	50 - 59 Years	54.69 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	0	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive									Estrogen Receptor Positive										1	5		Postmenopausal		1.03	4536	Dead	1	Dead of Other Causes		12.42739726	0	10	0		0	3		0	0	1	0	0			Her2	MB-5174	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			15
MB.5175	50 - 59 Years	50.08 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	15	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	4		Postmenopausal		2.04	5616	Alive	0	Alive		15.38630137	0	10	0		0	2		0	1	0	0	0			Basal	MB-5175	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.5176	50 - 59 Years	53.96 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	4	Severe	Postmenopausal		3.03	3379	Dead	1	Dead of Other Causes		9.257534247	0	9.257534247	0		0	1		1	0	0	0	0			Luminal A	MB-5176	Progesterone Receptor Negative				Progesterone Receptor Negative					OddCluster	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5177	60 - 69 Years	68.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		1	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				2	4		Postmenopausal		5	1957	Dead	1	Dead of Other Causes		5.361643836	0	5.361643836	0		0	3		0	0	1	0	0			Luminal B	MB-5177	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			
MB.5178	60 - 69 Years	65.26 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	6		Postmenopausal		4.04	5530	Alive	0	Alive		15.15068493	0	10	0		0	3		0	0	1	0	0			Normal	MB-5178	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.5179	60 - 69 Years	68.6 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	3		Postmenopausal		4.03	5503	Alive	0	Alive		15.07671233	0	10	0		1	4		0	0	0	1	0			Luminal A	MB-5179	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			15
MB.5182	70 - 79 Years	78.04 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	3		Postmenopausal		4.06	4028	Dead	1	Dead of Other Causes		11.03561644	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5182	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5183	70 - 79 Years	74.34 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.03	3556	Dead	1	Dead of Other Causes		9.742465753	0	9.742465753	0		0	1		1	0	0	0	0			Luminal A	MB-5183	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5184	70 - 79 Years	79.76 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	14	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			1	4	Severe	Postmenopausal		3.04	2680	Dead	1	Dead of Other Causes		7.342465753	0	7.342465753	0		0	2		0	1	0	0	0			Luminal A	MB-5184	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			No Treatment	Other Biomarker Status			Other Biomarker Status		20
MB.5185	60 - 69 Years	61.88 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	4	Mild	Postmenopausal		4.07	2324	Dead	1	Dead of Disease		6.367123288	1	6.367123288	1		0	1		1	0	0	0	0			Luminal A	MB-5185	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.5186	40 - 49 Years	42.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										1	6		Premenopausal		1.02	5438	Alive	0	Alive		14.89863014	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5186	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.5188	60 - 69 Years	65.44 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER-/HER2-	Grade 3				Grade 3				2	10		Postmenopausal		5.05	582	Dead	1	Dead of Disease		1.594520548	1	1.594520548	1		0	5		0	0	0	0	1			Basal	MB-5188	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5189	60 - 69 Years	69.24 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	4	Absent	Postmenopausal		6.1	3359	Dead	1	Dead of Disease		9.202739726	1	9.202739726	1		0	1		1	0	0	0	0			Luminal A	MB-5189	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			50
MB.5193	80 - 89 Years	88.8 Years		Breast Carcinoma	Primary Site	Breast Carcinoma	Moderate	19	1		ERBB2 Negative								ERBB2 Negative	1	Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1	Grade 1							2	7		Postmenopausal		3.06	1628	Dead	1	Dead of Other Causes		4.460273973	0	4.460273973	0		0	3		0	0	1	0	0			Luminal A	MB-5193	Progesterone Receptor Positive	Progesterone Receptor Positive								European	Tissue Specimen	Discovery	3	Stage 0	Stage 0								Alive at 1 Year		Alive at 3 Years					Dead of Other Causes at 5 Years	Dead at 5 Years								TP53 Wild Type							Hormone Therapy	Other Biomarker Status					30
MB.5195	70 - 79 Years	72.16 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				1	5		Postmenopausal		4.03	5617	Alive	0	Alive		15.3890411	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5195	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5196	50 - 59 Years	52.98 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.03	2821	Dead	1	Dead of Disease		7.728767123	1	7.728767123	1		0	1		1	0	0	0	0			Luminal A	MB-5196	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			15
MB.5197	60 - 69 Years	62.11 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	9		Postmenopausal		4.05	5706	Alive	0	Alive		15.63287671	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5197	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5199	60 - 69 Years	65.35 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	24	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	5		Postmenopausal		4.03	5414	Alive	0	Alive		14.83287671	0	10	0		1	4		0	0	0	1	0			Basal	MB-5199	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			15
MB.5200	70 - 79 Years	70.23 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	18	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	1		Postmenopausal		4.03	1569	Dead	1	Dead of Disease		4.298630137	1	4.298630137	1		0	1		1	0	0	0	0			Luminal B	MB-5200	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5201	70 - 79 Years	73.17 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.04	2909	Dead	1	Dead of Other Causes		7.969863014	0	7.969863014	0		0	3		0	0	1	0	0			Luminal A	MB-5201	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5204	70 - 79 Years	76.91 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	3		Postmenopausal		2.05	5391	Alive	0	Alive		14.76986301	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5204	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			24
MB.5205	50 - 59 Years	50.24 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	26	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	ER-/HER2-	Grade 3				Grade 3				3	9		Premenopausal		5.07	5559	Alive	0	Alive		15.23013699	0	10	0		0	5		0	0	0	0	1			Basal	MB-5205	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			35
MB.5206	60 - 69 Years	67.45 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Moderate	15	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative	1	Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2						Grade 2		1	2		Postmenopausal		3.03	5453	Alive	0	Alive		14.93972603	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5206	Progesterone Receptor Negative							Progesterone Receptor Negative		European	Tissue Specimen	Discovery	3	Stage 0							Stage 0		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years		TP53 Wild Type							No Treatment	Other Biomarker Status					15
MB.5208	50 - 59 Years	52.43 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Postmenopausal		4.05	4557	Alive	0	Alive		12.48493151	0	10	0		0	5		0	0	0	0	1			Basal	MB-5208	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			27
MB.5209	70 - 79 Years	79.17 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	4	Severe	Postmenopausal		4.12	1476	Alive	0	Alive		4.043835616	0	4.043835616	0		1	4		0	0	0	1	0			Basal	MB-5209	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			60
MB.5211	60 - 69 Years	68.42 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	7		Postmenopausal		4.06	4514	Alive	0	Alive		12.36712329	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5211	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.5212	80 - 89 Years	80.17 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				1	5		Postmenopausal		4.07	5283	Alive	0	Alive		14.4739726	0	10	0		1	4		0	0	0	1	0			Luminal B	MB-5212	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.5213	70 - 79 Years	74.98 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Postmenopausal		6.05	1302	Dead	1	Dead of Disease		3.567123288	1	3.567123288	1		0	5		0	0	0	0	1			Her2	MB-5213	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5214	60 - 69 Years	66.57 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	2		Postmenopausal		3.04	3221	Dead	1	Dead of Other Causes		8.824657534	0	8.824657534	0		0	2		0	1	0	0	0			Normal	MB-5214	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5215	70 - 79 Years	74.11 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	8		Postmenopausal		6.06	3561	Dead	1	Dead of Disease		9.756164384	1	9.756164384	1		0	3		0	0	1	0	0			Luminal B	MB-5215	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.5218	40 - 49 Years	42.11 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	1		Premenopausal		4.02	5598	Alive	0	Alive		15.3369863	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-5218	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.5219	50 - 59 Years	55.77 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Absent	Postmenopausal		3.04	5354	Alive	0	Alive		14.66849315	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5219	Progesterone Receptor Positive				Progesterone Receptor Positive					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.5221	60 - 69 Years	63.53 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	High	15	0		ERBB2 Negative								ERBB2 Negative	1	Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1							Grade 1	1	8		Postmenopausal		2.04	3939	Dead	1	Dead of Other Causes		10.79178082	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5221	Progesterone Receptor Positive								Progesterone Receptor Positive	European	Tissue Specimen	Discovery	3	Stage 0								Stage 0	Alive at 1 Year		Alive at 3 Years					Alive at 5 Years								Alive at 5 Years	TP53 Wild Type						TP53 Wild Type	No Treatment	Other Biomarker Status					20
MB.5222	70 - 79 Years	76.2 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative	3	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	10		Postmenopausal		4.03	3355	Dead	1	Dead of Other Causes		9.191780822	0	9.191780822	0		1	4		0	0	0	1	0			Her2	MB-5222	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5223	40 - 49 Years	42.05 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	18	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 2				Grade 2				3	4	Severe	Premenopausal		4.04	4340	Dead	1	Dead of Disease		11.89041096	1	10	0		0	2		0	1	0	0	0			Basal	MB-5223	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			22
MB.5224	90+ Years	90.23 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	7		Postmenopausal		5.04	2982	Dead	1	Dead of Disease		8.169863014	1	8.169863014	1		0	1		1	0	0	0	0			Luminal A	MB-5224	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.5225	60 - 69 Years	68.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	1	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Postmenopausal		4.06	1298	Dead	1	Dead of Disease		3.556164384	1	3.556164384	1		0	5		0	0	0	0	1			Basal	MB-5225	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			30
MB.5226	70 - 79 Years	75.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	25	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	4	Mild	Postmenopausal		4.03	5349	Alive	0	Alive		14.65479452	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-5226	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5227	70 - 79 Years	74.46 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	4	Absent	Postmenopausal		4.03	2296	Alive	0	Alive		6.290410959	0	6.290410959	0		0	1		1	0	0	0	0			Luminal A	MB-5227	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			15
MB.5228	70 - 79 Years	72.56 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	7		Postmenopausal		4.06	5422	Alive	0	Alive		14.85479452	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5228	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5229	30 - 39 Years	39.99 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	1	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Premenopausal		5.05	1019	Dead	1	Dead of Disease		2.791780822	1	2.791780822	1		1	4		0	0	0	1	0			Basal	MB-5229	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5230	40 - 49 Years	48.17 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Moderate	19	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2						Grade 2		1	3				3.03	5275	Alive	0	Alive		14.45205479	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5230	Progesterone Receptor Positive							Progesterone Receptor Positive		European	Tissue Specimen	Discovery	3	Stage 0							Stage 0		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years		TP53 Wild Type							Radiotherapy	Other Biomarker Status					15
MB.5231	60 - 69 Years	61.28 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative										1	5		Postmenopausal		3.05	497	Dead	1	Dead of Disease		1.361643836	1	1.361643836	1		1	4		0	0	0	1	0			Her2	MB-5231	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5232	70 - 79 Years	74.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 2				Grade 2				1	10		Postmenopausal		3.03	5131	Alive	0	Alive		14.05753425	0	10	0		0	5		0	0	0	0	1			Basal	MB-5232	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			14
MB.5233	70 - 79 Years	79.59 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.06	5203	Alive	0	Alive		14.25479452	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5233	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5235	50 - 59 Years	59.04 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative		Grade 2				Grade 2				1	9		Postmenopausal		3.01	5488	Alive	0	Alive		15.03561644	0	10	0		0	5		0	0	0	0	1			Basal	MB-5235	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			6
MB.5236	60 - 69 Years	63.02 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	3	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Postmenopausal		5.13	5000	Alive	0	Alive		13.69863014	0	10	0		0	5		0	0	0	0	1			Basal	MB-5236	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			65
MB.5238	40 - 49 Years	46.03 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				3	5		Premenopausal		5.04	1324	Dead	1	Dead of Disease		3.62739726	1	3.62739726	1		0	2		0	1	0	0	0			Normal	MB-5238	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5239	60 - 69 Years	69.5 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative									Estrogen Receptor Positive		Grade 2				Grade 2				1	9		Postmenopausal		3.03	5157	Alive	0	Alive		14.12876712	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5239	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			15
MB.5240	50 - 59 Years	56.92 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.02	3115	Dead	1	Dead of Other Causes		8.534246575	0	8.534246575	0		0	2		0	1	0	0	0			Luminal A	MB-5240	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.5243	60 - 69 Years	62.79 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1				Grade 1				2	1		Postmenopausal		3.11	1153	Dead	1	Dead of Other Causes		3.15890411	0	3.15890411	0		0	1		1	0	0	0	0			Luminal B	MB-5243	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			55
MB.5244	60 - 69 Years	69.2 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	21	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	6		Postmenopausal		4.08	3724	Alive	0	Alive		10.20273973	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5244	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.5251	70 - 79 Years	76.77 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	3		Postmenopausal		2.04	3374	Dead	1	Dead of Disease		9.243835616	1	9.243835616	1		0	3		0	0	1	0	0			Luminal A	MB-5251	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.5253	60 - 69 Years	69.59 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	6	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2					Grade 2			1	3		Postmenopausal		3.06	3062	Dead	1	Dead of Other Causes		8.389041096	0	8.389041096	0		0	1		1	0	0	0	0			Luminal A	MB-5253	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		30
MB.5255	50 - 59 Years	58.7 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	4		Postmenopausal		4.03	1607	Alive	0	Alive		4.402739726	0	4.402739726	0		0	2		0	1	0	0	0			Normal	MB-5255	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years																			Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5256	70 - 79 Years	70.31 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.05	3242	Dead	1	Dead of Disease		8.882191781	1	8.882191781	1		0	1		1	0	0	0	0			Luminal A	MB-5256	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.5258	70 - 79 Years	72.77 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	10		Postmenopausal		4.06	3032	Dead	1	Dead of Other Causes		8.306849315	0	8.306849315	0		0	5		0	0	0	0	1			Basal	MB-5258	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			30
MB.5259	40 - 49 Years	41.28 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	3	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Premenopausal		5.07	1385	Dead	1	Dead of Disease		3.794520548	1	3.794520548	1		1	4		0	0	0	1	0			Her2	MB-5259	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.5260	70 - 79 Years	72.23 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	7		Postmenopausal		4.03	5102	Alive	0	Alive		13.97808219	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5260	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5261	60 - 69 Years	66.12 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.03	3494	Dead	1	Dead of Other Causes		9.57260274	0	9.57260274	0		0	1		1	0	0	0	0			Luminal B	MB-5261	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5264	40 - 49 Years	46.4 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	8		Premenopausal		4.04	5153	Alive	0	Alive		14.11780822	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5264	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.5266	70 - 79 Years	76.83 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High		0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	1		Postmenopausal		4.06	2509	Dead	1	Dead of Other Causes		6.873972603	0	6.873972603	0		0	3		0	0	1	0	0			Luminal B	MB-5266	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.5267	50 - 59 Years	52.77 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	2		Premenopausal		3.03	2132	Dead	1	Dead of Disease		5.84109589	1	5.84109589	1		0	2		0	1	0	0	0			Luminal A	MB-5267	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5268	40 - 49 Years	47.98 Years		Breast Carcinoma	Primary Site	Breast Carcinoma	Moderate	8	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2	Grade 2							1	3		Premenopausal		3.06	5584	Alive	0	Alive		15.29863014	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5268	Progesterone Receptor Positive	Progesterone Receptor Positive								European	Tissue Specimen	Discovery	3	Stage 0	Stage 0								Alive at 1 Year		Alive at 3 Years					Alive at 5 Years	Alive at 5 Years															Radiotherapy	Other Biomarker Status					30
MB.5270	60 - 69 Years	67.1 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	22	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	8		Postmenopausal		5.07	5596	Alive	0	Alive		15.33150685	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5270	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.5271	50 - 59 Years	58.25 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	9		Postmenopausal		3.08	5025	Alive	0	Alive		13.76712329	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5271	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.5272	40 - 49 Years	40.71 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	Moderate	13	0		ERBB2 Negative						ERBB2 Negative		ERBB2 Negative		Estrogen Receptor Positive					Estrogen Receptor Positive		Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3								1	4	Severe	Premenopausal		4.04	5602	Alive	0	Alive		15.34794521	0	10	0		0	2		0	1	0	0	0			Basal	MB-5272	Progesterone Receptor Negative						Progesterone Receptor Negative			OddCluster	Tissue Specimen	Discovery	3	Stage 0						Stage 0			Alive at 1 Year		Alive at 3 Years					Alive at 5 Years						Alive at 5 Years										Radiotherapy	Other Biomarker Status				Other Biomarker Status	20
MB.5273	60 - 69 Years	60.33 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	6		Postmenopausal		4.04	1826	Dead	1	Dead of Disease		5.002739726	1	5.002739726	1		0	1		1	0	0	0	0			Luminal B	MB-5273	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.5275	70 - 79 Years	72.19 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	3		Postmenopausal		3	2279	Dead	1	Dead of Other Causes		6.243835616	0	6.243835616	0		1	4		0	0	0	1	0			Her2	MB-5275	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			
MB.5277	30 - 39 Years	35.78 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Low	21	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative	1	Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive		Grade 2			Grade 2					1	8		Premenopausal		3.04	5908	Alive	0	Alive		16.18630137	0	10	0		0	2		0	1	0	0	0			Normal	MB-5277	Progesterone Receptor Positive			Progesterone Receptor Positive							Tissue Specimen	Validation	3										Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years													No Treatment	Other Biomarker Status					18
MB.5278	40 - 49 Years	47.92 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	11	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										1	4		Premenopausal		1.04	2999	Dead	1	Dead of Disease		8.216438356	1	8.216438356	1		0	2		0	1	0	0	0			Normal	MB-5278	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	3	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											No Treatment	Other Biomarker Status			Other Biomarker Status		20
MB.5279	60 - 69 Years	66.55 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	17	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative	1	Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3					Grade 3			1	8		Postmenopausal		4.08	2063	Dead	1	Dead of Other Causes		5.652054795	0	5.652054795	0		0	3		0	0	1	0	0			Luminal A	MB-5279	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											No Treatment	Other Biomarker Status			Other Biomarker Status		40
MB.5280	40 - 49 Years	45.85 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	1		Premenopausal		4	2336	Dead	1	Dead of Disease		6.4	1	6.4	1		1	4		0	0	0	1	0			Normal	MB-5280	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			2
MB.5281	50 - 59 Years	55.72 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	4	Mild	Postmenopausal		4.03	2379	Alive	0	Alive		6.517808219	0	6.517808219	0		1	4		0	0	0	1	0			Luminal A	MB-5281	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			15
MB.5284	60 - 69 Years	68.18 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	3		Postmenopausal		6.08	1960	Dead	1	Dead of Other Causes		5.369863014	0	5.369863014	0		0	1		1	0	0	0	0			Luminal A	MB-5284	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.5287	60 - 69 Years	69.46 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.04	3720	Dead	1	Dead of Other Causes		10.19178082	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5287	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5288	70 - 79 Years	70.1 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	3		Postmenopausal		4.07	3852	Dead	1	Dead of Other Causes		10.55342466	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5288	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.5289	60 - 69 Years	65.45 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	8		Postmenopausal		5.05	2610	Dead	1	Dead of Other Causes		7.150684932	0	7.150684932	0		0	1		1	0	0	0	0			Luminal A	MB-5289	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			26
MB.5290	60 - 69 Years	69.42 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.04	1108	Dead	1	Dead of Other Causes		3.035616438	0	3.035616438	0		1	4		0	0	0	1	0			Luminal A	MB-5290	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			22
MB.5291	60 - 69 Years	67.25 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	9		Postmenopausal		3.03	4606	Alive	0	Alive		12.61917808	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5291	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5292	80 - 89 Years	82.06 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	5		Postmenopausal		3.01	1453	Dead	1	Dead of Disease		3.980821918	1	3.980821918	1		0	1		1	0	0	0	0			Luminal B	MB-5292	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			5
MB.5293	70 - 79 Years	70.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	26	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.06	5240	Alive	0	Alive		14.35616438	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5293	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5294	30 - 39 Years	31.71 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	32	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		6.2	3394	Alive	0	Alive		9.298630137	0	9.298630137	0		0	5		0	0	0	0	1			Basal	MB-5294	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			99
MB.5295	60 - 69 Years	60.51 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	22	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 2				Grade 2				1	10		Postmenopausal		3.05	2268	Dead	1	Dead of Other Causes		6.21369863	0	6.21369863	0		0	5		0	0	0	0	1			Basal	MB-5295	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			25
MB.5296	70 - 79 Years	78.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				2	5		Postmenopausal		6.08	414	Dead	1	Dead of Disease		1.134246575	1	1.134246575	1		1	4		0	0	0	1	0			Basal	MB-5296	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.5298	40 - 49 Years	49.63 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	38	5	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	10		Premenopausal		6.05	2547	Dead	1	Dead of Disease		6.978082192	1	6.978082192	1		0	5		0	0	0	0	1			Basal	MB-5298	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			23
MB.5299	50 - 59 Years	53.35 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Postmenopausal		5.08	501	Dead	1	Dead of Disease		1.37260274	1	1.37260274	1		0	5		0	0	0	0	1			Basal	MB-5299	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			40
MB.5300	50 - 59 Years	55.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				1	8		Postmenopausal		2.03	4970	Alive	0	Alive		13.61643836	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5300	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5301	60 - 69 Years	64.46 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	ER-/HER2-	Grade 2				Grade 2				1	8		Postmenopausal		3.04	5222	Alive	0	Alive		14.30684932	0	10	0		0	1		1	0	0	0	0			Her2	MB-5301	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			18
MB.5302	50 - 59 Years	52.81 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	6	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1					Grade 1			1	3		Postmenopausal		2.12	5085	Alive	0	Alive		13.93150685	0	10	0		1	4		0	0	0	1	0			Normal	MB-5302	Progesterone Receptor Negative					Progesterone Receptor Negative				OddCluster	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		60
MB.5305	60 - 69 Years	61.88 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	27	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.06	4483	Dead	1	Dead of Disease		12.28219178	1	10	0		0	1		1	0	0	0	0			Luminal A	MB-5305	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.5306	50 - 59 Years	58.26 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	7		Postmenopausal		4.03	4792	Alive	0	Alive		13.12876712	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5306	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			15
MB.5308	60 - 69 Years	67.62 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	19	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	4		Postmenopausal		4.05	3143	Dead	1	Dead of Disease		8.610958904	1	8.610958904	1		0	2		0	1	0	0	0			Normal	MB-5308	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5310	70 - 79 Years	71.4 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.06	3524	Alive	0	Alive		9.654794521	0	9.654794521	0		0	1		1	0	0	0	0			Luminal A	MB-5310	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.5311	70 - 79 Years	73.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER-/HER2-	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.05	1730	Dead	1	Dead of Disease		4.739726027	1	4.739726027	1		0	2		0	1	0	0	0			Luminal A	MB-5311	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			27
MB.5312	50 - 59 Years	50.6 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5				6.12	1137	Dead	1	Dead of Disease		3.115068493	1	3.115068493	1		1	4		0	0	0	1	0			Her2	MB-5312	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy	Other Biomarker Status		Other Biomarker Status			60
MB.5313	70 - 79 Years	79.12 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	19	14	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	1		Postmenopausal		3.06	1396	Dead	1	Dead of Disease		3.824657534	1	3.824657534	1		1	4		0	0	0	1	0			Her2	MB-5313	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.5315	50 - 59 Years	52.13 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	16	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	4	Severe			6.16	1291	Dead	1	Dead of Disease		3.536986301	1	3.536986301	1		1	4		0	0	0	1	0			Her2	MB-5315	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			80
MB.5317	60 - 69 Years	69.7 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	8	1		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 2					Grade 2			2	8		Postmenopausal		4.03	1609	Dead	1	Dead of Disease		4.408219178	1	4.408219178	1		0	3		0	0	1	0	0			Luminal B	MB-5317	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	3	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		15
MB.5318	60 - 69 Years	60.96 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				1	5		Postmenopausal		4.04	425	Dead	1	Dead of Disease		1.164383562	1	1.164383562	1		1	4		0	0	0	1	0			Luminal B	MB-5318	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.5322	60 - 69 Years	66.58 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	2		Postmenopausal		4.05	3069	Dead	1	Dead of Disease		8.408219178	1	8.408219178	1		0	1		1	0	0	0	0			Luminal A	MB-5322	Progesterone Receptor Negative				Progesterone Receptor Negative					European/Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.5323	30 - 39 Years	31.26 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	4	Severe	Premenopausal		4.03	4732	Alive	0	Alive		12.96438356	0	10	0		0	5		0	0	0	0	1			Basal	MB-5323	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			15
MB.5324	60 - 69 Years	64.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	18	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.02	5049	Alive	0	Alive		13.83287671	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5324	Progesterone Receptor Positive				Progesterone Receptor Positive					OddCluster	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			10
MB.5325	40 - 49 Years	43.04 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.16	5116	Alive	0	Alive		14.01643836	0	10	0		0	5		0	0	0	0	1			Basal	MB-5325	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			80
MB.5327	60 - 69 Years	66.94 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 2				Grade 2				1	5		Postmenopausal		3.05	4906	Alive	0	Alive		13.44109589	0	10	0		1	4		0	0	0	1	0			Her2	MB-5327	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5328	70 - 79 Years	74.57 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	1	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	1		Postmenopausal		4.1	426	Dead	1	Dead of Other Causes		1.167123288	0	1.167123288	0		0	3		0	0	1	0	0			Luminal B	MB-5328	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			50
MB.5329	60 - 69 Years	64.64 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	16	4		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Negative				Estrogen Receptor Negative			Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3					Grade 3			3	2		Postmenopausal		6.13	1372	Dead	1	Dead of Disease		3.75890411	1	3.75890411	1		0	2		0	1	0	0	0			Luminal A	MB-5329	Progesterone Receptor Negative					Progesterone Receptor Negative				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative			ERBB2/ER/PR Negative		65
MB.5330	70 - 79 Years	70.49 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.05	3436	Dead	1	Dead of Other Causes		9.41369863	0	9.41369863	0		1	4		0	0	0	1	0			Luminal A	MB-5330	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5331	50 - 59 Years	54.69 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive	3	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 2				Grade 2				1	2		Postmenopausal		3.05	3724	Dead	1	Dead of Disease		10.20273973	1	10	0		0	2		0	1	0	0	0			Luminal A	MB-5331	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			23
MB.5332	60 - 69 Years	68.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	16	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				2	5		Postmenopausal		4.04	2965	Dead	1	Dead of Disease		8.123287671	1	8.123287671	1		0	1		1	0	0	0	0			Her2	MB-5332	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			18
MB.5334	70 - 79 Years	78.44 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	9		Postmenopausal		4.04	2562	Dead	1	Dead of Other Causes		7.019178082	0	7.019178082	0		0	1		1	0	0	0	0			Luminal A	MB-5334	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5335	40 - 49 Years	41.81 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Premenopausal		4.05	757	Dead	1	Dead of Disease		2.073972603	1	2.073972603	1		0	5		0	0	0	0	1			Basal	MB-5335	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			27
MB.5338	60 - 69 Years	61.24 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	1		Postmenopausal		4.04	1550	Dead	1	Dead of Disease		4.246575342	1	4.246575342	1		1	4		0	0	0	1	0			Luminal B	MB-5338	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5339	70 - 79 Years	71.78 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				2	3		Postmenopausal		5.03	5147	Alive	0	Alive		14.10136986	0	10	0		0	2		0	1	0	0	0				MB-5339	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5341	50 - 59 Years	56.37 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	2		Postmenopausal		3.04	5305	Alive	0	Alive		14.53424658	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5341	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5345	70 - 79 Years	76.87 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 1				Grade 1				2	4		Postmenopausal		4.03	5192	Alive	0	Alive		14.22465753	0	10	0		0	2		0	1	0	0	0			Normal	MB-5345	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5347	50 - 59 Years	56.89 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	3		Postmenopausal		5.05	5460	Alive	0	Alive		14.95890411	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5347	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5348	40 - 49 Years	41.27 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	16	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.03	5090	Alive	0	Alive		13.94520548	0	10	0		0	5		0	0	0	0	1			Basal	MB-5348	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			15
MB.5349	70 - 79 Years	72.88 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.03	3784	Alive	0	Alive		10.36712329	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5349	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			15
MB.5350	60 - 69 Years	66.7 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER-/HER2-	Grade 3				Grade 3				2	4	Mild	Postmenopausal		5.05	1609	Dead	1	Dead of Disease		4.408219178	1	4.408219178	1		0	2		0	1	0	0	0			Luminal B	MB-5350	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5351	40 - 49 Years	47.35 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				1	4	Mild	Premenopausal		4	5405	Alive	0	Alive		14.80821918	0	10	0		0	2		0	1	0	0	0			Normal	MB-5351	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			2
MB.5358	70 - 79 Years	72.88 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	3	3		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2			Grade 2					2	3		Postmenopausal		4.11	865	Dead	1	Dead of Disease		2.369863014	1	2.369863014	1		0	1		1	0	0	0	0			Luminal A	MB-5358	Progesterone Receptor Negative			Progesterone Receptor Negative						European	Tissue Specimen	Discovery	3	Stage 0			Stage 0						Alive at 1 Year		Dead of Disease at 3 Years	Dead at 3 Years				Dead of Disease at 5 Years			Dead at 5 Years						TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					57
MB.5361	70 - 79 Years	76.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	3	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.08	461	Dead	1	Dead of Disease		1.263013699	1	1.263013699	1		0	1		1	0	0	0	0			Luminal A	MB-5361	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.5364	50 - 59 Years	56.89 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	3		Postmenopausal		4.03	3773	Dead	1	Dead of Disease		10.3369863	1	10	0		0	2		0	1	0	0	0			Normal	MB-5364	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5365	70 - 79 Years	79.29 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	22	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	7		Postmenopausal		4.05	691	Dead	1	Dead of Disease		1.893150685	1	1.893150685	1		0	1		1	0	0	0	0			Luminal A	MB-5365	Progesterone Receptor Positive				Progesterone Receptor Positive					European/Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5366	70 - 79 Years	75.56 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				2	5		Postmenopausal		5.08	5059	Alive	0	Alive		13.86027397	0	10	0		0	1		1	0	0	0	0			Her2	MB-5366	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.5368	70 - 79 Years	77.15 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	8	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				2	4		Postmenopausal		5.03	3004	Dead	1	Dead of Other Causes		8.230136986	0	8.230136986	0		0	2		0	1	0	0	0			Normal	MB-5368	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			15
MB.5369	60 - 69 Years	66.18 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.05	1179	Dead	1	Dead of Disease		3.230136986	1	3.230136986	1		0	1		1	0	0	0	0			Luminal A	MB-5369	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5370	60 - 69 Years	62.55 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	5	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3					Grade 3			1	8		Postmenopausal		4.04	3579	Dead	1	Dead of Other Causes		9.805479452	0	9.805479452	0		0	3		0	0	1	0	0			Luminal B	MB-5370	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		22
MB.5373	60 - 69 Years	67.13 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	14	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				2	4		Postmenopausal		5.05	76	Alive	0	Alive		0.208219178	0	0.208219178	0		0	1		1	0	0	0	0			Luminal B	MB-5373	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II																												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5377	30 - 39 Years	35.14 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	28	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				3	8		Premenopausal		6.09	3060	Dead	1	Dead of Disease		8.383561644	1	8.383561644	1		0	1		1	0	0	0	0			Luminal B	MB-5377	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			45
MB.5378	50 - 59 Years	57.99 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	ER-/HER2-	Grade 3				Grade 3				3	10		Postmenopausal		5.09	368	Dead	1	Dead of Disease		1.008219178	1	1.008219178	1		0	5		0	0	0	0	1			Basal	MB-5378	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			45
MB.5381	40 - 49 Years	44 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Premenopausal		5.1	5137	Alive	0	Alive		14.0739726	0	10	0		1	4		0	0	0	1	0			Her2	MB-5381	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			50
MB.5382	60 - 69 Years	69.27 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	7		Postmenopausal		5.06	3487	Dead	1	Dead of Other Causes		9.553424658	0	9.553424658	0		0	1		1	0	0	0	0			Luminal A	MB-5382	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5383	80 - 89 Years	83.9 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.15	3410	Dead	1	Dead of Disease		9.342465753	1	9.342465753	1		0	1		1	0	0	0	0			Luminal A	MB-5383	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			75
MB.5384	60 - 69 Years	61.05 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	1		Postmenopausal		3.03	2135	Dead	1	Dead of Other Causes		5.849315068	0	5.849315068	0		0	1		1	0	0	0	0			Luminal A	MB-5384	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			13
MB.5385	80 - 89 Years	83.32 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Moderate	17	0		ERBB2 Positive							ERBB2 Positive	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1						Grade 1		1	4	Absent	Postmenopausal		2.04	4464	Dead	1	Dead of Other Causes		12.23013699	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5385	Progesterone Receptor Positive							Progesterone Receptor Positive		European	Tissue Specimen	Discovery	3	Stage 0							Stage 0		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years									Hormone Therapy, Radiotherapy	Other Biomarker Status					20
MB.5386	60 - 69 Years	65.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	7		Postmenopausal		3.04	5082	Alive	0	Alive		13.92328767	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5386	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5387	40 - 49 Years	45.33 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	High	10	2		ERBB2 Negative						ERBB2 Negative		ERBB2 Negative		Estrogen Receptor Negative					Estrogen Receptor Negative		Estrogen Receptor Negative	ER-/HER2-	Grade 3								3	10		Premenopausal		5.03	1369	Dead	1	Dead of Disease		3.750684932	1	3.750684932	1		0	5		0	0	0	0	1			Basal	MB-5387	Progesterone Receptor Negative						Progesterone Receptor Negative			European	Tissue Specimen	Discovery	3	Stage 0						Stage 0			Alive at 1 Year		Alive at 3 Years					Dead of Disease at 5 Years						Dead at 5 Years										Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative				ERBB2/ER/PR Negative	13
MB.5388	60 - 69 Years	69.8 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.03	4408	Dead	1	Dead of Other Causes		12.07671233	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5388	Progesterone Receptor Positive				Progesterone Receptor Positive					European/Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5389	60 - 69 Years	64.76 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	18	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.06	3743	Dead	1	Dead of Other Causes		10.25479452	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5389	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			31
MB.5390	30 - 39 Years	37.27 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	23	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		6.03	928	Dead	1	Dead of Disease		2.542465753	1	2.542465753	1		0	5		0	0	0	0	1			Basal	MB-5390	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			13
MB.5392	50 - 59 Years	57.34 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	19	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	4	Severe	Postmenopausal		4.03	5066	Alive	0	Alive		13.87945205	0	10	0		1	4		0	0	0	1	0			Her2	MB-5392	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			14
MB.5395	70 - 79 Years	71.51 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	3		Postmenopausal		4.03	4955	Alive	0	Alive		13.57534247	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5395	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			14
MB.5396	60 - 69 Years	61.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	9		Postmenopausal		4.03	4970	Alive	0	Alive		13.61643836	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5396	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			14
MB.5397	60 - 69 Years	61.16 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	3		Postmenopausal		4.1	5114	Alive	0	Alive		14.0109589	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5397	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			50
MB.5398	70 - 79 Years	71.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	4	Absent	Postmenopausal		5.04	5386	Alive	0	Alive		14.75616438	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5398	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5399	70 - 79 Years	73.1 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	6	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	3		Postmenopausal		2.04	3204	Dead	1	Dead of Disease		8.778082192	1	8.778082192	1		0	1		1	0	0	0	0			Luminal A	MB-5399	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			22
MB.5401	70 - 79 Years	75.42 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.02	2105	Alive	0	Alive		5.767123288	0	5.767123288	0		0	1		1	0	0	0	0			Luminal A	MB-5401	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			12
MB.5402	80 - 89 Years	81.76 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.03	3233	Dead	1	Dead of Other Causes		8.857534247	0	8.857534247	0		0	1		1	0	0	0	0			Luminal A	MB-5402	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			16
MB.5403	80 - 89 Years	85.94 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		5.05	2872	Dead	1	Dead of Other Causes		7.868493151	0	7.868493151	0		0	3		0	0	1	0	0			Luminal A	MB-5403	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5404	80 - 89 Years	81.57 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.07	2242	Dead	1	Dead of Disease		6.142465753	1	6.142465753	1		0	1		1	0	0	0	0			Luminal A	MB-5404	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.5405	60 - 69 Years	64.43 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	3		Postmenopausal		5.05	3528	Alive	0	Alive		9.665753425	0	9.665753425	0		0	3		0	0	1	0	0			Luminal B	MB-5405	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5407	30 - 39 Years	36.03 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	8		Premenopausal		4	3011	Alive	0	Alive		8.249315068	0	8.249315068	0		0	2		0	1	0	0	0			Luminal A	MB-5407	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			1
MB.5408	60 - 69 Years	65.48 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Negative	ER-/HER2-	Grade 2				Grade 2				1	4	Severe	Postmenopausal		3.03	3042	Alive	0	Alive		8.334246575	0	8.334246575	0		0	2		0	1	0	0	0			Normal	MB-5408	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.5409	50 - 59 Years	51.62 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Postmenopausal		6.04	5262	Alive	0	Alive		14.41643836	0	10	0		1	4		0	0	0	1	0			Her2	MB-5409	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.5410	60 - 69 Years	66.45 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	8		Postmenopausal		4.06	2787	Alive	0	Alive		7.635616438	0	7.635616438	0		0	3		0	0	1	0	0			Luminal A	MB-5410	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5411	40 - 49 Years	43.61 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	20	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Premenopausal		5.04	780	Dead	1	Dead of Disease		2.136986301	1	2.136986301	1		1	4		0	0	0	1	0			Her2	MB-5411	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.5412	50 - 59 Years	51.87 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	11	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2			Grade 2					1	3		Premenopausal		3.03	3850	Alive	0	Alive		10.54794521	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5412	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	3	Stage 0			Stage 0						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years						TP53 Wild Type		TP53 Wild Type					Radiotherapy	Other Biomarker Status					14
MB.5417	40 - 49 Years	45.8 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Premenopausal		6.12	3212	Alive	0	Alive		8.8	0	8.8	0		0	1		1	0	0	0	0			Her2	MB-5417	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			60
MB.5418	60 - 69 Years	64.15 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				2	5		Postmenopausal		5.05	2260	Alive	0	Alive		6.191780822	0	6.191780822	0		0	1		1	0	0	0	0			Luminal B	MB-5418	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5420	70 - 79 Years	71.49 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	5		Postmenopausal		4.04	3018	Alive	0	Alive		8.268493151	0	8.268493151	0		0	5		0	0	0	0	1			Basal	MB-5420	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5421	60 - 69 Years	68 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	10		Postmenopausal		4.04	5245	Alive	0	Alive		14.36986301	0	10	0		0	5		0	0	0	0	1			Basal	MB-5421	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			20
MB.5422	40 - 49 Years	47.14 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1				Grade 1				1	6				2.06	1382	Dead	1	Dead of Disease		3.78630137	1	3.78630137	1		0	1		1	0	0	0	0			Luminal A	MB-5422	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			32
MB.5424	60 - 69 Years	66.42 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	2		Postmenopausal		3.03	2506	Dead	1	Dead of Disease		6.865753425	1	6.865753425	1		0	1		1	0	0	0	0			Luminal A	MB-5424	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			13
MB.5425	60 - 69 Years	67.59 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				2	7		Postmenopausal		4.08	1484	Dead	1	Dead of Disease		4.065753425	1	4.065753425	1		0	1		1	0	0	0	0			Luminal A	MB-5425	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.5426	50 - 59 Years	53.69 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	32	11	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	10		Postmenopausal		6.05	1039	Dead	1	Dead of Disease		2.846575342	1	2.846575342	1		1	4		0	0	0	1	0			Basal	MB-5426	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5428	50 - 59 Years	55.36 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	4		Postmenopausal		3.03	4514	Alive	0	Alive		12.36712329	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5428	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5429	80 - 89 Years	86.04 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Absent	Postmenopausal		3.04	921	Dead	1	Dead of Other Causes		2.523287671	0	2.523287671	0		0	1		1	0	0	0	0			Luminal A	MB-5429	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.5431	40 - 49 Years	49.91 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	4		Premenopausal		3.03	476	Dead	1	Dead of Disease		1.304109589	1	1.304109589	1		0	5		0	0	0	0	1			Basal	MB-5431	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5432	60 - 69 Years	61 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	7		Postmenopausal		4.04	2955	Dead	1	Dead of Other Causes		8.095890411	0	8.095890411	0		0	3		0	0	1	0	0			Luminal A	MB-5432	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.5433	60 - 69 Years	69.37 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.06	2421	Alive	0	Alive		6.632876712	0	6.632876712	0		0	3		0	0	1	0	0			Luminal A	MB-5433	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.5434	70 - 79 Years	71.07 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	16	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				2	9		Postmenopausal		5.11	1355	Dead	1	Dead of Disease		3.712328767	1	3.712328767	1		0	3		0	0	1	0	0			Luminal B	MB-5434	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			55
MB.5435	70 - 79 Years	77.09 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	2	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										1	9		Postmenopausal		1.05	3120	Dead	1	Dead of Other Causes		8.547945205	0	8.547945205	0		0	1		1	0	0	0	0			Luminal B	MB-5435	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5440	40 - 49 Years	49.05 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	High	17	1		ERBB2 Negative						ERBB2 Negative		ERBB2 Negative		Estrogen Receptor Negative					Estrogen Receptor Negative		Estrogen Receptor Negative		Grade 3								3	10		Premenopausal		5.04	3511	Alive	0	Alive		9.619178082	0	9.619178082	0		0	5		0	0	0	0	1			Basal	MB-5440	Progesterone Receptor Negative						Progesterone Receptor Negative				Tissue Specimen	Validation	3	Stage II						Stage II			Alive at 1 Year		Alive at 3 Years					Alive at 5 Years						Alive at 5 Years										Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative				ERBB2/ER/PR Negative	18
MB.5441	90+ Years	90.08 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	4	Mild	Postmenopausal		4.07	291	Dead	1	Dead of Other Causes		0.797260274	0	0.797260274	0		0	3		0	0	1	0	0			Her2	MB-5441	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Dead of Other Causes at 1 Year	Dead at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.5442	40 - 49 Years	44.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.07	5194	Alive	0	Alive		14.23013699	0	10	0		1	4		0	0	0	1	0			Basal	MB-5442	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.5444	40 - 49 Years	49.58 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 1				Grade 1				1	7		Premenopausal		2.03	4588	Alive	0	Alive		12.56986301	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5444	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5446	50 - 59 Years	51.25 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	4	Mild	Postmenopausal		5.05	4885	Dead	1	Dead of Disease		13.38356164	1	10	0		1	4		0	0	0	1	0			Her2	MB-5446	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			25
MB.5447	60 - 69 Years	68.1 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	16	5	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	6		Postmenopausal		3.02	4466	Dead	1	Dead of Disease		12.23561644	1	10	0		0	1		1	0	0	0	0			Luminal B	MB-5447	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			12
MB.5450	30 - 39 Years	38.92 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Premenopausal		4.02	3708	Alive	0	Alive		10.15890411	0	10	0		0	5		0	0	0	0	1			Basal	MB-5450	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			12
MB.5451	40 - 49 Years	43.44 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Premenopausal		3.03	4923	Alive	0	Alive		13.48767123	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5451	Progesterone Receptor Positive				Progesterone Receptor Positive					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5453	30 - 39 Years	36.99 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	3	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	4		Premenopausal		5.06	1719	Dead	1	Dead of Disease		4.709589041	1	4.709589041	1		0	2		0	1	0	0	0			Normal	MB-5453	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5454	50 - 59 Years	55.57 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	10		Postmenopausal		6.06	1520	Dead	1	Dead of Disease		4.164383562	1	4.164383562	1		1	4		0	0	0	1	0			Luminal B	MB-5454	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5455	70 - 79 Years	73.24 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	4	Mild	Postmenopausal		4.02	1854	Dead	1	Dead of Other Causes		5.079452055	0	5.079452055	0		0	2		0	1	0	0	0			Luminal A	MB-5455	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			10
MB.5457	50 - 59 Years	52.57 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3				3.03	4828	Dead	1	Dead of Disease		13.22739726	1	10	0		0	2		0	1	0	0	0			Luminal A	MB-5457	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			16
MB.5458	50 - 59 Years	54.96 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	13	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	5		Postmenopausal		5.05	4891	Alive	0	Alive		13.4	0	10	0		1	4		0	0	0	1	0			Basal	MB-5458	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5459	60 - 69 Years	64.07 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	22	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				2	5		Postmenopausal		5.04	2724	Dead	1	Dead of Disease		7.463013699	1	7.463013699	1		0	1		1	0	0	0	0			Luminal B	MB-5459	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5460	50 - 59 Years	55.59 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	9		Postmenopausal		4.01	4490	Alive	0	Alive		12.30136986	0	10	0		0	1		1	0	0	0	0			Basal	MB-5460	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			5
MB.5463	70 - 79 Years	71.91 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	28	16		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive										2	9		Postmenopausal		3.1	1744	Dead	1	Dead of Other Causes		4.778082192	0	4.778082192	0		0	3		0	0	1	0	0			Luminal B	MB-5463	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	3	Stage II					Stage II				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Other Causes at 5 Years					Dead at 5 Years											Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		48
MB.5464	60 - 69 Years	65.58 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	4		Postmenopausal		2.04	3496	Dead	1	Dead of Other Causes		9.578082192	0	9.578082192	0		0	3		0	0	1	0	0			Luminal A	MB-5464	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			18
MB.5465	60 - 69 Years	69.83 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	11	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Postmenopausal		4.05	564	Dead	1	Dead of Disease		1.545205479	1	1.545205479	1		0	5		0	0	0	0	1			Basal	MB-5465	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			25
MB.5467	30 - 39 Years	36.01 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	7		Premenopausal		4.02	4895	Alive	0	Alive		13.4109589	0	10	0		0	3		0	0	1	0	0			Normal	MB-5467	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			10
MB.5468	40 - 49 Years	48.1 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	High	9	1		ERBB2 Positive						ERBB2 Positive		ERBB2 Positive		Estrogen Receptor Negative					Estrogen Receptor Negative		Estrogen Receptor Negative	ER-/HER2-	Grade 3								3	10		Premenopausal		5.05	2981	Alive	0	Alive		8.167123288	0	8.167123288	0		0	5		0	0	0	0	1			Basal	MB-5468	Progesterone Receptor Negative						Progesterone Receptor Negative			European	Tissue Specimen	Discovery	3	Stage 0						Stage 0			Alive at 1 Year		Alive at 3 Years					Alive at 5 Years						Alive at 5 Years			TP53 Wild Type					TP53 Wild Type		Chemotherapy, Radiotherapy	Other Biomarker Status				Other Biomarker Status	25
MB.5470	40 - 49 Years	48.07 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative	1	Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 1				Grade 1				1	9		Premenopausal		2	1262	Dead	1	Dead of Disease		3.457534247	1	3.457534247	1		0	1		1	0	0	0	0			Basal	MB-5470	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			
MB.5471	60 - 69 Years	67.54 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	3		Postmenopausal		4.03	4869	Alive	0	Alive		13.33972603	0	10	0		1	4		0	0	0	1	0			Luminal A	MB-5471	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			13
MB.5472	70 - 79 Years	74.78 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.05	587	Dead	1	Dead of Disease		1.608219178	1	1.608219178	1		0	1		1	0	0	0	0			Luminal A	MB-5472	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5473	70 - 79 Years	72.61 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	3		Postmenopausal		6.07	3777	Dead	1	Dead of Other Causes		10.34794521	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5473	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.5474	40 - 49 Years	46.26 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	15	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Premenopausal		5.07	5089	Alive	0	Alive		13.94246575	0	10	0		1	4		0	0	0	1	0			Her2	MB-5474	Progesterone Receptor Negative				Progesterone Receptor Negative					European/Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.5475	70 - 79 Years	73.55 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	2		Postmenopausal		4.05	76	Dead	1	Dead of Other Causes		0.208219178	0	0.208219178	0		0	1		1	0	0	0	0			Luminal B	MB-5475	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Dead of Other Causes at 1 Year	Dead at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			23
MB.5477	50 - 59 Years	59.02 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.07	3309	Alive	0	Alive		9.065753425	0	9.065753425	0		0	3		0	0	1	0	0			Luminal B	MB-5477	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.5478	70 - 79 Years	72.23 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	24	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	3		Postmenopausal		6.04	1029	Dead	1	Dead of Other Causes		2.819178082	0	2.819178082	0		0	1		1	0	0	0	0			Luminal A	MB-5478	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5481	50 - 59 Years	57.62 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	1	Invasive Ductal Breast Carcinoma									ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	6		Postmenopausal		5.06	1391	Dead	1	Dead of Disease		3.810958904	1	3.810958904	1		0	1		1	0	0	0	0			Luminal B	MB-5481	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5482	40 - 49 Years	40.75 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.03	530	Dead	1	Dead of Disease		1.452054795	1	1.452054795	1		0	5		0	0	0	0	1			Basal	MB-5482	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			16
MB.5483	40 - 49 Years	44.5 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 2				Grade 2				3	5		Premenopausal		5.05	1273	Dead	1	Dead of Disease		3.487671233	1	3.487671233	1		0	1		1	0	0	0	0			Her2	MB-5483	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5484	40 - 49 Years	47.3 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	17	0		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2			Grade 2					1	7		Premenopausal		3.04	4973	Alive	0	Alive		13.62465753	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5484	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	3	Stage 0			Stage 0						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years						TP53 Wild Type		TP53 Wild Type					Hormone Therapy, Radiotherapy	Other Biomarker Status					20
MB.5485	80 - 89 Years	80.08 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	9		Postmenopausal		5.06	954	Dead	1	Dead of Other Causes		2.61369863	0	2.61369863	0		0	3		0	0	1	0	0			Luminal B	MB-5485	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5486	70 - 79 Years	75.65 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	9		Postmenopausal		4.05	3699	Dead	1	Dead of Disease		10.13424658	1	10	0		0	1		1	0	0	0	0			Luminal B	MB-5486	Progesterone Receptor Positive				Progesterone Receptor Positive					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5489	50 - 59 Years	53.6 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.03	5296	Alive	0	Alive		14.50958904	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5489	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			15
MB.5490	60 - 69 Years	65.31 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.08	1536	Dead	1	Dead of Disease		4.208219178	1	4.208219178	1		0	1		1	0	0	0	0			Luminal A	MB-5490	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				No Treatment	Other Biomarker Status		Other Biomarker Status			40
MB.5491	70 - 79 Years	72.25 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate		0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	8		Postmenopausal		4.13	1975	Dead	1	Dead of Disease		5.410958904	1	5.410958904	1		0	3		0	0	1	0	0			Luminal B	MB-5491	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			65
MB.5492	70 - 79 Years	74.28 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	8	6		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 3					Grade 3			2	3		Postmenopausal		6.1	701	Dead	1	Dead of Disease		1.920547945	1	1.920547945	1		0	2		0	1	0	0	0			Luminal A	MB-5492	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	3										Alive at 1 Year		Dead of Disease at 3 Years			Dead at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		51
MB.5493	60 - 69 Years	69.84 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	2		Postmenopausal		4.1	1717	Dead	1	Dead of Disease		4.704109589	1	4.704109589	1		0	3		0	0	1	0	0			Luminal B	MB-5493	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			51
MB.5495	40 - 49 Years	42.64 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Mild	Premenopausal		3.04	4662	Alive	0	Alive		12.77260274	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5495	Progesterone Receptor Positive				Progesterone Receptor Positive					OddCluster	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.5497	60 - 69 Years	69.56 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	1		Postmenopausal		3.04	5187	Alive	0	Alive		14.2109589	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-5497	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5498	60 - 69 Years	64.1 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	HER2+	Grade 3				Grade 3				1	1		Postmenopausal		4.03	3001	Alive	0	Alive		8.221917808	0	8.221917808	0		1	4		0	0	0	1	0			Her2	MB-5498	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5499	60 - 69 Years	65.5 Years	Tubular Breast Carcinoma	Tubular Breast Carcinoma	Primary Site	Tubular Breast Carcinoma	High	18	0		ERBB2 Negative								ERBB2 Negative		Estrogen Receptor Positive						Estrogen Receptor Positive	Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 1							Grade 1	1	4	Mild	Postmenopausal		2.04	3712	Alive	0	Alive		10.16986301	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5499	Progesterone Receptor Positive								Progesterone Receptor Positive	European	Tissue Specimen	Discovery	3	Stage 0								Stage 0	Alive at 1 Year		Alive at 3 Years					Alive at 5 Years								Alive at 5 Years	TP53 Wild Type						TP53 Wild Type	No Treatment	Other Biomarker Status					20
MB.5502	50 - 59 Years	51.62 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	7		Premenopausal		3.06	1799	Alive	0	Alive		4.928767123	0	4.928767123	0		0	3		0	0	1	0	0			Luminal B	MB-5502	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years												TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.5505	70 - 79 Years	74.26 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.03	3583	Alive	0	Alive		9.816438356	0	9.816438356	0		0	3		0	0	1	0	0			Luminal B	MB-5505	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5510	70 - 79 Years	75.73 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				1	3		Postmenopausal		4.07	3093	Dead	1	Dead of Disease		8.473972603	1	8.473972603	1		0	1		1	0	0	0	0			Luminal A	MB-5510	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.5511	50 - 59 Years	54.18 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	10		Postmenopausal		4.04	4437	Alive	0	Alive		12.15616438	0	10	0		1	4		0	0	0	1	0			Her2	MB-5511	Progesterone Receptor Positive				Progesterone Receptor Positive					OddCluster	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				No Treatment	Other Biomarker Status		Other Biomarker Status			20
MB.5513	80 - 89 Years	86.55 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	14	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				2	6		Postmenopausal		5.06	1099	Dead	1	Dead of Disease		3.010958904	1	3.010958904	1		0	3		0	0	1	0	0			Basal	MB-5513	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			29
MB.5514	60 - 69 Years	63.45 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	4	Mild	Postmenopausal		4.04	4771	Alive	0	Alive		13.07123288	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5514	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5518	70 - 79 Years	72.39 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	4	Mild	Postmenopausal		5.04	926	Dead	1	Dead of Disease		2.536986301	1	2.536986301	1		0	1		1	0	0	0	0			Luminal B	MB-5518	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5519	70 - 79 Years	72.61 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.09	4816	Alive	0	Alive		13.19452055	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5519	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			45
MB.5520	30 - 39 Years	38.49 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	7		Premenopausal		6.05	489	Dead	1	Dead of Disease		1.339726027	1	1.339726027	1		0	2		0	1	0	0	0			Luminal A	MB-5520	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5521	60 - 69 Years	69.27 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	High	11	0		ERBB2 Negative						ERBB2 Negative		ERBB2 Negative		Estrogen Receptor Positive					Estrogen Receptor Positive		Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3								1	4	Severe	Postmenopausal		4.09	3744	Alive	0	Alive		10.25753425	0	10	0		1	4		0	0	0	1	0			Luminal B	MB-5521	Progesterone Receptor Negative						Progesterone Receptor Negative			European	Tissue Specimen	Discovery	3	Stage 0						Stage 0			Alive at 1 Year		Alive at 3 Years					Alive at 5 Years						Alive at 5 Years			TP53 Wild Type					TP53 Wild Type		Hormone Therapy, Radiotherapy	Other Biomarker Status				Other Biomarker Status	45
MB.5525	60 - 69 Years	63.2 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	7		Postmenopausal		4.06	60	Alive	0	Alive		0.164383562	0	0.164383562	0		0	3		0	0	1	0	0			Luminal B	MB-5525	Progesterone Receptor Negative				Progesterone Receptor Negative					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0																					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			28
MB.5526	40 - 49 Years	45.42 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	High	4	0		ERBB2 Negative						ERBB2 Negative		ERBB2 Negative		Estrogen Receptor Negative					Estrogen Receptor Negative		Estrogen Receptor Negative	ER-/HER2-	Grade 3								1	10		Premenopausal		4.04	4532	Alive	0	Alive		12.41643836	0	10	0		0	5		0	0	0	0	1			Basal	MB-5526	Progesterone Receptor Negative						Progesterone Receptor Negative			Asian	Tissue Specimen	Discovery	3	Stage 0						Stage 0			Alive at 1 Year		Alive at 3 Years					Alive at 5 Years						Alive at 5 Years			TP53 Mutation	TP53 Missense Mutation				TP53 Mutation		Radiotherapy	ERBB2/ER/PR Negative				ERBB2/ER/PR Negative	20
MB.5527	50 - 59 Years	53.48 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		13	8	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 2				Grade 2				3	4		Postmenopausal		5.02	4312	Alive	0	Alive		11.81369863	0	10	0		1	4		0	0	0	1	0			Her2	MB-5527	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			11
MB.5529	40 - 49 Years	40.21 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		5.07	444	Dead	1	Dead of Disease		1.216438356	1	1.216438356	1		0	5		0	0	0	0	1			Basal	MB-5529	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			35
MB.5530	50 - 59 Years	50.61 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	17	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				2	7		Postmenopausal		5.05	4035	Alive	0	Alive		11.05479452	0	10	0		0	1		1	0	0	0	0			Basal	MB-5530	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5531	60 - 69 Years	66.56 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 2				Grade 2				1	10		Postmenopausal		3.03	4820	Alive	0	Alive		13.20547945	0	10	0		0	5		0	0	0	0	1			Basal	MB-5531	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			15
MB.5532	60 - 69 Years	69.66 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	7		Postmenopausal		4.06	2396	Dead	1	Dead of Disease		6.564383562	1	6.564383562	1		0	1		1	0	0	0	0			Luminal A	MB-5532	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.5533	70 - 79 Years	71.64 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	4	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				2	1		Postmenopausal		5.04	4741	Alive	0	Alive		12.9890411	0	10	0		0	2		0	1	0	0	0			Normal	MB-5533	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5534	80 - 89 Years	80.09 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER-/HER2-	Grade 2				Grade 2				2	4	Severe	Postmenopausal		5.05	2373	Dead	1	Dead of Disease		6.501369863	1	6.501369863	1		0	1		1	0	0	0	0			Luminal B	MB-5534	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5535	40 - 49 Years	49.87 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	HER2+	Grade 3				Grade 3				3	5		Premenopausal		6.04	3604	Dead	1	Dead of Disease		9.873972603	1	9.873972603	1		1	4		0	0	0	1	0			Her2	MB-5535	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.5540	70 - 79 Years	76.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	4	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	1		Postmenopausal		6.04	1453	Dead	1	Dead of Disease		3.980821918	1	3.980821918	1		0	1		1	0	0	0	0			Luminal B	MB-5540	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.5541	60 - 69 Years	60.13 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.04	4989	Alive	0	Alive		13.66849315	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5541	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5543	70 - 79 Years	79.11 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	3		Postmenopausal		4.08	1033	Dead	1	Dead of Other Causes		2.830136986	0	2.830136986	0		0	1		1	0	0	0	0			Luminal A	MB-5543	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.5546	40 - 49 Years	40.96 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma		20	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive		Grade 2						Grade 2		1	7		Premenopausal		3.01	5036	Alive	0	Alive		13.79726027	0	10	0		0	3		0	0	1	0	0			Normal	MB-5546	Progesterone Receptor Positive							Progesterone Receptor Positive			Tissue Specimen	Validation	3	Stage I							Stage I		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years									No Treatment	Other Biomarker Status					5
MB.5547	40 - 49 Years	43.08 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	10		Premenopausal		5.06	2957	Alive	0	Alive		8.101369863	0	8.101369863	0		0	5		0	0	0	0	1			Basal	MB-5547	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			30
MB.5548	60 - 69 Years	62.43 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	26	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	10		Postmenopausal		4.1	760	Alive	0	Alive		2.082191781	0	2.082191781	0		0	5		0	0	0	0	1			Basal	MB-5548	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year															TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			50
MB.5549	50 - 59 Years	54.83 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 2				Grade 2				3	1		Postmenopausal		4.04	2668	Dead	1	Dead of Disease		7.309589041	1	7.309589041	1		1	4		0	0	0	1	0			Her2	MB-5549	Progesterone Receptor Negative				Progesterone Receptor Negative					OddCluster	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5550	80 - 89 Years	84.3 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	7	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.05	771	Alive	0	Alive		2.112328767	0	2.112328767	0		0	3		0	0	1	0	0			Luminal A	MB-5550	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year															TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			26
MB.5551	60 - 69 Years	67.24 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	10		Postmenopausal		4.05	3542	Alive	0	Alive		9.704109589	0	9.704109589	0		0	5		0	0	0	0	1			Basal	MB-5551	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			27
MB.5552	60 - 69 Years	69.77 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	6		Postmenopausal		2.08	1041	Dead	1	Dead of Disease		2.852054795	1	2.852054795	1		1	4		0	0	0	1	0			Luminal B	MB-5552	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			40
MB.5554	50 - 59 Years	57.75 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Moderate	14	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 1					Grade 1			1	2		Postmenopausal		2.05	4773	Alive	0	Alive		13.07671233	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5554	Progesterone Receptor Positive					Progesterone Receptor Positive				European	Tissue Specimen	Discovery	3	Stage 0					Stage 0				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years				TP53 Wild Type				TP53 Wild Type			Hormone Therapy, Radiotherapy	Other Biomarker Status			Other Biomarker Status		26
MB.5556	50 - 59 Years	53.56 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	1		Postmenopausal		4.04	4405	Alive	0	Alive		12.06849315	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5556	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5558	30 - 39 Years	35.13 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	10	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	5		Premenopausal		5.15	751	Alive	0	Alive		2.057534247	0	2.057534247	0		0	2		0	1	0	0	0			Basal	MB-5558	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year																						Chemotherapy	Other Biomarker Status		Other Biomarker Status			75
MB.5559	40 - 49 Years	42.12 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	14	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive		Grade 3				Grade 3				3	10		Premenopausal		5.1	565	Dead	1	Dead of Disease		1.547945205	1	1.547945205	1		0	5		0	0	0	0	1			Basal	MB-5559	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			48
MB.5560	40 - 49 Years	44.05 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 2				Grade 2				1	10		Premenopausal		3.03	4802	Alive	0	Alive		13.15616438	0	10	0		0	5		0	0	0	0	1			Basal	MB-5560	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			15
MB.5562	70 - 79 Years	73.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	2		Postmenopausal		3.03	3089	Dead	1	Dead of Other Causes		8.463013699	0	8.463013699	0		0	3		0	0	1	0	0			Luminal B	MB-5562	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5563	70 - 79 Years	76.3 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	11	0		ERBB2 Positive					ERBB2 Positive			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 2					Grade 2			1	3		Postmenopausal		3.03	3530	Dead	1	Dead of Other Causes		9.671232877	0	9.671232877	0		0	1		1	0	0	0	0			Luminal A	MB-5563	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	3	Stage I					Stage I				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Alive at 5 Years					Alive at 5 Years											No Treatment	Other Biomarker Status			Other Biomarker Status		15
MB.5565	60 - 69 Years	64.27 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma	High	11	2		ERBB2 Negative						ERBB2 Negative		ERBB2 Negative		Estrogen Receptor Negative					Estrogen Receptor Negative		Estrogen Receptor Negative	ER-/HER2-	Grade 3								3	10		Postmenopausal		5.06	3461	Alive	0	Alive		9.482191781	0	9.482191781	0		0	5		0	0	0	0	1			Basal	MB-5565	Progesterone Receptor Positive						Progesterone Receptor Positive			European	Tissue Specimen	Discovery	3	Stage 0						Stage 0			Alive at 1 Year		Alive at 3 Years					Alive at 5 Years						Alive at 5 Years			TP53 Wild Type					TP53 Wild Type		Chemotherapy, Hormone Therapy, Radiotherapy	Other Biomarker Status				Other Biomarker Status	30
MB.5566	30 - 39 Years	38.44 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	28	14	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	10		Premenopausal		6.06	4737	Alive	0	Alive		12.97808219	0	10	0		0	5		0	0	0	0	1			Basal	MB-5566	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			32
MB.5567	70 - 79 Years	74.95 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.04	232	Alive	0	Alive		0.635616438	0	0.635616438	0		0	1		1	0	0	0	0			Luminal A	MB-5567	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0																												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5571	70 - 79 Years	78.84 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	High	8	1		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2			Grade 2					2	7		Postmenopausal		4.05	4616	Dead	1	Dead of Disease		12.64657534	1	10	0		0	1		1	0	0	0	0			Luminal A	MB-5571	Progesterone Receptor Positive			Progesterone Receptor Positive						European	Tissue Specimen	Discovery	3	Stage 0			Stage 0						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years						TP53 Mutation	TP53 Frameshift Mutation	TP53 Mutation					Hormone Therapy	Other Biomarker Status					25
MB.5572	40 - 49 Years	47.88 Years	Medullary Breast Carcinoma	Medullary Breast Carcinoma	Primary Site	Medullary Breast Carcinoma		10	0		ERBB2 Negative						ERBB2 Negative		ERBB2 Negative		Estrogen Receptor Negative					Estrogen Receptor Negative		Estrogen Receptor Negative		Grade 3								1	10		Premenopausal		4.03	4697	Alive	0	Alive		12.86849315	0	10	0		0	5		0	0	0	0	1			Basal	MB-5572	Progesterone Receptor Negative						Progesterone Receptor Negative				Tissue Specimen	Validation	3	Stage I						Stage I			Alive at 1 Year		Alive at 3 Years					Alive at 5 Years						Alive at 5 Years										Radiotherapy	ERBB2/ER/PR Negative				ERBB2/ER/PR Negative	15
MB.5575	50 - 59 Years	52.63 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	1		Postmenopausal		3.04	3530	Dead	1	Dead of Other Causes		9.671232877	0	9.671232877	0		0	1		1	0	0	0	0			Luminal B	MB-5575	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5576	60 - 69 Years	67.79 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	1		Postmenopausal		4.04	4767	Alive	0	Alive		13.06027397	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-5576	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5577	60 - 69 Years	68.64 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	High	21	8		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Negative		Grade 3					Grade 3			2	3		Postmenopausal		6.12	1662	Dead	1	Dead of Disease		4.553424658	1	4.553424658	1		1	4		0	0	0	1	0			Her2	MB-5577	Progesterone Receptor Negative					Progesterone Receptor Negative					Tissue Specimen	Validation	3	Stage III					Stage III				Alive at 1 Year		Alive at 3 Years			Alive at 3 Years		Dead of Disease at 5 Years					Dead at 5 Years											Hormone Therapy	Other Biomarker Status			Other Biomarker Status		60
MB.5579	60 - 69 Years	68.82 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	11	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 3				Grade 3				2	2		Postmenopausal		6.06	2707	Dead	1	Dead of Disease		7.416438356	1	7.416438356	1		0	1		1	0	0	0	0			Luminal A	MB-5579	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5580	70 - 79 Years	75.28 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	17	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.05	2149	Dead	1	Dead of Other Causes		5.887671233	0	5.887671233	0		0	3		0	0	1	0	0			Luminal A	MB-5580	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5582	40 - 49 Years	46.43 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	3		Premenopausal		3.02	4056	Alive	0	Alive		11.11232877	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5582	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			10
MB.5583	50 - 59 Years	50.75 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	7		Premenopausal		3.03	3341	Alive	0	Alive		9.153424658	0	9.153424658	0		0	1		1	0	0	0	0			Luminal A	MB-5583	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Radiotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.5584	60 - 69 Years	69.55 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	1		Postmenopausal		4.04	2733	Dead	1	Dead of Other Causes		7.487671233	0	7.487671233	0		1	4		0	0	0	1	0			Her2	MB-5584	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.5585	70 - 79 Years	75.88 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma		10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	8		Postmenopausal		3.07	1617	Dead	1	Dead of Disease		4.430136986	1	4.430136986	1		1	4		0	0	0	1	0			Luminal A	MB-5585	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			35
MB.5588	60 - 69 Years	66.55 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	12	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				2	4		Postmenopausal		5.04	2434	Dead	1	Dead of Disease		6.668493151	1	6.668493151	1		1	4		0	0	0	1	0			Normal	MB-5588	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			18
MB.5589	70 - 79 Years	70.86 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	8		Postmenopausal		3.04	4807	Alive	0	Alive		13.16986301	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5589	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5590	60 - 69 Years	64.93 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	4	Mild	Postmenopausal		4.05	535	Alive	0	Alive		1.465753425	0	1.465753425	0		0	3		0	0	1	0	0			Luminal B	MB-5590	Progesterone Receptor Positive				Progesterone Receptor Positive					OddCluster	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year															TP53 Mutation	TP53 Missense Mutation		TP53 Mutation				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			26
MB.5592	60 - 69 Years	66.01 Years	Lobular Breast Carcinoma	Invasive Lobular Breast Carcinoma	Primary Site	Invasive Lobular Breast Carcinoma	Low	11	0		ERBB2 Negative					ERBB2 Negative			ERBB2 Negative		Estrogen Receptor Positive				Estrogen Receptor Positive			Estrogen Receptor Positive		Grade 2					Grade 2			1	8		Postmenopausal		3.04	790	Dead	1	Dead of Other Causes		2.164383562	0	2.164383562	0		0	1		1	0	0	0	0			Luminal B	MB-5592	Progesterone Receptor Positive					Progesterone Receptor Positive					Tissue Specimen	Validation	3										Alive at 1 Year		Dead of Other Causes at 3 Years			Dead at 3 Years		Dead of Other Causes at 5 Years					Dead at 5 Years											Radiotherapy	Other Biomarker Status			Other Biomarker Status		20
MB.5593	40 - 49 Years	40.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	17	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	5		Premenopausal		5.07	2775	Dead	1	Dead of Disease		7.602739726	1	7.602739726	1		1	4		0	0	0	1	0			Her2	MB-5593	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Chemotherapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.5596	50 - 59 Years	54.27 Years	Mixed Lobular and Ductal Breast Carcinoma	Invasive Ductal and Invasive Lobular Breast Carcinoma	Primary Site	Invasive Ductal and Invasive Lobular Breast Carcinoma	Moderate	25	4		ERBB2 Negative			ERBB2 Negative					ERBB2 Negative		Estrogen Receptor Positive		Estrogen Receptor Positive					Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2			Grade 2					2	3		Premenopausal		5.06	4912	Alive	0	Alive		13.45753425	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5596	Progesterone Receptor Positive			Progesterone Receptor Positive						Asian	Tissue Specimen	Discovery	3	Stage 0			Stage 0						Alive at 1 Year		Alive at 3 Years	Alive at 3 Years				Alive at 5 Years			Alive at 5 Years													Hormone Therapy	Other Biomarker Status					30
MB.5597	70 - 79 Years	75.38 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	1	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	3		Postmenopausal		4.06	982	Dead	1	Dead of Other Causes		2.690410959	0	2.690410959	0		0	1		1	0	0	0	0			Luminal A	MB-5597	Progesterone Receptor Positive				Progesterone Receptor Positive					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.5599	60 - 69 Years	62.88 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	7		Postmenopausal		4.04	4521	Alive	0	Alive		12.38630137	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5599	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5601	60 - 69 Years	61.73 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	3	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	3		Postmenopausal		4.03	4215	Alive	0	Alive		11.54794521	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5601	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			16
MB.5602	30 - 39 Years	39.7 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	11	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		6.08	4669	Alive	0	Alive		12.79178082	0	10	0		1	4		0	0	0	1	0			Basal	MB-5602	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			40
MB.5603	70 - 79 Years	70.79 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	15	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	2		Postmenopausal		4.04	3663	Alive	0	Alive		10.03561644	0	10	0		0	2		0	1	0	0	0			Luminal A	MB-5603	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5604	60 - 69 Years	66.88 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	7	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	1		Postmenopausal		4.05	4369	Alive	0	Alive		11.96986301	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5604	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5605	40 - 49 Years	40.37 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	23	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	3		Premenopausal		3.05	3711	Alive	0	Alive		10.16712329	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-5605	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			25
MB.5613	80 - 89 Years	80.21 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	8	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	10		Postmenopausal		4.1	4267	Alive	0	Alive		11.69041096	0	10	0		1	4		0	0	0	1	0			Luminal B	MB-5613	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			50
MB.5614	60 - 69 Years	62.87 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	8	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	9		Postmenopausal		4.03	3493	Dead	1	Dead of Disease		9.569863014	1	9.569863014	1		0	2		0	1	0	0	0			Luminal A	MB-5614	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Radiotherapy	Other Biomarker Status		Other Biomarker Status			17
MB.5616	40 - 49 Years	41.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	16	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	10		Premenopausal		6.04	4778	Alive	0	Alive		13.09041096	0	10	0		0	5		0	0	0	0	1			Basal	MB-5616	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			20
MB.5617	80 - 89 Years	81.63 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	4	Mild	Postmenopausal		4.06	3846	Dead	1	Dead of Other Causes		10.5369863	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5617	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			32
MB.5620	70 - 79 Years	79.42 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				2	8		Postmenopausal		4.06	1262	Dead	1	Dead of Disease		3.457534247	1	3.457534247	1		0	3		0	0	1	0	0			Luminal A	MB-5620	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			31
MB.5622	60 - 69 Years	62.89 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	1		Postmenopausal		4.05	1911	Alive	0	Alive		5.235616438	0	5.235616438	0		0	1		1	0	0	0	0			Luminal B	MB-5622	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			23
MB.5623	40 - 49 Years	44.99 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	3		Premenopausal		3.04	4134	Dead	1	Dead of Other Causes		11.3260274	0	10	0		0	1		1	0	0	0	0			Luminal B	MB-5623	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			20
MB.5625	40 - 49 Years	45.51 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	21	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	9		Premenopausal		5.08	969	Dead	1	Dead of Disease		2.654794521	1	2.654794521	1		0	5		0	0	0	0	1			Basal	MB-5625	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Mutation	TP53 Truncating Mutation		TP53 Mutation				Chemotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			40
MB.5626	70 - 79 Years	73.75 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	17	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		5.04	2489	Alive	0	Alive		6.819178082	0	6.819178082	0		0	1		1	0	0	0	0			Luminal A	MB-5626	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5628	60 - 69 Years	65.06 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	14	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Positive		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				2	5		Postmenopausal		6	1278	Dead	1	Dead of Disease		3.501369863	1	3.501369863	1		0	3		0	0	1	0	0			Luminal B	MB-5628	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			
MB.5629	70 - 79 Years	71.36 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	10	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	3		Postmenopausal		3.06	3114	Dead	1	Dead of Other Causes		8.531506849	0	8.531506849	0		0	1		1	0	0	0	0			Luminal A	MB-5629	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5632	70 - 79 Years	78.55 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	5	4	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	9		Postmenopausal		5.07	1145	Dead	1	Dead of Disease		3.136986301	1	3.136986301	1		0	1		1	0	0	0	0			Luminal B	MB-5632	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.5633	60 - 69 Years	62.7 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	9	7	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				3	4		Postmenopausal		6.06	1051	Dead	1	Dead of Disease		2.879452055	1	2.879452055	1		1	4		0	0	0	1	0			Basal	MB-5633	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage III				Stage III					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			30
MB.5634	50 - 59 Years	55.53 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				1	10		Postmenopausal		4.06	1887	Dead	1	Dead of Disease		5.169863014	1	5.169863014	1		0	5		0	0	0	0	1			Basal	MB-5634	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			30
MB.5635	50 - 59 Years	57.2 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	13	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	4	Mild	Postmenopausal		3.03	632	Dead	1	Dead of Disease		1.731506849	1	1.731506849	1		0	1		1	0	0	0	0			Luminal A	MB-5635	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5636	60 - 69 Years	68.49 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	2	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive										2	9		Postmenopausal		2.06	3249	Dead	1	Dead of Other Causes		8.901369863	0	8.901369863	0		0	3		0	0	1	0	0			Luminal B	MB-5636	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3										Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	Other Biomarker Status		Other Biomarker Status			30
MB.5638	60 - 69 Years	65.14 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.04	4551	Alive	0	Alive		12.46849315	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5638	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5640	50 - 59 Years	58 Years	Mucinous Breast Carcinoma	Mucinous Breast Carcinoma	Primary Site	Mucinous Breast Carcinoma	Low	15	0		ERBB2 Negative							ERBB2 Negative	ERBB2 Negative		Estrogen Receptor Positive							Estrogen Receptor Positive		Grade 2						Grade 2		1	4		Postmenopausal		3	4006	Alive	0	Alive		10.97534247	0	10	0		0	3		0	0	1	0	0			Normal	MB-5640	Progesterone Receptor Positive							Progesterone Receptor Positive			Tissue Specimen	Validation	3	Stage I							Stage I		Alive at 1 Year		Alive at 3 Years				Alive at 3 Years	Alive at 5 Years							Alive at 5 Years									No Treatment	Other Biomarker Status					1
MB.5641	70 - 79 Years	78.64 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 3				Grade 3				1	2		Postmenopausal		4.04	3625	Alive	0	Alive		9.931506849	0	9.931506849	0		0	1		1	0	0	0	0			Luminal B	MB-5641	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			22
MB.5642	60 - 69 Years	68.13 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	8	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				2	4	Mild	Postmenopausal		4.07	4213	Alive	0	Alive		11.54246575	0	10	0		0	1		1	0	0	0	0			Luminal A	MB-5642	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			34
MB.5645	70 - 79 Years	71.31 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	6	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- Low Proliferation	Grade 2				Grade 2				1	7		Postmenopausal		3.04	667	Dead	1	Dead of Other Causes		1.82739726	0	1.82739726	0		0	3		0	0	1	0	0			Luminal A	MB-5645	Progesterone Receptor Positive				Progesterone Receptor Positive					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			20
MB.5646	50 - 59 Years	58.4 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	14	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	1		Postmenopausal		4.06	4522	Alive	0	Alive		12.3890411	0	10	0		0	3		0	0	1	0	0			Luminal B	MB-5646	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			30
MB.5647	60 - 69 Years	65.43 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	48	4	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				2	6		Postmenopausal		6.07	924	Dead	1	Dead of Other Causes		2.531506849	0	2.531506849	0		0	1		1	0	0	0	0			Luminal A	MB-5647	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Other Causes at 3 Years		Dead at 3 Years			Dead of Other Causes at 5 Years				Dead at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			35
MB.5648	70 - 79 Years	74.92 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	8	2	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				2	8		Postmenopausal		4.08	4152	Alive	0	Alive		11.37534247	0	10	0		0	3		0	0	1	0	0			Luminal A	MB-5648	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			40
MB.5651	50 - 59 Years	51.98 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	3	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative	ER-/HER2-	Grade 3				Grade 3				3	3		Postmenopausal		5.05	630	Dead	1	Dead of Disease		1.726027397	1	1.726027397	1		0	2		0	1	0	0	0			Basal	MB-5651	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Dead of Disease at 3 Years		Dead at 3 Years			Dead of Disease at 5 Years				Dead at 5 Years												Chemotherapy, Hormone Therapy, Radiotherapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			26
MB.5652	60 - 69 Years	68.75 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Moderate	5	0	Invasive Ductal Breast Carcinoma	ERBB2 Positive				ERBB2 Positive				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Positive		Grade 3				Grade 3				1	4		Postmenopausal		4.03	3140	Dead	1	Dead of Other Causes		8.602739726	0	8.602739726	0		0	5		0	0	0	0	1			Normal	MB-5652	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy, Radiotherapy	Other Biomarker Status		Other Biomarker Status			15
MB.5653	60 - 69 Years	60.72 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	12	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 3				Grade 3				1	9		Postmenopausal		4.05	4263	Alive	0	Alive		11.67945205	0	10	0		1	4		0	0	0	1	0			Luminal B	MB-5653	Progesterone Receptor Negative				Progesterone Receptor Negative					European	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			25
MB.5654	80 - 89 Years	82.94 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	9	1	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive	ER+/HER2- High Proliferation	Grade 2				Grade 2				2	8		Postmenopausal		4.11	1915	Alive	0	Alive		5.246575342	0	5.246575342	0		0	1		1	0	0	0	0			Luminal B	MB-5654	Progesterone Receptor Positive				Progesterone Receptor Positive					Asian	Tissue Specimen	Discovery	3	Stage 0				Stage 0					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years					TP53 Wild Type			TP53 Wild Type				Hormone Therapy	Other Biomarker Status		Other Biomarker Status			55
MB.5655	60 - 69 Years	67.57 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	High	4	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Negative			Estrogen Receptor Negative				Estrogen Receptor Negative		Grade 3				Grade 3				1	10		Postmenopausal		4.05	4524	Alive	0	Alive		12.39452055	0	10	0		0	5		0	0	0	0	1			Basal	MB-5655	Progesterone Receptor Negative				Progesterone Receptor Negative						Tissue Specimen	Validation	3	Stage II				Stage II					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												Hormone Therapy	ERBB2/ER/PR Negative		ERBB2/ER/PR Negative			25
MB.5656	70 - 79 Years	74.76 Years	Ductal Breast Carcinoma	Invasive Ductal Breast Carcinoma	Primary Site	Invasive Ductal Breast Carcinoma	Low	16	0	Invasive Ductal Breast Carcinoma	ERBB2 Negative				ERBB2 Negative				ERBB2 Negative		Estrogen Receptor Positive			Estrogen Receptor Positive				Estrogen Receptor Positive		Grade 2				Grade 2				1	3		Postmenopausal		3.03	3792	Dead	1	Dead of Other Causes		10.3890411	0	10	0		0	2		0	1	0	0	0			Normal	MB-5656	Progesterone Receptor Positive				Progesterone Receptor Positive						Tissue Specimen	Validation	3	Stage I				Stage I					Alive at 1 Year	Alive at 1 Year	Alive at 3 Years		Alive at 3 Years			Alive at 5 Years				Alive at 5 Years												No Treatment	Other Biomarker Status		Other Biomarker Status			16
